²é¿´ÍêÕû°æ±¾: [-- ʲôÊÇSCIÆÚ¿¯ --]

¿¼²©ÂÛ̳ -> SCI -> ʲôÊÇSCIÆÚ¿¯ [´òÓ¡±¾Ò³] µÇ¼ -> ×¢²á -> »Ø¸´Ö÷Ìâ -> ·¢±íÖ÷Ìâ

kaobook 2011-08-17 22:27

ʲôÊÇSCIÆÚ¿¯

µÚÒ»Õ ʲôÊÇSCIÆÚ¿¯ }{Y)[w#R  
1£®SCI oiP 8~  
SCIÊÇÃÀ¹úEugene Garfield´´½¨µÄ¿ÆÑ§Ç鱨Ñо¿Ëù£¨Institute for Scientific Information,ISI£©ÓÚ1960Äê±à¼­³ö°æµÄ¿ÆÑ§ÒýÎÄË÷ÒýÊý¾Ý¿â¡£1992Ä꣬ISI¹éÊôÓÚThomson Scientific and Healthcare,²¢¸ÄΪThomson ISI£¬ÏÖÊôÓÚÌÀÄ·É­¹«Ë¾£¨The Thomson Corporation£©µÄÌÀÄ·É­¿Æ¼¼ÐÅÏ¢¼¯ÍÅ£¨Thomson Scientific£©ÆìÏ¡£ÏêÇé¿É¼û¸Ã¼¯ÍÅÍøÕ¾£ºhttp://scientific.thomson.com. SCIÓбðÓÚ¡¶»¯Ñ§ÎÄÕª¡·£¨Chemical Abstract,CA£©¡¢¡¶ÉúÎïѧÎÄÕª¡·£¨Biological Abstract,BA£©¡¢¡¶¹¤³ÌË÷Òý¡·£¨Engineering Index,EI£©¡¢¡¶¿ÆÑ§ÎÄÕª¡·£¨Scientific Abstract,SA£©¡£Í¨¹ý¼ìË÷SCI¾Í¿ÉÒÔ»ñµÃÒÔÏÂÐÅÏ¢£º K9v@L6pY=  
£¨1£©Ïà¹ØÂÛÎÄÊÇ·ñ±»ÒýÓùý£¿ @WIcH:_w-  
£¨2£©ÂÛÎĵÄÖ÷ÒªÄÚÈÝÊÇʲô£¿ Do@ :|n  
£¨3£©Ïà¹Ø¿ÎÌâµÄ×ÛÊöÒÔ¼°×îнøÕ¹ºÍÑÓÉ죿 +QNFu){G  
£¨4£©Ä³Ò»ÀíÂÛÓÐûÓеõ½½øÒ»²½µÄ֤ʵ£¿  |*079v  
£¨5£©Ä³·½·¨ÓÐûÓеõ½¸Ä½ø£¿ h>v;1Q O9D  
£¨6£©Ä³¸ÅÄîÊÇʲô£¿ÓÉË­Ìá³öÀ´µÄ£¿ @fR^":.h  
£¨7£©Ä³ÎÊÌâÓÐûÓнøÒ»²½¿±ÎóºÍÐÞÕý£¿ j?Ki<MD1  
£¨8£©»¹ÓÐË­ÔÚ´ÓÊÂÕâ·½ÃæµÄÑо¿£¿ mG[S"?C  
£¨9£©Ä³Ñо¿»ú¹¹»òÕß´óѧ×î½ü·¢±íÁËÄÄЩÎÄÕ£¿ d # :&Uw  
£¨10£©Ä³ÀíÂÛ»ò¸ÅÄîÓÐûÓÐÓ¦Óõ½ÐµÄÁìÓòÖÐÈ¥£¿ $ JI`&  
£¨11£©Ïà¹ØÑо¿ÈËÔ±·¢±í¹ýÄÄЩÂÛÎÄ£¿ 9tmYrhb$  
SCIµÄ¼Ç¼°üÀ¨ÂÛÎÄÓëÒýÎÄ£¬ÆäÒýÎļǼËùÉæ¼°µÄ·¶Î§Ê®·Ö¹ã·º£¬°üÀ¨Êé¼®£¬ÆÚ¿¯ÂÛÎÄ£¬»áÒéÂÛÎÄ£¬×¨ÀûºÍÆäËû¸÷ÖÖÀàÐ͵ÄÎÄÏס£Ëùº­¸ÇµÄѧ¿Æ³¬¹ý100¸ö£¬ËüÊÕ¼ȫÊÀ½ç³ö°æµÄÊýѧ£¬ÎïÀí£¬»¯Ñ§£¬Å©Òµ£¬ÁÖÒµ£¬Ò½Ñ§£¬ÉúÎ»·¾³£¬²ÄÁÏ£¬¹¤³Ì¼¼Êõ£¬ÐÐΪ¿ÆÑ§µÈ×ÔÈ»¿ÆÑ§ÁìÓòµÄºËÐÄÆÚ¿¯¡£¾­¹ý40¶àÄêµÄ·¢Õ¹ÍêÉÆ£¬ÒÑ´Ó¿ªÊ¼Ê±µÄµ¥Ò»Ó¡Ë¢ÐÍ·¢Õ¹³ÉΪ¹¦ÄÜÇ¿´óµÄµç×Ó»¯£¬¼¯³É»¯£¬ÍøÂ绯µÄ´óÐͶàѧ¿Æ£¬×ÛºÏÐÔ¼ìË÷ϵͳ¡£ $"[1yQ<p  
SCI¸ù¾ÝÆÚ¿¯À´Ô´ÖÖÀà»®·ÖΪSCIºÍSCI-E¡£Web of ScientificµÄÍøÕ¾Îªhttp://scientific.thomson.com/products/wos/¡£ j`I[M6Qxh  
2.Ñ¡¿¯¹ý³Ì  (A 2x  
£¨1£©Ñ¡¿¯ eUvIO+av  
ISIÿÖÜ´ÓÊý¾Ý¿âÖÐÔö¼Ó»òɾ³ýÆÚ¿¯£¬Ã¿ÄêISI±à¼­²¿ÆÀÉó½ü2000ÖÖÐÂÆÚ¿¯¡£±»ÆÀÉóµÄÆÚ¿¯Ö»ÓÐ10%----12%±»Ñ¡Óã¬ÍË»ØÂÊ´ï88%¡£´ËÍ⣬ÿÄêÉÐÓÐ150--200ÖÖÒѽøÈëµÄÆÚ¿¯±»ÖÐ;ÌÔÌ­£¬ISIÊý¾Ý¿âµÄÏÖÓÐÆÚ¿¯Ò²ÔÚ²»¶Ïɸѡ¸üС£ 5T,Doxo  
¼ÆÁ¿Ö¸±ê¸ù¾ÝÖÊÁ¿ÓëÊýÁ¿ÅÅÁУ¬·Ö±ð°üÀ¨ÆÚ¿¯µÄ¸²¸ÇÂÊ¡¢ÆÚ¿¯µÄ»ù±¾³ö°æ±ê×¼¡¢Ñ§ÊõÄÚÈÝ¡¢ÆÚ¿¯×÷ÕߵĹú¼Ê»¯³Ì¶ÈÒÔ¼°Éæ¼°µÄÒýÎÄÊý¾Ý¡£ c;_GZ}8  
£¨2£©ÌÔÌ­ Ju$=Tn  
ISI¶Ôÿһѧ¿ÆµÄÆÀÉóÁ½Äê½øÐÐÒ»´Î¡£ISI»áÁªÂç³ö°æÈ˼ì²éÆÚ¿¯µÄ³ö°æÇé¿ö¡£Ä³Ð©ÆÚ¿¯µÄ¶ÁÕßȺ»áÒòΪ³ö°æÊ±¼ä²»¼°Ê±¶ø²»ÔÙÒýÓøÿ¯£¬Ê¹Ó°ÏìÒò×Ó½µµÍ¡£±»ÌÔÌ­ÆÚ¿¯ÉêÇ븴ÒéÒ»°ãÔÚÆÀÉóºó12----18Öܺ󱻿¼ÂÇ£¬´Ó±»ÌÔÌ­ÆÚ¿¯ÖÐÖØÐÂɸѡ³öSCIÆÚ¿¯»¹ÐèÒª3Äêʱ¼ä¡£ Q\G8R^9j p  
£¨3£©ÒýÎÄ·ÖÎö }J .f 5WaG  
ISIʹÓõļ¸ÖÖÒýÎÄ×ÊÁÏ£¬°üÀ¨ÒýÎÄÂÊ¡¢Ó°ÏìÒò×Ó¡¢¼°Ê±Ö¸±ê¡£¶ÔÐÂÆÚ¿¯ISIÒª¼ìË÷ÆÚ¿¯×÷ÕßÓë±àί»á³ÉÔ±µÄ³ö°æ¼Ç¼¡£ISIÕªÒýµÄÎÄÏ×À´×Ô8000ÖÖºËÐÄÆÚ¿¯£¬×î¾ßÓдú±íÐÔ¡£ DX.u"&Mm  
£¨4£©ÏÖ¿¯Ä¿Â¼ 9_'xq.uP  
¸ÃÊý¾Ý¿âÆÀÑ¡±ê×¼ÓëÒýÎÄË÷ÒýÏàËÆ£¬ÒýÎÄÁ¿±ÈSCIÉÙ£¬µ«Æä¸²¸ÇÂÊÏ൱¿É¹Û¡£ 3 #R~>c2  
£¨5£©µç×Ó°æÆÚ¿¯ \7Hzj0hSi  
1994Äê7ÔÂISIÑ¡ÓÃÁ˵ÚÒ»·Ýµç×ÓÆÚ¿¯£¨The Online Journal of Knowledge Synthesis for Nursing£©¡£1998Äê4ÔÂISIÑ¡ÓÃÁË17ÖÖµç×ÓÆÚ¿¯×÷ΪÆÚ¿¯Ô´¡£´«Í³ÆÚ¿¯ÖÐÊ®·ÖÖØÒªµÄÐÅÏ¢£¬ÈçѧÊõÄÚÈÝ¡¢±àÅŸñʽ¡¢»ù½ð×ÊÖú¡¢Éó¸å»úÖÆ¡¢±à¼­²¿Óë×÷ÕßµÄÏêϸÐÅÏ¢¡¢¹ú¼Ê»¯Ç÷ÊÆµÈ£¬ÔÚµç×ÓÆÚ¿¯ÖÐͬÑùÖØÒª¡£ quc?]rb  
3.ÈçºÎÍÆ¼öÆÚ¿¯ÆÀÉó½ü 3F 2> &p|7  
ISI¾­³£½øÐÐÓû§µ÷²éºÍÊг¡Ñо¿¡£Èç¹ûÒª¸øISIÍÆ¼öÆÚ¿¯×öÆÀÑ¡£¬¿ÉÒÔÓëEditorial Development DepartmentÁªÏµ£¨Fax£º215--386--6362¡£E-mail£ºJournals@isinet.com£©£¬²¢ÌṩÆÚ¿¯µÄÈ«³Æ¡¢ISSNºÅÂë¡¢Ö÷±àµÄÐÕÃû¡¢µØÖ·ºÍÆÚ¿¯µÄ³ö°æÕß¡£Èç¹û¿ÉÄÜ£¬½«×îÐÂÒ»ÆÚÆÚ¿¯¼ÄÈ¥£¬ËæºóµÄµÚ2°æ¡¢µÚ3°æÒ»µ©³ö°æÒ²ÂíÉϼÄÈ¥¡£Í¬Ê±¸½Ò»·Ý¶ÌÐÅ£¬ËµÃ÷Õâ¸öÆÚ¿¯µÄ¶ÀÌØÖ®´¦ÒÔ¼°ÓëÆäËûÆÚ¿¯µÄ²»Í¬Ö®´¦¡£½«Æä¿¯Ñù±¾¼ÄÖÁ£º .!0),KmkK  
Publication Processing Department [dFxW6n  
Institute for Scientific Information \~:Kp Kq  
3501 Market Street h4H~;Wl0  
Philadelphia,PA 19104 M $#zvcp  
USA pI7\]e  
4.SSCI¼ò½é CF9a~^+%  
SSCIÊÇSocial Scientific Citation Index<<Éç»á¿ÆÑ§ÒýÎÄË÷Òý>>µÄËõд¡£SSCI´´¿¯ÓÚ1956Ä꣬ÊÇISI´Ó50¶à¸öÁìÓòµÄ3300¶à¸öÖØÒªµÄ¹ú¼ÊÆÚ¿¯ÖУ¬Í¨¹ý¼ÆËã¼°¼ìË÷ÎÄÕÂÖ÷ÌâºÍÒýÎĺó½¨Á¢ÆðµÄ×ÛºÏÐÔÉç¿ÆÎÄÏ×Êý¾Ý¿â£¬ÄÚÈÝÉæ¼°¾­¼Ã¡¢·¨ÂÉ¡¢¹ÜÀí¡¢ÐÄÀíѧ¡¢ÇøÓòÑо¿¡¢Éç»áѧ¡¢ÐÅÏ¢¿ÆÑ§µÈ50¸öÁìÓò¡£ÊÕ¼ÎÄÏ×ÀàÐͰüÀ¨Ñо¿ÂÛÎÄ¡¢ÊéÆÀ¡¢×¨ÌâÌÖÂÛ¡¢ÉçÂÛ¡¢ÈËÎï×Ô´«ºÍÊéÐŵȡ£µ±È»£¬SSCIµÄÊÕ¼ÆÚ¿¯ÓÐÒ»²¿·ÖÄÚÈÝÓëSCIÖØ¸´¡£2005ÄêµÄSSCIÏÂÔØÍøÖ·Îªhttp://scientific.thomson.com/media/pdfs/sourcepub--journals/wos_ssci_a5022_final.pdf¡£ÄϾ©´óѧÒѾ­½¨Á¢¡°ÖÐÎÄÉç»á¿ÆÑ§ÒýÎÄË÷Òý¡±£¨CSSCI£©£¬µÇÂ½ÍøÖ·http:www.cssci.com.cn²éѯ¡£ `g6XVa*%#  
5.ISTP¼ò½é aKS 2p3   
ISTPÊÇIndex to Scientific and Technical Proceedings<<¿ÆÑ§»áÒé¼Ë÷Òý>>µÄËõд£¬´´¿¯ÓÚ1978Äê¡£¸ÃË÷ÒýÊÕ¼ÁËÉúÃü¿ÆÑ§¡¢ÎïÀíÓ뻯ѧ¿ÆÑ§¡¢Å©Òµ¡¢ÉúÎïºÍ»·¾³¿ÆÑ§¡¢¹¤³Ì¼¼ÊõÓ¦ÓÃÓëÓ¦ÓÿÆÑ§µÈѧ¿ÆµÄ»áÒéÎÄÏס£°üÀ¨Ò»°ãÐÔ»áÒé¡¢×ù̸»á¡¢Ñо¿»á¡¢ÌÖÂۻᡢ·¢±í»áµÈµÄ»áÒéÎÄÏס£ÏêÇé²éÑ¯ÍøÖ·http://scientific.thomson.com/products/istp¡£ sLK J<=0i  
6.ISR¼ò½é X;flA*6V  
ISRÊÇIndex to Scientific Reviews<<¿ÆÑ§ÆÀÂÛË÷Òý>>µÄËõд£¬´´¿¯ÓÚ1974Äê¡£ÊÕ¼ÊÀ½ç¼°¸÷¹ú2700ÓàÖֿƼ¼ÆÚ¿¯¼°300ÓàÖÖ׍ָ¡¢´Ô¿¯ÖÐÓмÛÖµµÄÆÀÊöÂÛÎÄ¡£ÏêÇé¿É¼ûÍøÕ¾ 84)$ CA+NX  
aUSxy8%  
http://scientific.thomson.com/products/isr¡£ F6h3M~uR  
7.ÆäËû CCfuz&  
PCIÊÇPatent Citation Index<<רÀûÒýÓÃË÷Òý>>µÄËõд£¬ÊÕ¼·¢Ã÷רÀû¡£ÏêÇé¿É¼ûÍøÖ·£ºhttp://scientific.thomson.com/products/pci¡£ [VIdw 92  
<<ÒÕÊõÓëÈËÎÄÒýÎÄË÷Òý>>£¨Arts and Humanities Citation Index,A and HCI£©ÊÕ¼ÓëÒÕÊõ¡¢ÈËÎÄѧ¿ÆÓÐ¹ØµÄÆÚ¿¯Ä¿Â¼¡£ÏêÇé¿É¼û£º *XS@Ku  
W+BM|'%}|  
http://scientific.thomson.com/products/ahci¡£

kaobook 2011-08-17 22:27
µÚ¶þÕ SCIÆÚ¿¯Ó°ÏìÒò×Ó :HYqm*v;W  
rhMsZ={M  
SCIÆÚ¿¯Ó°ÏìÒò×Ó N)lzX X  
SCIÆÚ¿¯Ó°ÏìÒò×Ó£¨impact factor, IF£©ÊÇÖ¸ÎÄÕÂÔÚÌØ¶¨Äê·Ý»òʱÆÚ±»ÒýÓÃµÄÆµÂÊ£¬ÊǺâÁ¿Ò»¸öѧÊõÆÚ¿¯Ó°ÏìÁ¦µÄÖØÒªÖ¸±êºÍѧÊõ¿¯ÎïµØÎ»µÄÖ÷ÒªÒòËØ£¬ÓÉEugene Garfield ÔÚ20ÊÀ¼Í60Äê´ú´´Á¢£¬ËüµÄ½¨Á¢ÊÇÔÚSCI»ù´¡ÉϵÄÒ»ÖÖͳ¼Æ½á¹û¡£Ä¿Ç°Ëù˵µÄÓ°ÏìÒò×ÓÊÇ´Ó1975Ä꿪ʼ¡£ P_j ?V"i<  
Ó°ÏìÒò×Ó=£¨¸Ã¿¯Ç°Á½Äê·¢±íÂÛÎÄÔÚͳ¼Æµ±Äê±»ÒýÓõÄ×Ü´ÎÊý£©¡Â£¨¸Ã¿¯Ç°Á½Äê·¢±íÂÛÎÄ×ÜÊý£© 7e/Uc!&*  
ʾÀý1. Pg-~^"?y  
2007ÄêÓ°ÏìÒò×Ó¼ÆËã }.3F|H  
Ó°ÏìÒò×Ó£¨2007£©=A¡ÂB ve.iyr  
ÆäÖУ¬AΪ¸ÃÆÚ¿¯2005-2006ÄêÂÛÎÄÔÚ2007Äê±»ÒýÓõÄ×Ü´ÎÊý£»BΪ¸ÃÆÚ¿¯2005-2006ÄêËùÓÐÂÛÎÄ×ÜÊý¡£ u ?7(A %  
ÀýÈ磬2007ÄêNature GeneticsµÄÓ°ÏìÒò×Ó¼ÆËã·½·¨ÈçÏ£º ?t'ZX~k  
2005Äê³ö°æµÄÎÄÏ×ÔÚ2006Äê±»ÒýÓõĴÎÊý=5789£¨´Î£© lJi '%bOi  
2006Äê³ö°æµÄÎÄÏ×ÔÚ2007Äê±»ÒýÓõĴÎÊý=4193£¨´Î£© %RL\t5 TV  
2005Äê³ö°æµÄÎÄÏ×Êý=203£¨Æª£© c ^G\w+_  
2006Äê³ö°æµÄÎÄÏ×Êý=210£¨Æª£© U u(ysN4`  
¸Ã¿¯2007ÄêµÄÓ°ÏìÒò×Ó=£¨5789+4193£©¡Â£¨203+210£©=24.17£¨´Î/ƪ£©¡£ 5~<> h~yJ  
Òò´Ë£¬2007ÄêNature GeneticsµÄÓ°ÏìÒò×ÓÊÇ24.17¡£±íÃ÷¸ÃÆÚ¿¯ÔÚ¹ýÈ¥Á½Äê·¢±íµÄÂÛÎÄÔÚ2007ÄêÆ½¾ùÊÕµ½24ÌõÒýÎÄ¡£ ') 5W  
2.ÆäËû³£ÓÃµÄÆÚ¿¯ÆÀ¹ÀÖ¸±ê 1.o-2:]E  
£¨1£©¼°Ê±Ö¸Êý£¨immediacy index£©ÊǼÆËãijһÆÚ¿¯ÂÛÎĵÄÂÛÎÄÔÚ¸ÃÄê¶È±»ÒýÓõÄËÙ¶È¡£ ^TyusfOz  
¼°Ê±Ö¸Êý¼ÆËãµÄ·½·¨£º [@ "H2#CQ  
¼°Ê±Ö¸Êý=£¨¸ÃÆÚ¿¯ÎÄÏ×±»µ±ÄêÒýÓõÄ×Ü´ÎÊý£©¡Â£¨¸ÃÆÚ¿¯µ±ÄêÎÄÏ××ÜÊý£© r62x*?/  
ʾÀý I}p uN!  
2005Ä꼰ʱָÊý¼ÆËã ^LfCLI9Z  
¼°Ê±Ö¸Êý£¨2005Ä꣩=A¡ÂB :M`|*~V~$  
ÆäÖУ¬AΪ2005Äê³ö°æµÄÎÄÏ×ÔÚ2005Äê±»ÒýÓõĴÎÊý£»BΪ2005Äê³ö°æµÄÎÄÏ×Êý¡£ f?dNTfQ3mi  
£¨2£©±»ÒýÓðëË¥ÆÚ£¨cited halflife£©ÊǼÆËãijһÆÚ¿¯ËùµÇµÄÂÛÎÄÆ½¾ù¾­¹ý¶à³¤Ê±¼ä£¬ÈÔÈ»»¹»á±»ÒýÓ᣼ÆËãµÄ·½·¨ÊÇ´Óµ±ÄêÍùǰÀۼƣ¬µ±Äê±»ÒýÓõÄÂÛÎÄÆªÊý´ïµ½È«²¿µÄ50%ʱ£¬¸ÃƪÂÛÎĵijö°æÄêµ½µ±ÄêµÄ¼ä¸ôÄêÊý¼´Îª´ËÆÚ¿¯µÄ±»ÒýÓðëË¥ÆÚ¡£°ëË¥ÆÚµÄÖµÔ½µÍ£¬±»ÒýÓÃ×÷Ϊ²Î¿¼ÎÄÏ×µÄʱЧÐÔÔ½¸ß¡£ MfJk`-%~  
£¨3£©ÒýÓðëË¥ÆÚ£¨citing halflife£©ÊǼÆËãijһÆÚ¿¯Æ½¾ùÒýÓöà¾ÃÒÔǰµÄÂÛÎÄ¡£¼ÆËã·½·¨ÊÇ´Óµ±ÄêÍùǰÀۼƣ¬µ±ÒýÓõÄÂÛÎÄÆªÊý´ïµ½È«²¿µÄ50%ʱ£¬¸ÃƪÂÛÎĵijö°æÄêµ½µ±ÄêµÄ¼ä¸ôÄêÊý¼´Îª´ËÆÚ¿¯µÄÒýÓðëË¥ÆÚ¡£Èô10ÄêÄÚÒýÓôÎÊýδ´ïµ½50%£¬ÆäÒýÓðëË¥ÆÚÖµÒÔ£¾10.0À´±íʾ¡£µ«¸ÃÆÚ¿¯±ØÐëÒýÓÃÆäËûÂÛÎÄ×ÜÊýÁ¿´ïµ½100´ÎÒÔÉϲÅÁÐÈ룬·ñÔòÔòÒÔ¿Õ°×±íʾ¡£°ëË¥ÆÚµÄÖµÔ½µÍ£¬±íÃ÷¸ÃÆÚ¿¯ËùÒýÓõIJο¼ÎÄÏ×ʵЧÐÔÔ½¸ß¡£ j$Vv'on  
ͨ¹ýJCR£¨Journal Citation Reports£¬ÆÚ¿¯ÒýÓñ¨µÀ£©¿ÉÒÔµÃÖª£º a { L`C"rJ  
ÄÄЩÊÇ×îÓÐÓ°ÏìÁ¦µÄÆÚ¿¯¡£ %aaOws  
ÄÄЩÊÇ×î³£ÓÃµÄÆÚ¿¯¡£ 76c4~IG#  
ÄÄЩÊÇ×îÈÈÃÅµÄÆÚ¿¯¡£ %\}|&z6  
ÄÇЩÆÚ¿¯³ö°æÁ¿×î´ó¡£ [{Fr{La`D'  
ÄÇЩÆÚ¿¯×î³£±»ÒýÓᣠBt B o%t&  
ÄÇЩÆÚ¿¯µÄÓ°ÏìÒò×Ӹ߻òµÍ¡£ ?p. dc ~tZ  
ÄÇЩÆÚ¿¯µÄ¡°Á¢¼´ÒýÓÃÂÊ¡±×î¸ß¡£ &m5WmEz>`  
ÄÄЩÆÚ¿¯ÒýÓü°±»ÒýÓõÄÇé¿ö¡£ 9*[!uu  
ÊÕ¼ÆÚ¿¯µÄÏêϸ³ö°æÐÅÏ¢¡£ <.l5>mgkCw  
3.ÆÚ¿¯Ó°ÏìÒò×ӵIJéÕÒ ({m["d  
·½·¨Ò»£ºµã»÷Á´½Ó£ºhttp://isi3.isiknowledge.comºóÔÙµã»÷Journal Citation Reports£¬½øÈëJCRÊý¾Ý¿â£¬¼´¿É²éÕÒµ±ÄêÆÚ¿¯µÄÓ°ÏìÒò×ÓµÈÖ¸±ê¡£È±µãÊÇÐèÒª¶©¹º²ÅÄܽøÈëJCRÊý¾Ý¿â¡£ U @ |{RP  
·½·¨¶þ£º´ò¿ªÓ¢ÎÄÍøÖ·http://www.google.com,ÊäÈëimpact factor,»òÕß´ò¿ªÖÐÎÄÁ´½ÓÍøÖ·http://www.google.com.cn£¬ÊäÈëÆÚ¿¯Ó°ÏìÒò×Ó¡£È±µãÊDz»Äܼ°Ê±²éµ½×îÐÂÐÅÏ¢£¬°üÀ¨ÆÚ¿¯Ó°ÏìÒò×Ó¡£ HNY{%D  
2005Äê£Ó£Ã£ÉÊÕ¼ÆÚ¿¯Ó°ÏìÒò×Ó£º£¯£¯£º£÷£÷£÷£®£ì£é£â£®£å£ã£î£õ£®£å£ä£õ£®£ã£î£¯£ó£ã£é£ê£ï£õ£ò£î£á£ì£²£°£°£µ£®£ø£ì£ó '&?47+W  
200£³ÄêÖйúÆÚ¿¯Ó°ÏìÒò×Ó£º vW"x)~B  
www.lib.ecnu.edu.cn/sci/jcr.doc sG}}a}U1  
4.ÆÚ¿¯Ó°ÏìÒò×ÓµÄÓ¦ÓüÛÖµ /{>ds-;-  
Ö÷Òª°üÀ¨ÒÔÏÂÄÚÈÝ£º cC"7Vt9b  
¡òͼÊé¹ÝÈËÔ± a+A/l  
}=?r`J+Ev;  
¶¨ÆÚ¿¯Òý½øÕþ²ß£¬Ïò¶ÁÕßÍÆ¼öÓÅÐãÆÚ¿¯¡£ 9rn!U2  
¿ª·¢ºÍ¹ÜÀíÆÚ¿¯¹Ý²Ø£¬Ð­Öú×ö³ö¿¯´æµµ¾ö¶¨¡£ Jfo|/JQ  
¡ò±à¼­ m1\>v?=K  
¡îÁ˽âºÍÕÆÎÕ×Ô¼ºÕÆÎÕµÄÆÚ¿¯Çé¿ö£¬Öƶ¨ÓÐЧµÄµÄ±à¼­¹æ»®ºÍÄ¿±ê¡£ dam.D.o"  
¡ò³ö°æÉÌ $T;3*D90  
¡î²â¶¨ÆÚ¿¯µÄÊг¡Ó°ÏìÁ¦¡£ Y)BKRS~  
¡òÂÛÎÄ×÷Õß h=`rZC  
¡îѰÕÒºÍÈ·¶¨Óë×Ô¼º×¨ÒµÏà¹ØµÄÆÚ¿¯¡£ k^R>xV  
¡îѰÕÒ×îÇ¡µ±×îÓÐÓ°ÏìÁ¦µÄµÄÆÚ¿¯·¢±íÆäÎÄÕ¡£ pNVao{::5  
¡îÈ·ÈÏÆÚ¿¯µÄѧÊõµØÎ»¡£ y,Dfqt  
¡òÐÅÏ¢Ñо¿·ÖÎöÈËÔ± >f`}CLsY  
¡î¸ú×ÙÎÄÏ×¼ÆÁ¿Ñ§µÄ·¢Õ¹Ç÷ÊÆ¡£ t9 &O0tpe  
¡îѧϰÑо¿ÒýÎÄģʽ¡£ <@JU0Z"a=  
¡îÑо¿×¨ÒµÑ§¿ÆµÄ·¢Õ¹±ä»¯Ç÷ÊÆ¡£ `kekc.*-[@  
5.ÆÚ¿¯Ó°ÏìÒò×ӵľÖÏÞÐÔ E62*J$wN@  
£¨1£©ÓÉÓÚѧ¿ÆµÄ²îÒìµ¼ÖÂÁËÆÚ¿¯Ó°ÏìÒò×ӵĴóСÏà²îÊýÊ®±¶¡£Ä³Ò»Ñ§¿ÆÆÚ¿¯µÄ×ÜÌåˮƽֻÄÜÕë¶Ô×ÔÉíµÄѧ¿ÆÁìÓò£¬ÒòΪÎÞÂÛÓ°ÏìÒò×Ó»¹ÊÇ×ÜÒýÓÃÊýÔÚѧ¿ÆÖ®¼ä¶¼Ã»ÓпɱÈÐÔ¡£ ) }?dYk  
£¨2£©Ó°ÏìÒò×ÓÊÇÒ»ÖÖͳ¼ÆÑ§ÉϵĸÅÄÊÇ´óÁ¿ÂÛÎIJúÉúµÄ½á¹û¡£Òò´Ë£¬Ó°ÏìÒò×ÓÓÃÓÚÆÀ¼ÛÆÚ¿¯µÄÕûÌåˮƽÊÇ¿ÉÐеġ£ ^e&,<+qY  
£¨3£©ÆÚ¿¯µÄ·¢Ðмä¸ô¡¢Ã¿ÆÚÊÕ¼µÄÂÛÎÄÆªÊý¸÷Óв»Í¬¡£Ã¿ÆÚÊÕ¼ÂÛÎĽ϶àµÄÆÚ¿¯¿ÉÄÜÒòΪ½ÏÈÝÒ×»ñµÃÒýÓôÎÊý£¬¶øÔÚͳ¼Æ×ÜÒýÓôÎÊýÉϾßÓÐÓÅÊÆ¡£ T}u'  
£¨4£©Â©ÒýºÍÎÄÏ××÷ÕßÒýÓõIJ»¹æ·¶£¬ÖîÈ硰תÒý¡±£¨¶Ô×Ô¼ºÃ»ÓÐÇ××Ô²éÔ½¹ýµÄÎÄÏ×´Ó±ðÈËÂÛÎĵÄÒýÎÄÖмÓÒÔÒýÓã©£»¡°³çÒý¡±£¨Îª×°µãÃÅÃæ£¬Ã¤Ä¿°áÓá°È¨ÍþÃûÖø¡±£¬»ò¹ÊÒâʹÓÃһЩʱ÷ÖµÄÊõÓïÃû´Ê£©£»²»Ç¡µ±µÄ¡°×ÔÒý¡±£¨×÷ÕßÒýÓÃ×Ô¼ºµÄÎÄÏ×±íÃ÷Ñо¿¹¤×÷µÄÁ¬ÐøÐÔ£¬µ«ÓеÄ×÷ÕßÒýÓÃ×Ô¼ºÒѾ­·¢±íµÄÓëÖøÎÄÖ÷Ìâ¹ØÁª²»´ó»òºÁ²»Ïà¹ØµÄÎÄÕ£¬ÒÔÀ©´ó×Ô¼ºµÄѧÊõÓ°Ï죩¡£ c-M&cU+=L  
Òò´Ë£¬ËäÈ»ÆÚ¿¯µÄÓ°ÏìÒò×ÓÊÇÆÚ¿¯ÆÀ¹À·Ç³£ÓÐÓõŤ¾ß£¬µ«ÓÐÒ»¶¨µÄ¾ÖÏÞÐÔ£¬±ØÐëÕýÈ·¶Ô´ý¡£ K32eZv`T7  
6.ÈçºÎ²é¿´Ä³ÆªÎÄÏ×±»ÒýÓõĴÎÊý£¬ÒÔ¼°¶¼±»ÄÇЩÂÛÎÄÒýÓà $f)Y !<bC  
·½·¨Ò»£ºÔÚSCIÎÄÏ×¼ìË÷½çÃæhttp:/www.isiknowledge.com£¬µã»÷×ó²à¡¾web of science¡¿,½øÈëÂÛÎļìË÷½çÃæ¡£ÒÔÒ³ÃæÖС¾general search¡¿ÎªÀý£¬Í¨¹ý±êÌâ×÷ÕßÄê·Ý×÷Õßµ¥Î»µÄ²éѯ»òÕß×éºÏ²éѯ¡£ 0 _&oMPY  
·½·¨¶þ£º´ò¿ªhttp://scholar.google.com,ÍøÒ³£¬ÊäÈëÎÄÏ×µÄÌâÄ¿»ò×÷Õߣ¬È»ºóµã»÷¡¾ËÑË÷¡¿¿ÉÒÔ¿´Ä³ÆªÎÄÏ×±»ÒýÓõĴÎÊý¡£µã»÷¡¾±»ÒýÓôÎÊý¡¿¿ÉÒÔ¿´µ½¸ÃÎÄÏ×±»ÄÇЩÂÛÎÄÒýÓá£

kaobook 2011-08-17 22:28
µÚÈýÕ SCIÂÛÎĵĻù±¾ÒªÇó cFH,fj  
1.¿Æ¼¼ÂÛÎĵ͍Òå hwC3['  
ÃÀ¹úÉúÎïѧ±à¼­Ð­»á°Ñ¿Æ¼¼ÂÛÎ͍ÒåΪ£ºÒ»ÆªÄܱ»½ÓÊܵÄԭʼ¿ÆÑ§³ö°æÎï±ØÐëÊÇÊ×´ÎÅû¶£¬²¢Ìṩ×ã¹»µÄ×ÊÁÏ£¬ÊÇͬÐÐÄܹ»£º¢ÙÆÀ¶¨Ëù¹Û²ìµ½µÄ×ÊÁϵļÛÖµ£»¢ÚÖØ¸´ÊµÑé½á¹û£»¢ÛÆÀ¼ÛÕû¸öÑо¿¹ý³ÌµÄѧÊõ¡£´ËÍ⣬Ëü±ØÐëÊÇÒ×ÓÚÈËÃǵĸйٽÓÊÜ¡¢±¾ÖÊÉϳ־ᢲ»¼ÓÏÞÖÆµØÎª¿ÆÑ§½çËùʹÓ㬲¢ÇÒÄÜΪһÖÖ»ò¶àÖÖ¹«ÈϵĶþ¼¶Ç鱨ԴËùÑ¡Óá£Öйú¹ú¼Ò±ê×¼GB7713-87ËùÖ¸µÄѧÊõÂÛÎÄÊÇ£º¡°Ä³Ò»Ñ§Êõ¿ÎÌâÔÚʵÑéÐÔ¡¢ÀíÂÛÐÔ»ò¹Û²âÐÔÉϾßÓÐеĿÆÑ§Ñо¿³É¹û»ò´´Ð¼û½âºÍ֪ʶµÄ¿ÆÑ§¼Ç¼£¬»òÊÇijÖÖÒÑÖªÔ­ÀíÓ¦ÓÃÓÚʵ¼ÊÖÐÈ¡µÃ×îнøÕ¹µÄ¿ÆÑ§×ܽᡱ¡£ RrRCT.+E  
2.SCIÂÛÎĵÄÌØµã ap=M$9L'  
¡òѧÊõÐÔ T?% F  
SCIÂÛÎIJ»Í¬Óڽ̲ģ¬Ò²²»Í¬ÓÚ¶ÁÊé±Ê¼Ç£¬ËüÊÇÒ»ÖÖѧÊõÐÔµÄÎÄÕ¡£ËùνѧÊõÊÇָϵͳºÍרÃŵÄѧÎÊ£¬ÊÇÓнÏÉîºñµÄʵ¼ù»ù´¡ºÍÒ»¶¨ÀíÂÛÌåϵµÄ֪ʶ¡£¿Æ¼¼ÂÛÎĵÄѧÊõÐÔÊÇָһƬ¿Æ¼¼ÂÛÎÄÓ¦¾ß±¸Ò»¶¨µÄѧÊõ¼ÛÖµ£¨ÀíÂÛ¼ÛÖµ£©¡£ÔËÓÿÆÑ§µÄÔ­ÀíºÍ·½·¨£¬Í¨¹ý˼¿¼·ÖÎö»òʵÑ飬×÷³öÅжϣ¬×îºóµÃ³öеļû½â»ò½áÂÛ¡£ÕâÖÖеļû½â»ò½áÂÛ£¬¿ÉÒÔÊÇÍÆ·­¾ÉµÄÀíÂÛ£¬Ò²¿ÉÒÔÊÇÓÃеĹ۵㽫һЩ·ÖÉ¢µÄ²ÄÁÏϵͳ¹á´©ÆðÀ´£¬¾­¹ýÌáÁ¶¼Ó¹¤£¬´ÓÀíÂÛÉϽøÐзûºÏÂß¼­µÄÂÛÖ¤Óë·ÖÎö»ò×÷³ö˵Ã÷¡£Òò´Ë£¬Ñ§ÊõÐÔÊǿƼ¼ÂÛÎĵÄÌØÕ÷¡£ { >4exyu6  
¡ò´´ÔìÐÔ£¨Ô­´´ÐÔÓë´´ÐÂÐÔ£© ggbew6L$Z  
SCIÂÛÎÄÊǶԿÆÑй¤×÷µÄÎÄ×ÖÐÔ×ܽᣬǿµ÷Ô­´´ÐÔÓë´´ÐÂÐÔ¡£Ô­´´ÐÔ²»µÈͬÓë´´ÐÂÐÔ£¬´´ÐÂÐÔ¿ÉÒÔÊDZðÈËÑо¿µÄÑÓÐø£¬¶øÔ­´´ÐÔÒâζ×ÅÒ»¸öÐÂÊÂÎï¡¢ÐÂÁìÓò¡¢ÐÂÎÊÌâµÄ¿ª´´¡£¿ÆÑ§Ñо¿µÄÄ¿µÄÔÚÓÚ´´Ô죬Òò´ËºâÁ¿SCIÂÛÎļÛÖµµÄ¸ù±¾±ê×¼¾ÍÔÚÓÚËûµÄ´´ÔìÐÔ¡£ /Wzic+v<>  
¡ò¹æ·¶ÐÔ <0lfkeD  
SCIÂÛÎıØÐë°´Ò»¶¨µÄ¸ñʽºÍÒªÇó½øÐй淶Êéд¡£ÀýÈ磬SCIÂÛÎĵIJο¼ÎÄÏ×ÖøÂ¼Ó¦¹æ·¶£¬ÎÄ×Ö±í´ïÓ¦¹æ·¶£¬ÓïÑԺͼ¼Êõϸ½ÚÓ¦²ÉÓùú¼Ê·¨¶¨µÄÃû´ÊÊõÓï¡¢Êý×Ö¡¢·ûºÅ¡¢¼ÆÁ¿µ¥Î»µÈ¡£SCIÂÛÎÄÒªÇó׼ȷ¡¢¼ò½à¡¢Í¨Ë³¡¢ÌõÀíÇå³þ¡£ &&t4G}*  
¡ò¿ÆÑ§ÐÔºÍ׼ȷÐÔ @AWKEo<7.I  
¿ÆÑ§ÐÔÊÇÖ¸SCIÂÛÎÄͬһ°ãÂÛÎÄÒÔ¼°Ò»ÇзǿƼ¼ÎÄÌåµÄ»ù±¾Çø±ð¡£¿ÆÑ§ÐÔÖ÷Òª°üÀ¨Á½·½Ã棺һ·½ÃæÊÇÖ¸ÂÛÎĵÄÄÚÈÝÊÇ¿ÆÑ§¼¼ÊõÑо¿µÄ³É¹û£»ÁíÒ»·½ÃæÊÇÖ¸ÂÛÎĵıí´ïÐÎʽ½á¹¹ÑϽ÷£¬Ë¼Î¬·ûºÏÂß¼­¹æÂÉ£¬²ÄÁÏÕæÊµ£¬·½·¨×¼È·¿É¿¿£¬¹Ûµã׼ȷÎÞÎó¡£×¼È·ÐÔÖ÷ÒªÊÇÖ¸SCIÂÛÎĵÄʵÑé¹ý³Ì¡¢ÊµÑé½á¹û¾ßÓпÉÖØ¸´ÐÔ¡£ RAxA H   
3.SCIÂÛÎĵĻù±¾ÒªÇó am@\$Sa4   
¡òÏȽøÐÔ ÏȽøÐÔÖ÷ÒªÌåÏÖÔÚ F lbL`@4M  
¨SÀíÂÛ·½ÃæµÄ´´Ð¼û½â£¬ÈçijЩÀíÂÛ·½ÃæµÄ¶ÀÌØ¼û½âºÍÕâЩ¼û½âµÄÒÀ¾Ý¡£ M22 ^.,Z  
¨SÓ¦Ó÷½ÃæµÄ´´Ð¼û½âµÈ£¬Èçз¢Ã÷¡¢Ð¼¼Êõ¡¢Ð²úÆ·¡¢ÐÂÉ豸»ò½ÒʾԭÓм¼Êõ×ªÒÆµ½ÐµĿÆÑ§ÁìÓòÖеÄЧ¹û¡£ ]D<r5P%  
¨SÑо¿·½·¨·½ÃæµÄ´´ÐÂÐÔ£¬ÈçÑо¿·½·¨·½ÃæµÄ´´Ð»òÍ»ÆÆ¡£ 8R-?x/:  
ҪעÒâ¿ÆÑд´ÐÂÓ¦¸Ã½¨Á¢ÔÚ¹ú¼ÊÑо¿ÒÑ´ïˮƽºÍ³Ì¶ÈµÄ»ù´¡ÉÏ£¬Êǹú¼Ê´´Ð¶ø²»ÊǹúÄÚ´´Ð¡£·ñÔò£¬ºÜÄÑ·¢±í¸ßˮƽµÄSCIÂÛÎÄ¡£µ±È»Òª¼ÇסÁ¢ÌâʱµÄ×îв»µÈÓÚ½áÌâʱµÄ×îС£ +EkZyM~z2  
¡ò¿ÉÐÐÐÔ <A!v'Y  
ËùνѡÌâµÄ¿ÉÐÐÐÔ£¬ÊÇÖ¸Äܹ»³ä·Ö·¢»Ó×÷ÕßµÄ×ÛºÏÌõ¼þ£¬¿ÉÒÔʤÈβ¢ÄÜÈçÆÚÍê³É¿ÆÑ§ÂÛÎĵİÑÎճ̶ȡ£Ó°ÏìÑ¡ÌâµÄ¿ÉÐÐÐÔÒòËØ°üÀ¨£º kOJs;k  
¨S¿ÆÑ§Ô­ÀíÉÏÊÇ¿ÉÐе쬾ø²»ÄÜÎ¥·´¿ÆÑ§Ô­ÀíºÍ×ÔÈ»¹æÂÉ¡£ 22(0Jb\_  
¨SÖ÷¹ÛÌõ¼þ£¬°üÀ¨×÷ÕßÖªÊ¶ËØÖʽṹ¡¢Ñо¿ÄÜÁ¦¡¢¼¼ÊõˮƽºÍÌØ³¤¡¢ÐËȤµÈ¡£ py@5]n%  
¨S¿Í¹ÛÌõ¼þ£¬°üÀ¨ÊµÑéÌõ¼þ¡¢¾­·Ñ×ÊÁÏ¡¢Ê±¼ä¡¢É豸µÈ¡£ JCS$Tm6y<_  
¡òÖØÒªÐÔ iB[%5i-  
׫д¿ÆÑÐÂÛÎĵÄÄ¿µÄÊÇΪÁ˽»Á÷ºÍÓ¦Óá£Òò´Ë£¬Ò»°ãÀ´Ëµ£¬·¢±íÔÚScience¡¢NatureºÍCellµÈ¶¥¼âSCIÆÚ¿¯µÄ¿ÆÑ§ÂÛÎÄÓÚ·¢±íÔÚÆÕͨSCIÆÚ¿¯µÄѧÊõÂÛÎĵIJ»Í¬ÔÚÓÚǰÕß½â¾ö»òÕ߻شðÁËÒ»¸ö·Ç³£ÖØÒªµÄÎÊÌ⣬¸ÃÑо¿ÔÚ¿ÆÑ§ÁìÓòÖоßÓÐÉîÔ¶Ó°Ïì»òÕßÓÐÖØ´óµÄ¾­¼Ã¡¢Éç»áÐ§Òæ£¬¶øºóÕßÔò½â¾ö»Ø´ðÁËÒ»¸öÆÕͨµÄÎÊÌâ¡£Òò´Ë£¬¿ÆÑ§Ñо¿ºÍ¼¼ÊõÑо¿Ñ¡ÌâµÄÊ×ÒªÔ­ÔòÊÇ£¬ÎªÊ²Ã´ÒªÑо¿¡¢ÓÐʲôʵ¼Ê×÷Óá¢ÆäÀíÂÛºÍѧÊõ¼ÛÖµ¡¢ÀúÊ·ºÍÏÖʵµÄÒâÒåÓÖÊÇʲô¡£ Z]"ktb;+[  
¡ò¿ÆÑ§ÐÔ }1Q]C"hY  
ËùÑ¡µÄ¿ÎÌâ±ØÐëÊôÓÚ¿ÆÑ§µÄ·¶³ë£¬Êǿ͹۴æÔڵĶø²»ÊÇÐé¹¹µÄ¡£ÅжÏһƪÂÛÎÄÓÐÎÞ¼ÛÖµ»ò¼ÛÖµµÄ´óС£¬Ê×ÏÈÊÇ¿´ÎÄÕµĹ۵ãºÍÄÚÈݵĿÆÑ§ÐÔÈçºÎ¡£Æä´Î£¬ÎÄÕÂÊÇ·ñ¾ßÓпÆÑ§ÐÔ»¹È¡¾öÓë×÷ÕßµÄÀíÂÛ»ù´¡ºÍרҵ֪ʶ¡£Ð´×÷SCIÂÛÎÄÊÇÔÚǰÈ˳ɾ͵Ļù´¡ÉÏ£¬±ØÐëÓ¦ÓÃǰÈËÌá³öµÄ¿ÆÑ§ÀíÂÛȥ̽Ë÷еÄÎÊÌâ¡£Òò´Ë£¬±ØÐë׼ȷµØÀí½âºÍÕÆÎÕǰÈ˵ÄÀíÂÛ£¬¾ßÓй㲩¶ø¼áʵµÄ»ù´¡¡£Èç¹û¶ÔSCIËùÉæ¼°ÁìÓòÖеĿÆÑгɹûÒ»ÎÞËùÖª£¬¾ÍºÜÄÑд³öÓмÛÖµµÄSCIÂÛÎÄ¡£ d;)Im "  
4.Ñ¡ÌâµÄ»ù±¾·½·¨ ym<G.3%1  
Ñ¡ÌâÒª´Óʵ¼Ê³ö·¢£¬Ñ¡ÔñÄÇЩÓмÛÖµ¡¢ÄÜ´Ù½ø¿ÆÑ§¼¼Êõ·¢Õ¹»òÐèÒªÆÈÇнâ¾öµÄÓÐÖØ´óÐ§ÒæµÄ¿ÎÌâ¡£¿ÆÑÐÂÛÎÄÊÇ·ñÄܹ»ÔÚSCIÆÚ¿¯·¢±í»òÄܹ»ÔÚʲôÑùµÄSCIÆÚ¿¯ÉÏ·¢±í£¬Ôںܴó³Ì¶ÈÉÏÈ¡¾öÓÚ¿ÎÌâµÄÖØÒªÐÔ¡£ 36.L1!d)pE  
5.Ñ¡Ìâ·½Ïò )2 u=U9  
¡òÑ¡Ôñؽ´ý½â¾öµÄÖØÒªÎÊÌâ UiF?Nx~  
¡òÑ¡Ôñ´¦ÓÚÇ°ÑØÎ»ÖõĿÎÌ⣬Óë¹ú¼Ê½Ó¹ì zziujs:  
6.Ñо¿¿ÎÌâÑ¡ÔñµÄ;¾¶ VO[s:e9L  
¡ò´Ó¿ÆÑ§ÎÄÏ××ÊÁÏÖÐÑ¡Ìâ uRwIxT2  
Ò»°ãÀ´Ëµ£¬SCIÆÚ¿¯Ó°ÏìÒò×ÓÔÚ3·ÖÒÔϵÄÎÄÕ¿ÉÄÜÖ»×öÁËÒ»²¿·Ö»úÀí£¨ÖÆ£©Ñо¿£¬¿Ï¶¨Óв»×ã»ò²»È«ÃæÖ®´¦¡£¹Ø¼üÊÇÄã×Ô¼ºÒªÈ¥Ë¼¿¼¡¢È¥·¢ÏÖ¡£°Ñ±ðÈ˵ÄÎÄÕÂÈÏÕæ¾«¶ÁÁË×ܻᷢÏÖ©¶´»ò²»×ãÖ®´¦¡£×¢Ò⣺ )\'U$  
¨SÏëÏë±ðÈËÕâÎÄÕÂÊÇÔõô×öµÄ¡£ l`fjz-eE  
¨SÃ÷°×ËûΪʲôҪÕâô×ö¡£ 5;C+K~Y  
¨S¸ÃÎÄÕ½â¾öÁËʲôÎÊÌ⣿Òý³öÁËʲôÎÊÌ⣿ }4  5|  
¨S¿´±¾ÊµÑé½á¹û£¬ÔÚ˼¿¼ÓÐʲôµØ·½²»ÍêÉÆ£¿ÓÐûÓÐÉîÈë»òÍØÕ¹µ½µ×£¿ FC/m,D50oI  
¡òÔÚ¿ÆÑйý³ÌÖÐÑ¡Ìâ mEr * n  
¡òÔÚʵ¼ùÓëм¼ÊõÓ¦ÓÃÖÐÑ¡Ìâ *5.s@L( VU  
7.Ñо¿¿ÎÌâÑ¡ÔñµÄÎóÇø D />REC^  
£¨1£©Ïë·¨£¨idea£©Ô½¶àÔ½ºÃ¡£ fA2H8"r  
£¨2£©Ò»Î¶×·Çó¸ïÐÂÐԵġ¢Í»ÆÆÐԵijɹû¡£ ]aXCi"fMs  
£¨3£©Êýѧ¡¢ÀíÂۺ͹«Ê¾Ô½¸´ÔÓÔ½ºÃ¡£ G *3O5m  
£¨4£©×·ÇóÊ·ÎÞǰÀý¡£ p4bQCI  
8.¿ÎÌâÉè¼Æ³£¼ûµÄ´íÎó H&6lQ30/)  
£¨1£©Ñо¿µÄ¿ÎÌâûÓÐÑôÐÔºÍÒõÐÔ¶ÔÕÕ×é¡£ n$F&gx'^  
£¨2£©È±·¦Ëæ»ú×é¡£ ~^w;`~L  
£¨3£©Ñù±¾ÊýÁ¿Ì«Ð¡¡£ B=J eZMn  
£¨4£©È±·¦Ë«Ã¤µÄÑо¿¡£ tE /j3  
£¨5£©¹Û²âÖ¸±ê»òÑù±¾´íÎó¡£ *.8@ hPy  
£¨6£©´íÎóÎÊÌâ¡£ IwiR2K  
£¨7£©´íÎó·ÖÎöͳ¼Æ¡£ 1X.5cl?V  
£¨8£©È±·¦Ò»¸ö¾ßÌå¼Ù˵£¬»ò¹ý·ÖÈÈÖÔÓÚÊý¾Ý²É¼¯¡£ &$ia#j{l  
£¨9£©È±·¦ÀíÂÛÒÀ¾Ý¡£ L!|c: 8  
£¨10£©Ã»ÓÐÒýÓùú¼ÊµÄ±ê×¼»òÖ¸±ê½øÐÐÆÀ¹À¡£ rgWGe6;!  
9. SCIÂÛÎĵĸñʽºÍÕûÌ幹˼ C%85Aq*4  
Ò»°ãSCIÂÛÎĵĸñʽΪ£º ' ^^]Or  
£¨1£©Title£¨±êÌ⣩¡£ Q7gBx p  
£¨2£©Authors£¨×÷ÕßÐÕÃû£©ºÍAddress£¨¹¤×÷µ¥Î»Ãû³ÆµØÖ·£©¡£ L NmsvU  
£¨3£©Abstract£¨ÕªÒª£©¡£ CTv-$7#  
£¨4£©Introduction£¨ÒýÑÔ£©¡£ 2VyLt=mdh  
£¨5£©Material and Metheds(²ÄÁϺͷ½·¨)¡£ J GnL[9P_  
£¨6£©Results£¨½á¹û£©¡£ q %i2' yE  
£¨7£©Discussion£¨ÌÖÂÛ£©¡£ #>g]CRN  
£¨8£©Acknowledgements(ÖÂл)¡£ h`F8GNx(  
£¨9£©References£¨²Î¿¼ÎÄÏ×£©¡£ `{s:lf  
dU+28  
¸½£ºSCIÂÛÎĵĸñʽºÍд×÷Òªµã 8q{ %n   
SCIÂÛÎĵĸñʽ д×÷Òªµã y)X1!3~(  
Abstract£¨ÕªÒª£© What did I do in a nutshell?(¸ÅÂÔ) [H$rdh[+  
Introduction£¨ÒýÑÔ£© What is the problem?(´æÔÚµÄÎÊÌâ) '+LC.lM  
Material and Metheds(²ÄÁϺͷ½·¨) How did I solve the problem?(ÎÒÔõô½â¾öÕâ¸öÎÊÌâ) w K0vKdi  
Results£¨½á¹û£© What din I found out?(ÎÒ·¢ÏÖÁËʲô) ^=Q/ H  
Discussion£¨ÌÖÂÛ£© What does it mean?(Îҵķ¢ÏÖÒâζ×Åʲô) v#J 2yg  
Acknowledgements(ÖÂл) Who helped me out?(Ë­°ïÁËÎÒ) N# $ob 9  
References£¨²Î¿¼ÎÄÏ×£© Whose wok did I refer to?(ÎҲο¼ÁËÄÇЩÎÄÏ×) p(o"K@I  
Appendics(¸½Â¼) Extra information£¨¶îÍâÊý¾Ý»ò×ÊÁÏ£©¡£

kaobook 2011-08-17 22:28
µÚËÄÕ ÈçºÎÊéдSCIÂÛÎĵıêÌâ W u?A} fH  
1.SCIÂÛÎıêÌâµÄÖØÒªÐÔ ,`kag~bZ  
£¨1£©¾ÍÏñÎÒÃÇÆ½Ê±¿´±¨Ö½ÏÈ¿´±êÌâÒ»Ñù£¬Éó¸åÈËÒ»°ãÊ×ÏȲ鿴SCIÂÛÎĵıêÌâºÍ£¨»ò£©×÷Õß¡£Èç¹û¸ÐÐËȤ£¬ÔÙ¿´ÕªÒª¡£Èç¹û»¹ÓÐÐËȤ£¬ËûÃÇ¿´ÂÛÎÄÖеÄͼºÍ±í£¬È»ºóͨ¶ÁÈ«ÎÄ¡£Òò´Ë£¬SCIÂÛÎıêÌâµÄºÃ»µÖ±½ÓÓ°Ïìµ½¶ÔÂÛÎĵĵÚÒ»Ó¡Ïó¡£ _D<=Yo  
£¨2£©ÂÛÎıêÌâÊÇһƪÂÛÎĸø³öµÄÉæ¼°ÂÛÎÄ·¶Î§ÓëˮƽµÄµÚÒ»¸öÐÅÏ¢£¬Óл­Áúµã¾¦µÄ×÷Óá£ÓÐÈËÈÏΪSCIÂÛÎıêÌâÊÇÎÄÕµÄÒ»°ë¡£ zpi Q;P  
£¨3£©SCIÂÛÎĵıêÌâÊÇ·ñ·´Ó³SCIÂÛÎĵÄÄÚÈÝÊÇÉó¸åÆÀ¹À±ê×¼Ö®Ò»¡£ v__n>*x  
£¨4£©SCIÂÛÎĵıêÌâÊÇÎÄÕª¡¢Ë÷Òý»òÌá¼µÈÇ鱨×ÊÁϵÄÖØÒª×é³É²¿·Ö¡£Ä¿Ç°£¬ÎÄÏ×»ò×ÊÁϵļìË÷Ö÷ÒªÒÀÀµÓÚ¼ÆËã»úÍøÂçϵͳ¡££¬SCIÂÛÎıêÌâÊDzéѯµÄÒÀ¾Ý¡£Òò´Ë£¬Èç¹ûÄãµÄ±êÌâ²»³ä·Ö£¬ºÜÉÙÓÐÈË»áÕÒµ½ÄãµÄ½á¹û»òÕßÔĶÁÄãµÄÂÛÎÄ¡£Ó°ÏìÄãµÄSCIÂÛÎÄÒýÓôÎÊýºÍ½»Á÷¡£ Q> OBK& '  
2. SCIÂÛÎıêÌâµÄÒªÇó BJA&{DMHm  
×î¼Ñ±êÌâµÄ±ê×¼ÊÇÒýÓÃ×îÉٵıØÐëÊõÓï׼ȷÃèÊöÂÛÎĵÄÄÚÈÝ¡£Ð´×÷ÒªÇó׼ȷ£¨accuracy£©¡¢¼ò½à£¨brevity£©¡¢Çå³þ£¨clarity£©¡¢ÓÐЧ£¨effectiveness£©ºÍÎüÒýÈË£¨attractive£©¡£·´Ó¦Õå×úóÈ·¶¨±êÌâ¡£ V\Q=EsHj   
¡ò׼ȷÍêÕû l=+hs  
×÷ΪSCIÂÛÎĵġ°±êÇ©¡±£¬ÂÛÎıêÌâÒªÄÜ׼ȷ±í´ïÂÛÎÄÄÚÈÝ£¬Ç¡µ±·´Ó³ËùÑо¿µÄ·¶Î§ºÍÉî¶È£¬Ó¦¸ÃÓëSCIÂÛÎĵÄÄÚÈݷdz£ÌùÇУ¬¼´ÌâÒª¿ÛÎÄ£¬ÎÄÒ²Òª¿ÛÌ⣬ºÁ²»º¬ºý¡£ÕâÊÇ׫дSCIÂÛÎĵĻù±¾Ô­Ôò¡£³£¼ûµÄ´íÎóÖ÷ÒªÓУº NA@ <v{z  
¨SÂÛÎıêÌâÌ«´ó»ò̫С¡£ }J_"/bB  
ÀýÈç Ddu1>"p-x  
ÂÛÎÄÌâÄ¿Transportation of corneal stem cells cuitured on amniotic membrane for corneal burn: experimental and clinical study(Chinese Medical Journal,2002,115(5):767-769)Ì«´ó¡£¸ÃÂÛÎÄÖ÷ÒªÑо¿ÁËcorneal stem cellsµÄÌåÍâÅàÑøºÍÌåÄÚ¶ÔÍÃÉÕÉ˵ÄÓ°Ïì¡£Òò´Ë£¬Ð´³Éexperimental and clinical studyÊDz»Ç¡µ±µÄ¡£Óá°in vitro and in vivo¡±À´Ìæ´úexperimental and clinical study¸üºÏÊÊ¡£ w^BF.Nu  
¨SÂÛÎıêÌâ±í´ï²»ÕýÈ· D^m`&asC  
ÀýÈç EU5^"\  
Experimental study on mechanism and rarity of metastases in skeletal muscle(Chinese Medical Journal,2002,115(11):1645-1649)Õâ¸ö±êÌâ¾ÍûÓаÑÑо¿µÄ¶ÔÏó¡¢ÎÊÌâ˵Çå³þ¡£ A-6><X's6  
¡ò  ¼òÃ÷¶óÒª @XJzM]*w&  
ÂÛÎÄÌâĿҪ¼ò½à£¬²»ÄÜÌ«³¤¡£Ò»°ãÏ£ÍûһƪÂÛÎıêÌâ²»Òª³¬¹ý100¸öÓ¢ÎÄ×Ö·û£¨characters£©£¬°üÀ¨¿Õ¸ñ¡¢±êµã¡£µ±È»²»Í¬µÄSCIÆÚ¿¯Óв»Í¬µÄÒªÇó¡£ÀýÈ磬ScienceÒªÇóÂÛÎıêÌâ²»³¬¹ý90¸ö×Ö·û¡£Journal of Biological ChemistryÒªÇóÂÛÎıêÌâ²»³¬³öÁ½ÐС£ EOj.Jrs~  
ÀýÈç (=\))t8J  
Importance of replication in microarray gene expression studies: statistical methods and evidence from repetitive cDNA hybridizations(Proc Natl Acad Sci USA,2000,97(18):9834-9839) ¡£ÆäÖеĸ±±êÌâÆä²¹³ä¡¢²ûÃ÷×÷Óá£Science¹æ¶¨¸±±êÌâ½öÏÞÓÃÓÚÑо¿ÎÄÕ¡¢ÆÀÂÛ¡¢ÌØÑûÎÄÕ¡£ NsJ]Tp5!  
¡òÇå³þ S%6V(L|  
¾¡¿ÉÄܽ«±í´ïºËÐÄÄÚÈݵÄÖ÷Ìâ´Ê·ÅÔÚ±êÌâµÄ¿ªÍ·¡£ :OKU@l|  
¡òÐÑÄ¿ e~1$x`DH  
±êÌâÒª¾ßÓÐÎüÒýÁ¦£¬Ò»Ä¿ÁËÈ»¡£ Ly_.% f  
ÀýÈç 95IR.Qfn!  
±êÌâ¡°Identification of human brain tumor initiating cells¡±(Nature,2004-11-18,432(7015):396-401)¸ÃÂÛÎÄÌâÄ¿ÌØ±ðÐÑÄ¿£¬Ò»¿´¾ÍÖªµÀÁËËûÃÇ·¢ÏÖÁËÄÔÖ×Áö¸Éϸ°û¡£Òò´Ë¸ÃÂÛÎľßÓÐÍ»ÆÆÐÔÒâÒå¡£Èç¹û½«ÂÛÎĵıêÌâ¸ÄΪ¡°CD+133 brain tumor fraction contains cells that are capable of tumor initiation in non-obese diabetic severe combined immunodeficient mouse brains ¡±¾ÍÏÔµÃÌ«³¤£¬¶øÇÒ²»¹»ÐÑÄ¿¡£ y,F|L?dIq  
µ«Òª×¢Òâ°ÑÎշִ磬²»¿É¹ý·ÖÐÑÄ¿¡£ 3d;w\#? L;  
³£¼ûµÄ´íÎó°üÀ¨Ê¡ÂÔ²»µ±ºÍ½é´ÊʹÓò»µ± 1 F+$\fLr  
[²»ÍƼö]Adhesion kinase controls actin assembly(Ê¡ÂÔ²»µ±µÄ±êÌâ)¡£ )uK Tf=;  
[ÍÆ¼ö]Focal Adhesion kinase controls actin assembly via a FERM-mediated interaction with the Arp2/3 complex(Ð޸ĺó)  q +*>T=k  
[²»ÍƼö]Mouse Behaviour(Ê¡ÂÔ²»µ±µÄ±êÌâ)¡£ Dy|DQ>?}  
[ÍÆ¼ö]Androgen Administration to Aged Male Mice Increase Anti-Anxiety Behaviour and Enhance Cognitive Performance(Ð޸ĺó)¡£ ]%<0V,G q  
3. SCIÂÛÎıêÌâµÄ¸ñʽ $E35 W=~)  
±êÌâӦλÓÚÊ×Ò³¶¥²¿¡£µ±ÌâÃû½Ï³¤Ê±£¬ÌâÍ·¿Õ4-5¸ñ£¬ÈçÒ»ÐÐд²»Í꣬ÁíÆðÒ»ÐУ¬±ÈǰһÐÐËõ½øÁ½¸ñÊéд¡£ÈçÓи±±êÌâʱ£¬ÁíÆðÒ»ÐУ¬±ÈÖ÷±êÌâÃûËõ½øÁ½¸ñ¼ÓÆÆÕÛºÅÊéдÌâÃû¡£µ±±êÌâ½Ï¶Ìʱ£¬¾ÓÖÐÊéд¡£±êÌâ¿Õ¸ñÁ½ÐÐÔÙд×÷ÕßÃû×ֺ͵¥Î»¡£´ËÍ⻹ҪעÒâÒÔÏÂÊÂÏ yiAusl;  
£¨1£©±êÌâ²»ÓÃÏ»®Ïß»òб×ÖÌå¡£ 0$I!\y\  
£¨2£©¾¡¿ÉÄܲ»Ó÷DZê×¼Ëõд¡£ | X0Ys8f  
£¨3£©±êÌâÒ»°ã²»Óôóд¡£ <^YZ#3~1T  
£¨4£©¾¡Á¿Ê¹±êÌâ³ÉΪһ¸ö¾ä×Ó£¬Ã¿¸ö´ÊµÄµÚÒ»¸ö×Öĸ´óд¡£ E?^A+)<"  
4. SCIÂÛÎıêÌâºÍ»ù½ð¿ÎÌâÃû³ÆµÄÇø±ð Z<~^(W7h  
SCIÂÛÎıêÌâÑ¡ÔñÓëÈ·¶¨²»Í¬ÓÚÉêÇë¿ÎÌâÃû³Æ¡£Ç°ÕßÖ÷Òª½«ÄãµÄ½á¹û£¨Äã·¢ÏÖÁËʲô£©£¬ºóÕßÖ÷Òª²àÖØÓÚÄãµÄ¼Æ»®£¨Ä㽫Ñо¿Ê²Ã´£©¡£ 90]{4]y;  
ÈçÏÂËùÁÐÊǹú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÖбêÏîÄ¿±êÌ⣺ SPY4l*kX  
£¨1£©¶ÌβºïÖÖȺÉú̬ѧÓëÐÐΪѧÑо¿¡£ @V5'+^O  
£¨2£©Ä§Ó󲡺¦Éú̬·ÀÖμ¼ÊõµÄ»ù´¡Ñо¿¡£ ]J6+nA6)  
£¨3£©CPKs¶ÔÑ×Ö¢ÓÕµ¼·Î΢Ѫ¹ÜÄÚÆ¤Ï¸°û¹Ç¼Ü±ä»¯µÄµ÷¿ØÑо¿¡£ bcy( ?(  
£¨4£©¼¡Çòµ°°×ÇáÁ´¼¤Ã¸ÓëʵÑéÐÔ¶¯ÂöÖàÑùÓ²»¯¹ØÏµ¡£ n:5*Tg9  
´ÓÖв»ÄÑ·¢ÏÖ£¬±êÌâ¶¼º¬ÓС°¡­¡­Ñо¿¡­¡­¡±¡£µ«ÊÇ£¬ÔÚ1972-2007ÄêNIHÖбê»ù½ð¿â£¬Ö»ÓÐÒ»¸ö»ù½ðº¬ÓÐStudy£º¡°Study of Women¡¯s Heaith Across the Nation¡£¡± K#],4OG  
ÈçÏÂËùÁÐÊÇNIHÖбêÏîÄ¿µÄÑ¡Ì⣺ n\D3EP<s  
£¨1£©Adult Stem Cells for Repsi Cardiac Damage¡£ gDJ@s    
£¨2£©Biology of Multiple Myeloma Stem Cells¡£ m%?b"kxL[  
£¨3£©Gene Expression Pattern of Liver Stem/Progenitor cells¡£ #O .-/&Z  
£¨4£©mTert-GFP and Pancreatic Progenitor Cells¡£ \w=7L- 8  
£¨5£©The Role of ABC Transporters in Stem Cells¡£ ]\:FFg_O6t  
ºÜ¶à³õѧÕß°ÑSCIÂÛÎĵıêÌâд³É¡°The study of¡­¡­.¡±¡¢¡°The research on¡­¡­.¡±µÈ¡£ÕâÀà±êÌâÔÚSCIÂÛÎÄÖÐÊǺÜÉÙ¼ûµÄ¡£ tKUy&]T  
5.±êÌâµÄ¾ä·¨½á¹¹ N#`aVW'{v2  
±êÌâͨ³£ÓÉÃû´ÊÐÔ¶ÌÓï¹¹³É£¬Èç¹û³öÏÖ¶¯´Ê£¬¶àΪ·Ö´Ê»ò¶¯Ãû´ÊÐÎʽ¡£ÓÉÓÚ³ÂÊö¾äÒ×ʹ±êÌâ¾ßÓÐÅжÏʽµÄÓïÒ壬ͬʱҲ²»¼ò½à£¬Òò´Ë£¬´ó²¿·Ö±à¼­ºÍѧÕß¶¼ÈÏΪ±êÌâ²»Ó¦¸ÃÓɳÂÊö¾ä¹¹³É¡£ÓÉÓÚ±êÌâ¾ä×ӱȽϼòµ¥£¬²¢ÎÞÐèÖ÷¡¢Î½¡¢±ö£¬Òò´Ë£¬´ÊÐòÒ²¾ÍÏÔµÃÓÈÎªÖØÒª¡£ÌرðÊÇ£¬Èç¹û´ÊÓï¼äµÄÐÞÊιØÏµÊ¹Óò»µ±£¬¾Í»áÓ°Ïì¶ÁÕßÕýÈ·Àí½â±êÌâµÄÕæÕýº¬Òå¡£ i#~1|2  
дSCIÂÛÎĵÄʱºò£¬²»ÒªÏÈд³ÉÖÐÎÄÔÙ·­Òë³ÉÓ¢Óï¡£ 8c'0"G@S  
¡ò¡ò¡ò¡ò¨S¨S¨S¨S¨S¨S

kaobook 2011-08-17 22:29
µÚ5ÕÂÈçºÎÊðÃû¡¢µ¥Î»Ãû³ÆºÍµØÖ· Vy:ER  
1.×÷Õß×ʸñ±ê×¼ 1*x4T%RF$  
¹ú¼ÊÉ϶ÔÓÚ×÷ÕßµÄ×ʸñÊÇÓÐÑϸñÒªÇóµÄ¡£ÓÐ×ʸñ³ÉΪSCIÂÛÎÄ×÷ÕßÓ¦·ûºÏÏÂÁÐËùÓбê×¼£¨criteria£©¡£ ?mt$c6-  
(1)ÖÁÉÙ²ÎÓ벿·Ö¿ÎÌâµÄ¹¹Ë¼ÓëÉè¼Æ¡¢×ÊÁÏ»òÊý¾Ý·ÖÎöºÍ½âÊÍ¡£ LE Y Y{G?  
(2)ÂÛÎĸåµÄÆð²Ý¡¢Ð´×÷»ò¶ÔÆäÖØÒªÑ§ÊõÄÚÈÝ×÷ÖØ´óÐ޸ġ£ Hf %;FaJ=  
(3)ͬÒâ×îºó¶¨¸å¡£ b}$m!c:<8  
Òò´Ë£¬×÷ÕßµÄ×ʸñÓ¦ÒÔÊÇ·ñʵ¼Ê²ÎÓëÒÔÉÏʵ¼Ê¹¤×÷Ϊ»ù´¡¡£½ö½ö³ï¼¯»òÌṩ×ʽð»òÊÕ¼¯×ÊÁÏÕß²¢²»Ó¦µ±³ÉΪ×÷Õߣ¬¶ÔÑо¿Ð¡×é½øÐÐÒ»°ãÐԵعÜÀíÖ¸µ¼ÕßÒ²²»×ãÒÔ³ÉΪ×÷Õß¡£ _TB\@)\  
2.ÊðÃûµÄÄ¿µÄ vfegIoZ  
£¨1£©Öø×÷ȨӵÓеÄÉêÃ÷¡£ÊðÃû±¾Éí¼´ÏòÉç»áÉêÃ÷×÷Õß¶Ô¸Ã×÷Æ·ÓµÓÐÁËÖø×÷Ȩ£¬ÈκθöÈ˺͵¥Î»²»ÄÜÇÖ·¸¡£ 'EREut,>'  
£¨2£©ÊðÃû±íʾÎÄÔð×Ô¸ºµÄ³Ðŵ¡£ M14_w ,  
£¨3£©ÊðÃû±ãÓÚ¶ÁÕßͬ×÷ÕßÁªÏµ¡£ eOn,`B1  
3.×÷Õߣ¨Á½ÈËÒÔÉÏ£©ÅÅÐòºÍ±í´ïÐÎʽ =WEfo;  
£¨1£©µÚÒ»×÷ÕßÊÇÖ÷Òª¸ºÔðÊÕ¼¯ºÍ·ÖÎöÊý¾Ý¡¢ÂÛÎĸåµÄÆð²ÝºÍд×÷¡£ \hM6 ykY-  
£¨2£©×îºóÒ»¸ö×÷ÕßÒ»°ãÊÇ¿ÎÌ⸺ÔðÈË£¬¶Ô¿ÎÌâºÍÂÛÎÄÈ«Ãæ¸ºÔð¡£ K)Db3JIIk  
£¨3£©ÆäËû×ø×ÅÓ¦¸ù¾ÝÆïÔÚÑо¿ÖеĵűÏ×À´ÅÅÐò¡£ v,|;uc+  
ÓÐʱ¿ÎÌâΪºÏ×÷ÏîÄ¿£¬Òò´Ë¿ÉÄÜÓÐÁ½Î»×÷ÕßΪͨÐÅ×÷Õß¡£±í´ïÐÎʽΪ£º Ya9uu@F  
Correspondence author: 1|gP :t}  
Xxxx,MD,PhD Tz*5;y%4  
Department of Neurology ~4`wfOvO  
University of San Francisco R9CAw>s  
4410 Clement St <![T~<.  
San Francisco,CA 94495 v}_$9&|S  
Tel:415-555-xxxx nlY ^  
Fax:415-555-xxxx z{n=G  
E-mail:kxxx@ucsf.edu Ti)n(G9$  
Or(¿ÉÒÔ²»ÓÃ) B\=&v8  
Xxxx,MD,PhD u51/B:+   
Department of Neurology 9/%|#b-z  
Huashan Hospital, Fudan University SA&wW\Ym]  
Shanghai 200135,China ;,A\bmC  
Tel:021-555-xxxx ~J2Q0Jv  
Fax:021-555-xxxx ^$L/Mv+  
E-mail:kxxx@yahoo.com.cn g<C})84y3  
4.×÷ÕßÖ°Ôð M`<D Z<:<  
(1)²»ÄÜÒ»¸åÁ½Í¶¡£(2)²»ÄÜÄóÔìºÍÆÛÆ­¡£ _NkN3f5 1L  
(3)ÂÛÎÄ×÷ÕßÊÇÖ÷ÒªµÄÑо¿Õߣ¬¶ÔÑо¿×÷³öÁËÖØÒª¹±Ï×£¬²¢ÊìϤԭʼÊý¾Ý¡£ b?^n '0  
(4)ËùÓÐ×÷Õß¿´¹ý×îºó¶¨¸å²¢¶ÔÆäÄÚÈݸºÔð¡£Èç¹û¸ÃÂÛÎÄ»òÆä²¿·ÖÄÚÈݱ»·¢ÏÖÓÐÎó»òÆÛÕ©£¬ËûÃÇÓ¦³Ðµ£ÔðÈΡ£ S&Sf}uK  
5.ÊðÃû¸ñʽ L~$RF {$  
×÷ÕßµÄÐÕÃûдÔÚÂÛÎıêÌâµÄÏ·½£¬¾ÓÖÐÊéд¡£µ±ÓÐÁ½Î»ÒÔÉÏ×÷Õßʱ£¬Ã¿Ò»×÷ÕßµÄÃû×ÖÓöººÅ·Ö¿ª£¬×îºó×÷ÕßµÄÃû×ÖµÄÇ°Ãæ¸ÄÓÃand·Ö¿ª¡£¹¤×÷µ¥Î»Ãû³ÆºÍµØÖ·Ó¦Î»ÓÚÊðÃûµÄÏ·½¡£µ±×÷ÕßÀ´×Ô²»Í¬µ¥Î»Ê±£¬¿ÉÒÔÓ÷ûºÅ»òÊý×Ö˵Ã÷¡£²»ÒªÔÚ¡°½ÌÊÚ¡±ºóÃæ¼Ó¡°²©Ê¿Éúµ¼Ê¦¡±¡£Ò»°ãÀ´Ëµ×÷Õߣ¨Í¨Ñ¶×÷Õß³ýÍ⣩µ¥Î»µÄÏêϸµØÖ·Èç½ÖµÀÃû»òºÅÂë²»ÐèҪдÃ÷¡£ -Gpj^aBU  
6.³£¼ûÎÊÌâºÍ×¢ÒâÊÂÏî Dpd$&Wr0Y  
SCIÂÛÎÄÊðÃûÌåÏÖµÄÒâÒå²»½öÊÇÈÙÓþ£¬¸ü¶àµÄÊÇÔðÈΡ£µ«ÊdzÉΪSCIÂÛÎĵÄ×÷Õߣ¬ÓÈÆäÊǵÚÒ»×÷Õߣ¬¿ÉÄÜÓëÕÒ¹¤×÷»ò½úÉý»òÉêÇë»ù½ðÖ±½ÓÏà¹Ø¡£Òò´Ë£¬ÓÐʱºòϵÖ÷Èβ¢Ã»ÓÐÖ±½Ó²ÎÓë¿ÎÌâµÄÑо¿£¬µ«ÓпÉÄܱ»ÄÉÈëΪ×÷Õß¡£Äê×ʱȽϵ͵ÄÑо¿ÈËÔ±Ò²¾­³£°Ñ×ÊÉîÑо¿ÈËÔ±ÁÐΪÂÛÎÄ×÷ÕßÒÔ±íʾ¸ÐлËû£¨ÃÇ£©µÄÖ§³Ö»òÕßÌá¸ßÂÛÎÄ·¢±íµÄ»úÂÊ¡£ÓÐʱ»ù´¡Ñо¿ÕßÁÐÁÙ´²Ò½ÉúΪÂÛÎÄ×÷ÕßÒÔ×÷Ϊ×éÖ¯ÑùÆ·ºÍ²¡ÈËÊý¾ÝµÄ½»»»Ìõ¼þ¡£¸ù¾Ý¹ú¼ÊÂÛÎÄÊðÃû×¼Ôò£¬ËùÓÐÕâЩ·½·¨»òÕßÀíÓɾù±»ÊÓΪ²»Ç¡µ±µÄÐÐΪ¡£ _~kcr5  
ÓÐʱ»áÓÐÖø×÷ȨºÍ×÷ÕßÅÅÁоÀ·×¡£±È½Ï¼òµ¥µÄ·½·¨ÊÇ£¬Ê×ÏÈ£¬ÄãºÍÄãµÄºÏ×÷ÕßͬÒâ×ñÑ­¹ú¼ÊÂÛÎÄÊðÃû×¼Ôò¡£Æä´Î£¬ÔÚÑо¿¿ªÊ¼Ö®Ç°£¬È·¶¨×÷ÕßÃûµ¥¡£×îºó£¬ÊÂÏÈ̽ÌÖ×÷ÕßÅÅÐòºÍË­½«ÊÇͨѶ×÷Õß¡£ m&q;.|W  
7.ÖйúÈËÐÕÃûÔÚSCIÂÛÎÄÖеıí´ï |-fx 0y   
ÖйúÈËÐÕÃûÔÚSCIÂÛÎÄÖÐÓв»Í¬µÄ±í´ï·½Ê½¡£¼ûʾÀý +XE21hb   
ÖйúÈËÐÕÃû£º½ðУ°²¡£ &J b.OCf  
±í´ï·½Ê½£º *ls6#j@  
¨SXiaoan Jin£¨³£¼ûÓÚSCIÆÚ¿¯£©£¬¼ìË÷¹Ø¼ü´ÊΪ£ºJin£¬X CnH R&`  
¨SXiaoAn Jin£¨³£¼ûÓÚSCIÆÚ¿¯£©£¬¼ìË÷¹Ø¼ü´ÊΪ£ºJin£¬X co3 ,8\N0  
¨SXiao-An Jin£¨³£¼ûÓÚSCIÆÚ¿¯£©£¬¼ìË÷¹Ø¼ü´ÊΪ£ºJin£¬XA 6dL>Rzl$Dk  
¨SJin,Xiaoan£¨ÉÙ¼ûÓÚSCIÆÚ¿¯£©£¬¼ìË÷¹Ø¼ü´ÊΪ£ºJin£¬X IdxToMr  
¨SJIN£¬Xiaoan£¨ÉÙ¼ûÓÚSCIÆÚ¿¯£©£¬¼ìË÷¹Ø¼ü´ÊΪ£ºJin£¬X ".%LBs~$  
¨SXiao An Jin£¨An±í´ïΪMiddle name£¬²»ÍƼö£© 0UJ`<Bfd  
¨SJin Xiao An£¨ÖÐʽ±í´ï£¬²»ÕýÈ·£© Y14R"*t~  
¡ò¡ò¡ò¡ò¨S¨S¨S¨S¨S¨S Y:,R7EO{!  

kaobook 2011-08-17 22:29
µÚ6Õ ÈçºÎSCIÂÛÎĵÄÕªÒª {*;]I?9Al  
1.ÕªÒªµÄ¶¨Òå Q!X_&ao )O  
ÕªÒª£¨abstract»òsummary£©ÊǶÔÂÛÎÄÄÚÈݵĸÅÀ¨£¬ÊÇÒÔÌṩÎÄÏ×ÄÚÈݸü¸ÄΪĿµÄ£¬¼òÃ÷¶óÒª¡¢ÕýÈ·¼ÌÐøÎÄÏ×ÖØÒªµÄÄÚÈݵĶÌÎÄ¡£ÕªÒªÖ÷Ҫ˵Ã÷ÂÛÎĵÄÄ¿µÄ¡¢ËùÓõķ½·¨¼´È¡µÃµÄ½á¹û¼°ÒâÒå¡£ÕªÒªÊÇSCIÂÛÎĵıØÒª¸½¼Ó²¿·Ö£¬Ö»Óн϶̵ÄÎÄÕ²ÅÄÜÊ¡ÂÔ¡£ "g%:#'5  
2.ÕªÒªµÄ×÷Óà 9>3Ltnn0  
¡ò±¨µÀÂÛÎÄÐÅÏ¢ 4Qel;  
ÕªÒªÓ¦¾ßÓжÀÁ¢ÐÔºÍ×ÔÖ÷ÐÔ£¬²¢ÇÒº­¸ÇÂÛÎĵÄÖ÷ÒªÐÅÏ¢£¬ÒÔ±ã¶ÁÕßѸËÙ×÷³öÅжϣ¬ÊÇ·ñÓбØÒªÔĶÁÈ«ÎÄ¡£Ðí¶à×÷ÕßµÄSCIÂÛÎÄÕªÒª½Ï¼òÂÔ£¬Ã»ÓÐ×¢Ò⽫ÎÄÕÂÖ÷ÒªÄÚÈÝÌåÏÖÔÚÕªÒªÖУ¬´Ó¶øÓ°ÏìÂÛÎĵĽ»Á÷ºÍ·¢±í¡£ +){a[@S@x  
¡òµç×ÓÎÄÏ×¼ìË÷ hlFU"u_  
ÕªÒªÊǶþ´ÎÎÄÏ×µÄÖøÂ¼ÄÚÈÝ¡£Òò´Ë£¬ÕªÒª±ØÐëÄÉÈë×ã¹»µÄ¹Ø¼üÐÅÏ¢£¬Èç½á¹û¡¢¹Û²ì¡¢Ç÷ÊÆµÈ£¬Ê¹¶ÁÕ߿ɲο¼ÄãµÄ¹¤×÷¡£ {Okik}Oh  
¡òÓÃÓÚÉó¸å¹ý³Ì G^rh*cb K  
Ò»°ãSCIÆÚ¿¯±à¼­°ÑÂÛÎĵÄÌâÄ¿ºÍÕªÒªË͸øºòÑ¡Éó¸åÈË£¬Éó¸åÈ˸ù¾ÝÕªÒªÄÚÈÝÀ´¾ö¶¨ÊÇ·ñÓÐÐËȤ»òÕßÖµµÃ»¨Ê±¼äÉóÔĴ˸塣 ru/zLj:  
3.ÕªÒª½á¹¹ 9Ir~X|}\iL  
Ò»°ãժҪΪһ¸ö×ÔÈ»¶Î£¨one paragraph£©¡£ÕªÒªµÄÖ÷Òª½á¹¹¿ÉÒÔ¸ÅÀ¨ÎªÒÔÏÂËĸö²¿·Ö£¬°´Ë³ÐòÅÅÁУº B N*,!fx  
£¨1£©´æÔÚÎÊÌâºÍÖ÷ÒªÑо¿µÄÄ¿µÄ£¨Motivation/Problem Statement£©¡£ #~URLN  
£¨2£©ÊµÑéÉè¼ÆÓë·½·¨£¨Methods/Procedure/Approach£©¡£ wAYzR$i  
£¨3£©×îÖØÒªµÄ½á¹û£¨Results/Findings/Product£©¡£ I"cQ5gF?A  
£¨4£©Ö÷Òª½áÂÛ£¨Conclusion/Implications£©¡£ p=-B~:  
4.ÕªÒªµÄ¾ßÌåÄÚÈÝ p#;dLM/EA  
ÕªÒª½á¹¹  ÄÚÈÝ  À´Ô´ *M5$ h*;v  
±³¾°×ÊÁÏÎÊÌâÑо¿Ä¿µÄ  What did you investigate and why?  Introduction XuFm4DEJ  
ʵÑéÉè¼ÆÓë·½·¨  What did you do?  Methods krr-ZiK  
½á¹û  What did you find out?  Results p~, 3A:i  
½âÊͺͽáÂÛ  What do you results mean? So what?   Discussion 4('0f:9z+  
5.ÊéдժҪµÄ»ù±¾ÒªÇóºÍ×¢ÒâÊÂÏî Y1yXB).AH8  
£¨1£©ÕªÒªÎªSCIÂÛÎÄÈ«Îĵĸ߶ÈŨËõ¡£È·±£×¼È·¡¢¼ò½à¶ø³ä·ÖµØ±íÊöÂÛÎĵÄÖ÷ҪĿµÄ¡¢·½·¨¼°È¡µÃµÄÖ÷Òª½á¹û¼°ÒâÒå¡£ (Y'UvZlM%P  
£¨2£©¾«¶Ì¼òÃ÷£¬ÄÚÈÝÃ÷È·ÍêÕû¡£Ò»°ãSCIÂÛÎÄÕªÒªÒÔ200-300×ÖΪÒË¡£µ«Ó¦×¢ÒⲻͬµÄSCIÆÚ¿¯ÒªÇóÒ²²»Ò»Ö£¬ÈçScienceÒªÇóÕªÒªÔÚ125×Ö»ò¸üÉÙ¡£ e<L 9k}c  
£¨3£©ÕªÒªÖ»ÊÇÎÄ×ÖÃèÊö¡£Ã»ÓÐÈκÎÐÎʽµÄ˵Ã÷£¬Èçͼ¡¢±í¡¢×¢ÊÍ¡£Îª·½±ã¼ìË÷ϵͳת¼£¬Ó¦¾¡Á¿±ÜÃâʹÓû¯Ñ§½á¹¹¡¢Êýѧ±í´ïʽ¡¢½Ç¶ÈºÍÏ£À°ÎĵÈÌØÊâ·ûºÅ¡£ f>s#Ngvc  
£¨4£©ÕªÒªµÄµÚÒ»¾ä»°×îÖØÒª£¬ÄÚÈݰüÀ¨ÁËÑо¿¶¯»ú£¨motivation: why do we care about the problem and the results? £©ºÍ´æÔÚµÄÎÊÌ⣨problem statement: what problem are you trying to solve?£©£¬Òò´Ë·´Ó³ÄãÎÄÕÂÑо¿µÄ·½ÏòºÍÖØÒªÐÔ¡£ k5fH ;  
£¨5£©Ó¦²ûÊöÂÛÎĵÄÖ÷ÒªÄÚÈÝ¡£ÄÚÈݱØÐ뾫Ðıàд£¬³¢ÊÔÐí¶à°æ±¾¡£ *C3uMiz  
£¨6£©ÒªÒýÆð¶ÁÕßµÄÐËȤ£¬ÒªÔ­´´¡£ A{ i][1N  
£¨7£©±ÜÃâ²»±ØÒªµÄ»°£¬Èç¡°In recent years¡­¡±¡¢¡°¡­has received great attention¡­¡±¡¢¡°There has been great interest in¡­¡±¡£ (:&&;]sI  
£¨8£©±ÜÃâÓÿÉÄܵ¼Ö¶ÁÕß»ìÏýµÄËõÂÔÓï»òÊõÓï¡£ÈçÈ·ÓÐÐèÒª£¬Ó¦ÔÚËõд·ûºÅµÚÒ»´Î³öÏÖʱ¸ø³öÆäÈ«³Æ¡£ 8g# c%eZ  
£¨9£©²»Ó¦°üº¬²Î¿¼ÎÄÏס£ .`p<hA)%[C  
£¨10£©²»Ó¦°üº¬Èß³¤µÄ±³¾°×ÊÁÏ¡£  r21?c|IP  
£¨11£©¿ÉÒÔÓÐһЩÊý×Ö£¬µ«²»Òª¹ý¶à¡£ _:ZFCDO  
£¨12£©ÔÙ´ÎÈ·ÈÏÕªÒªÄÚÈÝ¡£Ò»µ©ÄãÍê³ÉÕªÒª£¬ÐèÒªÔÚ¼ì²é£¬ÒÔÈ·±£ÄÚÈÝÓëÂÛÎÄÍêÈ«Ïà·û¡£ &# vk4C_8m  
6.ժҪд×÷µÄÈ˳ƺÍÓï̬ DGa#d_I  
ÓÉÓÚÖ÷¶¯Óï̬µÄ±í´ï¸üΪ׼ȷ£¬ÇÒ¸üÒ×ÔĶÁ£¬Òò¶øÄ¿Ç°´ó¶àÊýSCIÆÚ¿¯¶¼ÌᳫʹÓÃÖ÷¶¯Óï̬¡£Nature¡¢CellµÈÆÚ¿¯ÆÕ±éʹÓõÚÒ»È˳ƺÍÖ÷¶¯Óï̬µÄ±í´ï·½Ê½¡£±ÜÃâʹÓõÚÈýÈ˳ƣ¬Èç¡°This paper reported that¡­¡±¡£ |aI|yq)  
7.ÕªÒªµÄд×÷ʱ̬ 0%h [0jGj  
´óÖ¿ÉÒÔ×ñÑ­ÒÔÏÂÔ­Ôò¡£ u=d`j  
£¨1£©½éÉܱ³¾°×ÊÁÏ»ò²ûÊÍÑо¿µÄÖ÷ҪĿ±êʱ£¬Èç¹û¾ä×ÓÄÚÈݲ»ÊÜʱ¼äÓ°Ï죬ÊÇÆÕ±éÊÂʵ£¬Ó¦Ê¹ÓÃÏÖÔÚʱ£»Èç¹û¾ä×ÓµÄÄÚÈÝÊǶÔijÖÖÑо¿Ç÷ÊÆµÄ¸ÅÊö£¬ÔòʹÓÃÏÖÔÚÍê³Éʱ¡£ Vr&el  
£¨2£©¸ÅÊöʵÑé³ÌÐò¡¢·½·¨ºÍÖ÷Òª½á¹ûʱ£¬Í¨³£Óùýȥʱ¡£ c{'$=lR "  
£¨3£©ÐðÊö½áÂÛ»ò½¨Òéʱ£¬¿ÉʹÓÃÏÖÔÚʱ¡£ 7.7Cluh5,  
È»¶ø£¬²»Í¬µÄSCIÆÚ¿¯Óв»Í¬µÄÒªÇó¡£ÓÉÓÚ¸÷SCIÆÚ¿¯¶¼ÓÐÆä¾ßÌåÒªÇó£¬Òò´ËҪȷ¶¨Ôڵݽ»ÄúµÄÂÛÎÄ֮ǰͨ¶Á×÷ÕßÖ¸ÄÏ£¬°´ÕÕ¸ÃÆÚ¿¯µÄÒªÇó½øÐÐÕýÈ·µÄ¸ñʽ»¯¡£ 4)z3X\u|Z2  
8.ժҪд×÷¼¼ÇÉ 6T^N!3p_  
¾¡¹ÜÕªÒª³öÏÖÔÚÂÛÎĵÄ×îÇ°Ãæ£¬µ«ÕªÒªÒ»°ãÓ¦¸ÃÔÚÎÄÕ¸÷Ö÷Òª²¿·ÖÍê³ÉºóÔÙд¡£ÒòΪժҪ×ܽáÁËÂÛÎÄ£¬ÕâÑùÓÐÀûÓÚÎÄÕÂÒªµãµÄÌáÁ¶¡£ÓÅÐãµÄÕªÒªÄÜÓÐЧץס¶ÁÕßµÄÐËȤ¡£¿ªÊ¼Ð´×÷ժҪʱ£¬¿ÉÒÔ´ÓIntroduction¡¢Material and Methods¡¢Results and DiscussionÕ½ÚÖÐÑ¡ÔñÕû¸ö¾ä×Ó»ò¹Ø¼ü¶ÌÓ²¢°ÑËûÃǰ´Âß¼­ÅÅÁС£È»ºó×ÅÊÖÐ޸ĻòÌí¼ÓÎÄ×Ö¡£¼òµ¥µØËµ£¬Ò»°ãÏÈ´ÓһЩ¼òµ¥µÄ±³¾°×ÊÁÏ¿ªÊ¼£¬ÓÃÒ»Á½¾ä»°½âÊÍΪʲôҪ×öÕâÏîÑо¿¼°ÓëÄãÑо¿Ïà¹ØµÄ±³¾°ÌØÉ«¡£Æä´ÎÊǼòÊö×öÁËʲô¡£×îºóÒ»¾äӦΪÑо¿½áÂÛ£¬ÎªÊ²Ã´½á¹ûÊǺÜÖØÒª£¬Ç¿µ÷Ñо¿µÄ´´ÐºÍÒâÒå¡£ [ E$$nNs  
9.Ëõ¶ÌÕªÒª·½·¨ S  KB@  
²»Í¬µÄSCIÆÚ¿¯ÆäÕªÒªµÄ³¤¶ÈÓÐËù²»Í¬¡£Ò»°ãËõ¶ÌÕªÒªµÄµÄ·½·¨ÈçÏ£º k9*J*7l-m  
£¨1£©È¡Ïû²»±ØÒªµÄ×־䣬Èç¡°It is reported¡­¡±¡°Extensive investigations show that¡­¡±¡°The author discusses¡­¡±¡°This paper concerned with¡­¡± gZw\*9Q9  
£¨2£©¶ÔÎïÀíµ¥Î»¼°Ò»Ð©Í¨ÓôʿÉÒÔÊʵ±½øÐмò»¯¡£ KW&nDu t  
£¨3£©È¡Ïû»ò¼õÉÙ±³¾°½éÉÜ£¨background information£©¡£ K%Usjezv&  
£¨4£©Ö»ÃèÊöÐÂÇé¿ö¡¢ÐÂÄÚÈÝ£¬¹ýÈ¥µÄÑо¿Ï¸½Ú¿ÉÒÔÈ¡Ïû¡£ GIl:3iB49  
£¨5£©×÷ÕßÔÚÎÄÏ×ÖÐ̸¼°µÄδÀ´¼Æ»®²»ÄÉÈëÕªÒª¡£ N; rXl8  
£¨6£©¾¡Á¿¼ò»¯Ò»Ð©´ë´ÇºÍÖØ¸´µÄ´ÊÓï¡£ c_~XL ^B@  

kaobook 2011-08-17 22:31
µÚ7Õ ÈçºÎSCIÂÛÎĵĹؼü´Ê re7!p(W?,  
1.¹Ø¼ü´Ê &(lMm)  
¹Ø¼ü´Ê£¨key word£©ÊÇÕªÒªÄÚÈݵÄŨËõ£¬ÊÇ·´Ó³SCIÂÛÎĵÄÖ÷ÌâÄÚÈݵÄ×îÖØÒªµÄ´Ê¡¢´Ê×éºÍ¶ÌÓһ°ãÑ¡ÓÃ3-6¸ö¡£¹Ø¼ü´ÊÒ²ÊÇSCIÂÛÎĵÄÎÄÏ×¼ìË÷±êʶ£¬±í´ïÎÄÏ×Ö÷Òª¸ÅÄîµÄ×ÔÈ»ÓïÑÔÓôʡ£¹Ø¼ü´ÊÊÇΪ·½±ã¼ÆËã»ú¼ìË÷£¨search engine£©Óõģ¬ÒªÇó´ÊÒåÃ÷È·£¬Ò»´ÊÒ»Òâ¡£ ~ wfoK7T}  
2.¹Ø¼ü´ÊµÄåàÑ¡ ILNE 4n  
£¨1£©´ÓÌâÄ¿ÖÐÕÒ¡£ÂÛÎĵÄÖ÷ҪŨËõ£¬×îÒ×ÕÒµ½¡£ jIKBgsiF/  
£¨2£©´ÓÕªÒªÖÐÕÒ¡£ÕªÒªÊÇÂÛÎĵÄÄÚÈÝŨËõ£¬°üÀ¨×îÖØÒªµÄ·½·¨¡¢½á¹û¡¢½áÂۺ͹ؼüÊý¾Ý¡£ _Mlhum t  
£¨3£©´ÓÂÛÎĵÄС±êÌâÖÐÕÒ¡£ËüÊÇ·´Ó³ÂÛÎÄÖ÷ÌâµÄ²ã´Î±êÌâ¡£ g* %bzfk=|  
£¨4£©´Ó½áÂÛÖÐÕÒ¡£¿ÉÕÒµ½ÌâÄ¿¡¢ÕªÒª¡¢Ð¡±êÌâÖЩѡµÄ½ÏÎªÖØÒªµÄ¹Ø¼ü´Ê¡£ j6`6+W=S(  
3.¹Ø¼ü´ÊµÄÊéд 55L gBD  
¹Ø¼ü´Ê£º×ó¸ñ¶¥Æð£¬ºó¿ÕÒ»¸ñд¹Ø¼ü´Ê¡£ O ,l\e 3;  
4.¹Ø¼ü´ÊµÄλÖà A8J?A#R*{q  
Ò»°ãÇé¿öÏ£¬¹Ø¼ü´ÊλÓÚÕªÒªÖ®ºó¡£ FSv1X  
5.Êéд¹Ø¼ü´ÊӦעÒâÊÂÏî Pv#KmSA9  
£¨1£©¹Ø¼ü´Ê²»ÒªÈ«²¿À´×ÔÂÛÎĵÄÌâÄ¿¡£ 4>l0V<  
£¨2£©¹Ø¼ü´Ê²»ÒªÖظ´¡£ 6e zcS}:+  

kaobook 2011-08-17 22:31
°ËÕÂÈçºÎÊéдSCIÂÛÎĵÄÒýÑÔ£¨Ç°ÑÔ£© {798=pC<.  
1.ÒýÎİüÀ¨µÄÄÚÈÝ f;R>Pr;rD  
£¨1£©¿ÎÌâµÄÌá³ö±³¾°¡£ (:JjQ`i  
£¨2£©Ç°ÈËÑо¿¾­¹ý¡¢³É¹û¡¢ÏÖʵÇé¿ö¼°´æÔÚµÄÎÊÌâºÍÆÀ¼Û¡£ Ac J>$L)  
£¨3£©ËµÃ÷Äã×öÕâÏîÑо¿µÄÔ­Òò¡£½éÉÜ¿ÎÌâµÄÐÔÖÊ¡¢·¶³ë¼°ÆäÖØÒªÐÔ£¬Í»³öÑо¿µÄÄ¿µÄ»òÕßÐèÒª½â¾öµÄÎÊÌâ¡£ iEe#aO"D!  
£¨4£©Ñо¿¹ý³ÌËù²ÉÓõķ½·¨¡¢Ñо¿¹¤×÷µÄз¢ÏÖºÍÒâÒå¡£ gUspGsfr  
2.ÒýÎÄд×÷µÄ»ù±¾ÒªÇó O6/xPeak  
£¨1£©ÑÔ¼òÒâê࣬ÌõÀíÇå³þ¡£ÒÔ×Á·µÄÓïÑÔ£¬±íÊöÑо¿¿ÎÌâµÄÀ´ÁúÈ¥Âö¼°Ñо¿½á¹û¡£Ò»°ãSCIÂÛÎÄÒýÑÔÔÚ450×ÖÒÔÄÚ£¬2-4¸ö×ÔÈ»¶Î¡£ RTZ :U@  
£¨2£©¾¡Á¿×¼È·¡¢Çå³þÇÒ¼ò½àµØÖ¸³öËù̽Ë÷ÎÊÌâµÄ±¾Öʺͷ¶Î§£¬¶ÔÑо¿±³¾°µÄ²ûÊö×öµ½·±¼òÊʶȡ£ÎÄÏ×ÒýÓúÍÊý¾ÝÌṩһ¶¨Òª×¼È·£¬ÇмDZÜÃâÆ¬ÃæÕªÂ¼²¿·Ö½á¹û¶ø²»·´Ó¦ÎÄÏ×µÄ×ÜÌå½á¹û¡£ÒýÓõÄÊý¾ÝÒ²ÒªÕýÈ·£¬ÌرðÊǶþ´ÎÒýÓõÄÊý¾Ý¡£ <M=';h^w2  
£¨3£©Òª°Ñ¸ÃÁìÓò¹ýÈ¥ºÍÏÖÔÚµÄ×´¿öÈ«Ãæ¸ÅÀ¨×ܽá³öÀ´£¬ÌرðÊÇ×îнøÕ¹µÄÒýÓá£ÔÚ±³¾°½éÉܺÍÎÊÌâµÄÌá³öÖУ¬Ó¦ÒýÓá°×îÏà¹Ø¡±µÄÎÄÏ×ÒÔÖ¸Òý×÷Õß¡£ÒªÓÅÏÈÑ¡ÔñÒýÓõÄÎÄÏ×°üÀ¨Ïà¹ØÑо¿ÖеÄԭʼ¡¢ÖØÒªºÍ×î¾ß˵·þÁ¦µÄÎÄÏס£Á¦½ä²»Ç¡µ±µØ´óÁ¿¡°×ÔÒý¡±¡£ÒýÓÃÎÄÏ×ʱ²»ÒªÔ­Îij­Â¼£¬ÒªÓÃ×Ô¼ºµÄ»°×ܽáÃèÊö¡£ sSNCosb  
£¨4£©²ÉÈ¡Êʵ±µÄ·½Ê½Ç¿µ÷×÷ÕßÔÚ±¾´ÎÑо¿ÖÐ×îÖØÒªµÄ·¢ÏÖ»ò¹±Ï×£¬ÈöÁÕß˳×ÅÂß¼­µÄÑݽøÔĶÁÂÛÎÄ¡£ 2HSb.&7-G  
£¨5£©½âÊÍ»ò¶¨ÒåרÃÅÊõÓï»òËõд´Ê£¬ÒÔ°ïÖú±à¼­¡¢Éó¸åÈ˺ͶÁÕßÔĶÁ¸å¼þ¡£ h+5 @I%WX  
3.ÒýÑÔµÄд×÷ 6vF/e#},  
£¨1£©´æÔÚʲôÎÊÌ⣿£¨What is the problem?£©ÂÛÎÄÒýÑÔµÄ×÷ÓÃÊÇ¿ª×ÚÃ÷ÒåÌá³ö±¾ÎÄÒª½â¾öµÄÎÊÌâ¡£ÒýÑÔÓ¦¿ªÃżûɽ¡¢¼òÃ÷¶óÒª¡£ÃèÊöÄãÖ¼ÔÚ½â¾öµÄÎÊÌâ¡£×ܽáÏà¹Ø±³¾°Ñо¿¡¢¹Ø¼ü¹ØÏµºÍ¸ÅÄʹ¶ÁÕßÄܹ»Àí½âÄãµÄʵÑé¡£ A=0@UqM  
£¨2£©ÎªÊ²Ã´ÄãµÄÑо¿ÊÇÖØÒªµÄ£¿£¨Why is your proposal important?£©¼òÒª²ûÊöǰÈËÔÚÕâ·½ÃæËù×ö¹ýµÄ¹¤×÷¡£Ê²Ã´ÊÇÒÑÖªµÄ£¬Ä¿Ç°´æÔÚµÄÎÊÌâ»òδ½â¾öµÄÎÊÌâ¡£»Ø´ðºÍ×ܽáÏà¹ØÑо¿£¬Ìá³öÄãÑо¿µÄÀíÓÉ¡£ÔÚ·ÖÎö¹ýÈ¥Ñо¿µÄ¾ÖÏÞÐԺͲûÃ÷×Ô¼ºÑо¿µÄ´´ÐµãʱҪÉ÷ÖØ¡£Ò»¶¨Òª×ñѭʵÊÂÇóÊǵÄÔ­ÔòÀ´¿Í¹Û¹«ÕýÆÀ¼Û±ðÈ˵Ť×÷£¬²»Òª°Ņ̃¸ß×Ô¼ºÑо¿µÄ¼ÛÖµ½¨Á¢ÔÚ±áµÍ±ðÈ˵Ť×÷Ö®ÉÏ¡£¶ÔǰÈ˹¤×÷µÄ¸ÅÀ¨Ò²²»Òª¶ÏÕÂÈ¡ÒåºÍÐîÒâÍáÇú±ðÈ˵ÄÒâ˼¶øÍ»³ö×Ô¼º·½·¨µÄÓŵ㡣ÐðÊöǰÈ˹¤×÷µÄǷȱÒÔÇ¿µ÷×Ô¼ºÑо¿µÄ´´ÐÂʱ£¬Ó¦É÷ÖØÇÒÁôÓÐÓàµØ¡£×î³£Óõıí´ï·½Ê½ÊÇ¡°To the best of our knowledge, we find/ identify for the first time¡­¡±¡£ÔÚһƪÂÛÎÄÖУ¬¶ÔǰÈ˹¤×÷µÄ¸ÅÀ¨Ó¦¾¡¿ÉÄÜ·ÅÔÚÒýÑÔÖС£ÔÚÕýÎÄÖУ¬Èç·ÇºÜ±ØÒª£¬¾Í²»ÒªÔÙÇ¿µ÷ÁË¡£ fwy"w  
£¨3£©ÄãÈçºÎ½â¾öÕâЩÎÊÌ⣿£¨What solution do you propose?£©¼òÊöÄãµÄʵÑ飻һ°ãµÄʵÑéÉè¼ÆºÍ·½·¨£»ÄãµÄз½·¨»òÖØÒª½á¹ûÓÐʲô¹ã·ºµÄÓ°Ïì»òÒâÒå¡£ qZ&a76t  
4.ÒýÑÔд×÷ʱ̬ºÍÓï̬µÄÓ¦Óà q#jEv-j.  
£¨1£©ÐðÊöÓйØÏÖÏó»òÆÕ±éÊÂʵʱ£¬³£ÓÃÏÖÔÚʱ¡£ ~x\Cmu9`  
£¨2£©ÃèÊöÌØ¶¨Ñо¿ÁìÓòÖÐ×î½üµÄijÖÖÇ÷ÊÆ£¬»òÕßÇ¿µ÷±íʾijЩ¡°×î½ü¡±·¢ÉúµÄʼþ¶ÔÏÖÔÚµÄÓ°Ïìʱ£¬³£²ÉÓÃÏÖÔÚÍê³Éʱ¡£ lAz2%s{6  
£¨3£©ÔÚ²ûÊö×÷Õß±¾ÈËÑо¿µÄ·½·¨¼°½á¹ûµÄ¾ä×Óʱ£¬¶àʹÓùýȥʽ¡£ v[smQO  
£¨4£©ÔÚ²ûÊö×÷Õß±¾ÈËÑо¿Ä¿µÄµÄ¾ä×ÓÖÐÓ¦ÓÐÀàËÆ¡°In this study,¡­¡±¡¢¡°The experiment reported here.¡±µÈ´Ê£¬ÒÔ±íʾËùÉæ¼°µÄÄÚÈÝÊÇ×÷ÕßÏÖÔڵŤ×÷£¬¶ø²»ÊÇÖ¸ÆäËûѧÕß»òÕß×÷Õß¹ýÈ¥µÄÑо¿¡£ H@Q`  
£¨5£©Êǵ±µØÊ¹ÓõÚÒ»È˳ÆÈç¡°we¡±»ò¡°our¡±£¬ÒÔÃ÷È·µØÖ¸Ã÷ÊÇ×÷Õß±¾È˵Ť×÷¡£ r,Ds[s)B  
¡¾ÍƼö¡¿We conducted this study to determine whether ... 4 A5t*e  
[²»ÍƼö]This study was conducted to determine whether ¡­ t{6ap+%L  
5.ÒýÑÔд×÷Öг£¼ûµÄ´íÎó =&N$Vqn  
£¨1£©ÒýÑÔ¹ý¼ò¡£ *Wso3 6an  
£¨2£©Ïà¹Ø±³¾°Ñо¿½»´úº¬ºý¡£ _; 7fraqX  
£¨3£©ÆÌµæÌ«Ô¶£¬ÈÆÁËÒ»¸ö´óȦ×ӲŽøÈëÖ÷Ìâ¡£ ^&-a/'D$,  
£¨4£©ÃèÊö¸ÃÑо¿µÄÖØÒªÐÔ£¬µ«ÊÇ¿´Ã»Óн»´úÏà¹ØµÄÀàËÆÑо¿¡£ gvGi %g q  

kaobook 2011-08-17 22:33
µÚ9ÕÂÈçºÎSCIÂÛÎĵÄʵÑé²ÄÁϺͷ½·¨ !DcX 8~~@  
ʵÑé²ÄÁϺͷ½·¨£¨Materials and Methods£©Õ½ÚÃèÊöÄãÊÇÔõÑùÀ´Ñо¿ÎÊÌ⣨How did you study the problem£©£¬°üÀ¨£º¢ÙÄãÓÃÁËʲô£¿£¨What did you use?£©¢ÚʵÑé¹ý³Ì£¿£¨How did you proceed?£© /< QSe  
1.ʵÑé²ÄÁϺͷ½·¨µÄÖØÒªÐÔ .[(P  
£¨1£©¿ÆÑ§³É¹û±ØÐëÊÇ¿ÉÖØ¸´ÐԵġ£¡°ÊµÑé²ÄÁϺͷ½·¨¡±Õ½ڵĹؼüÊDZ£Ö¤ËûÈË¿ÉÒÔÖØ¸´ÄãµÄ½á¹û£¬ÒòΪ±¾Õ½ÚÃèÊöÄã×öÁËʲô¡¢Ôõô×öºÍÓÃÁËʲô¡£ K(OaW)j  
£¨2£©ÉóºËÕß³£³£×ÐϸÑо¿±¾Õ½ڡ£Éó¸åÕ߸ù¾ÝÄãÌṩµÄʵÑé²ÄÁϺͷ½·¨À´ÅжϺ;ö¶¨ºóÊÇ·ñÂÛÎĵĽá¹û¿ÉÒÔÐÅÈΡ£Èç¹ûÉó¸åÕßÈÏΪʵÑé²ÄÁϺͷ½·¨ÓÐȱÏÝ£¬Ôò¸ÃÂÛÎĵÄÉè¼ÆÒ²ÓÐȱÏÝ¡£Æä½á¹ûÊǸÃÂÛÎı»¾Ü¾ø¡£ Ue!Q."  
Òò´Ë£¬ËäȻʵÑé²ÄÁϺͷ½·¨µÄд×÷Ïà¶Ô½ÏΪ¼òµ¥£¬µ«ÊÇÐèҪעÒâµÄÎÊÌâ²»ÉÙ£¬Öа¡Ó´µÄÔÚÓÚÍêÕûµÄÃèÊö¡£ÍêÕûÐÔ¾ÍÊÇʵÑéµ±ÖеÄÿһ¸ö»·½Ú¶¼Òª×¢Òâµ½£¬²»Òª¹Ë´Ëʧ±Ë£¬ÒÅÂ©Ò»Ð©ÖØÒªÄÚÈÝ¡£ 8W,*eke?  
2. ʵÑé²ÄÁϺͷ½·¨µÄÖ÷ÒªÄÚÈÝ K(3&27sGN  
ʵÑé²ÄÁϺͷ½·¨²¿·Ö¿ÉÒÔ°´ÒÔÏÂÈý¸ö·½ÃæÀ´ÃèÊö¡£ =fWdk\Wv  
£¨1£©ÄãÓÃÁËʲô£¬°üÀ¨£º !FP"M+  
¨SʵÑé¶ÔÏó£¨experimental subjects£©£ºÒ»°ãÊÇÈË¡¢¶¯Îï¡¢Ö²Îï»òÕßһЩ×éÖ¯µÈ£¬ËûÃǵĻù±¾ÐÅÏ¢ÒªÃèÊöÃ÷È·¡£Òª×¢ÒâSCIÂÛÎÄÆÚ¿¯´ó¶à¶ÔÇ£³¶µ½ÈË»ò¶¯ÎïµÄʵÑé¶¼ÊÇÒª¶¯ÎïίԱ»á£¨Institutional Animal care and Use Committee, IACUC£©»òÂ×ÀíίԱ»á£¨Institutional review Boards, IRB£©Í¨¹ý¡£ÏêÇéÁ´½ÓÍøÖ·£ºhttp://grants.nih.gov/grants/olaw/GuideBook.pdf¡£ºÍhttp://www.hhs.gov/ohrp/irb/irb_guidebook.htm¡£·½·¨Ñ§Ò»¶¨Òª×öµ½£ºÁÙ´²Ñо¿Óв¡ÈËÖªÇéͬÒâÊ飬ͨ¹ýÂ×ÀíίԱ»áÅú×¼£»¶¯ÎïʵÑé·ûºÏ±¾ÈË´óѧ»òÕßÑо¿µ¥Î»µÄ¶¯Îï¹ÜÀíÓ붯ÎïʵÑéµÄÕ³̵ȡ£Òò´Ë£¬ÈÏÕæÔĶÁͶ¸å¿¯ÎïÖйØÓÚʵÑéµÄÏêϸ¹æ¶¨¡£Èç¹ûÎ¥·´ÕâÒ»¹æ¶¨£¬¿ÉÄܻᱻ²»½ÓÊÜÆÀÉó»ò·¢±í¡£ÒªÃèÊöʵÑ鶯ÎïµÄfull binominal latin names¡¢ÖÖϵºÍÀ´Ô´¡£ iRs V#s  
ʾÀýÒ» ¶¯ÎïµÄʵÑéÃèÊö 2LK]Q/WG,+  
Animal model Hg whe=P  
All surgical procedures postoperative care was performed in accordance with guidelines of the Yale Animal Care and Use Committee. Focal cortical ischesia was induced in male mice(8-10 weeks old)weighing 20-25gm by photothrombosis of cortical microvessels as described previously in detail (Boquillon et al.,1992;Schroeter et al.,2002).Each mouse was anesthetized with 25 isoflurane and maintained with 1% isoflurane in an oxygen/air mixture using a gas anesthesia mask in a stereotaxic frame(Stoelting, Wood Dale,IL).The recal temperature was controlled during surgery at 37¡À0.5¡æ with a homeothermic blanket(Harvard Apparatus,Holliston,MA)¡­ %)JRbX<c  
ʾÀý¶þ ÈËÌåʵÑéÃèÊö [+gzdLad  
Human samples JY@X2'>v/  
The experiments were carried out in accordance with the Declaration of Helsinki(2000) of the World Medical Association and the protocols approved by the Institutional Research Review Board at ¡Á¡Á¡ÁHospital of Beijing University,with informed consent¡­ Azn:_4O  
¨SʵÑé²ÄÁÏ£¨experimental materials£©£º¶Ô²ÄÁϵÄÃèÊöÓ¦Çå³þºÍÏêϸ¡£Èç¹û²ÉÓÃͨÓòÄÁϺÍͨÓ÷½·¨£¬Ö»Ðè¼òµ¥Ìá¼°¡£ÀýÈ磬¡°Detail on calculating CBF have been described previously (reference)¡±»òÕß¡°the CBF was calculated based on 7E\gxQ(vU  
The protocol as previously described (reference)¡±¡£Èç¹û²ÉÓÃÓиĽøµÄÌØÊâ²ÄÁϺÍʵÑé·½·¨£¬¾ÍÓ¦¸Ã½ÏÏêϸµÄ¼ÓÒÔ˵Ã÷¡£»¯Ñ§Ò©Æ·ºÍʵ¼ÊµÄÉÌÒµÀ´Ô´Ó¦¸Ã˵Ã÷£¬µ«Êǹ«Ë¾µØÖ·²»±ØËµÃ÷£¬Èç¡°¡­poly-l-Lysine(Sigma#1309)¡±·ÇÉÌÒµÀ´Ô´µÄ»¯Ñ§Ò©Æ·ºÍÊÔ¼Á±ØÐëÌṩµØÖ·£¬Èç¡°The DCX antibody was kindly provived by Peter A.Rice(Buck Institute La Jolla,CA)¡±¡£ g}r^Xzd;  
¨SʵÑéÉ豸£¨experimental equipment£©:Òª¶ÔÒÇÆ÷Ðͺš¢Éú²ú³§¼Ò¡¢ÊµÑé¹ý³ÌÖеÄÓÃ;µÈ×÷Ïêϸ˵Ã÷£»É豸ʹÓÃʱһЩ±ØÒªµÄµÄ²½Öè²»¿ÉÊ¡ÂÔ£¬ÓÈÆäÊÇ¿ÉÄܶÔʵÑé½á¹ûÔì³ÉÌØ¶¨Ó°ÏìµÄ²Ù×÷¸üÒªÏêϸ˵Ã÷¡£ÕâÑù×öµÄºÃ´¦ÊÇΪÁËÔÚDiscussionÕ½ÚÖÐÄܹ»½øÐжÔÓ¦µÄ·ÖÎö¡£ÀýÈ磬һЩÉ豸ÔÚʹÓÃǰҪУÕý£¨calibration£©£¬ÓеÄÒªÇóÿ½×¶ÎÊÔÑéÖ®ºó¶¼ÒªÖØÐÂУÕý£¬ÒÔ±£Ö¤½á¹ûµÄÕýÈ·ÐÔ¡£Ò»¶¨ÒªÏêϸ˵Ã÷ÄãµÄ²Ù×÷²½Öè»òУÕý¹ý³Ì£¬±ãÓÚÆÀÉóÈË·ÖÎöÄãµÄ½á¹ûµÄ¿É¿¿ÐÔ¡£ w+Vk3c5uI)  
ʾÀýÈý ʵÑéÉ豸ºÍʵÑé¹ý³ÌµÄ·½·¨Ð´×÷ Mr.JLW  
Apparatus cAibB&`~  
NRI data were acquired at 1.5-T clinical MRI system(Signa,GE Medcial Systems)using the product head coil and foam cushions to minimize head movement. A standard 3D inversion recovery prepped T1-weighted spoiled gradient dcho(GE)sequence (echo time [TE]/repetition time [TR]=8.6/1.6ms;field of view [FOV] of 24mm, 1mm isotropic resolution)was acquire for anatomical localization and a CSF-nulled T2-weighted FLAIR sequence(TE/TR=11002/145ms,FOV 24mm,slice thinkness of 5mm,256x192matrix) was acquired to identify regions of prior cerebral infarction¡­ s|gp  
Stroke,2006,37:382-387 )-q\aX$])  
£¨2£©ÊµÑé¹ý³Ì£¨experimental procedures£©£º¶ÔʵÑéµÄÕû¸ö²Ù×÷Á÷³ÌÃèÊöÒªÏêÂԵõ±¡¢ÖصãÍ»³ö¡£Ó¦×ñÑ­µÄÔ­ÔòÊǸø³ö×ã¹»µÄϸ½ÚÐÅÏ¢ÒÔ±ãÈÃͬÐÐÄܹ»Öظ´ÊÔÑé¡£Èç¹û·½·¨ÐÂÓ±ÇÒ²»Ôø·¢±í¹ý£¬Ó¦ÌṩËùÓбØÐèµÄµÄϸ½Ú£»Èç¹ûËù²ÉÓõķ½·¨ÒѾ­¹«¿ª±¨µÀ¹ý£¬ÒýÓÃÏà¹ØµÄÎÄÏ×¼´¿É¡£ÐðÊöʱ£¬²»ÒªÂÞÁÐʵÑé¹ý³Ì£¬¶øÖ»ÐðÊöÖ÷ÒªµÄ¡¢¹Ø¼üµÄ¡£²¢ËµÃ÷ʹÓò»Í¬ÓÚÒ»°ãʵÑéµÄµÄÉ豸ºÍ²Ù×÷·½·¨£¬´Ó¶øÊÇÑо¿³É¹ûµÄ¹æ·¶ÐÔ¸ü¼ÓÏÊÃ÷¡£ÐðÊöʵÑé¾­¹ý£¬Í¨³£²ÉÓÃÑо¿¹¤×÷µÄÂß¼­Ë³Ðò£¬¶ø²»°´ÊµÑéÏȺó˳Ðò£¬Òª×¥×¡»·½Ú£¬£¬´Ó¸´ÔÓµÄÊÂÎïÖÐÀí³öÂöÂ磬°´Æä·¢Õ¹±ä»¯¹æÂÉд¡£ $+TYvA'N  
£¨3£©½á¹ûµÄͳ¼Æ´¦Àí£¨How the data were analyzed?£©¡£ÊµÑéµÄ½á¹ûÐèÒª½øÐÐͳ¼Æ´¦Àíʱ£¬ÒªÌṩ×ã¹»µÄÐÅÏ¢£¬°üÀ¨£º T`Ro)ORC #  
¨SʵÑéÖØ¸´Á˼¸´Î£¬Ò»°ãÀ´ËµÊµÑéÖÁÉÙÖØ¸´Èý´Î¡£ >HIt}Zh  
¨S¾ùÖµ¡£ '=@r7g.2  
¨S±ê×¼Îó£¨SEM£©»ò±ê×¼²î£¨SD£©¡£ xx0k$Dqt2I  
¨Sͳ¼Æ·ÖÎöµÄ·½·¨¡£ [?I/ Uo8  
¨SPÖµ£¨P value£©¡£ /Zx8nx'{V  
3.²ÄÁϺÍд×÷·½·¨µÄÒªµã Efvq?cG&  
£¨1£©ÃèÊöʵÑé¹ý³ÌÓ¦×ñÑ­µÄÔ­ÔòÊǸø³ö×ã¹»µÄϸ½ÚÐÅÏ¢ÒÔ±ãÈÃͬÐÐÄܹ»Öظ´ÊÔÑ飬±ÜÃâ»ìÈëÓйؽá¹û»ò·¢ÏÖijЩ·½ÃæµÄÄÚÈÝ¡£ 5v3RVaqZ  
£¨2£©Ð´×÷ʱҪÏêÂԵõ±¡£×ñÑ­µÄÔ­ÔòÊÇ£ºÈç¹û·½·¨ÐÂÓ±ÇÒ²»Ôø·¢±í¹ý£¬Ó¦ÌṩËùÓбØÒªµÄϸ½Ú£»Èç¹ûËù²ÉÓõķ½·¨ÒѾ­¹«¿ª±¨µÀ¹ý£¬ÒýÓÃÏà¹ØµÄÎÄÏ×¼´¿É¡£Èç¹û¸Ä½ø£¬¿ÉÓá°Briefly¡±¡°In brief¡±½«¸Ä½øµÄ²¿·ÖÁí¼Ó˵Ã÷¡£ QXB|!'  
£¨3£©Ò©Æ·ºÍÊÔ¼ÁµÄŨ¶È£¬Ê²Ã´Ê±ºò´¦ÀíµÄ¡¢´¦Àíʱ¼äµÄ³¤¶ÈµÈÐðÊöÒ²ºÜÖØÒª£¬ÌرðÊǵ±Ìõ¼þÓб仯ʱ¡£ /sV?JV[t  
£¨4£©¿ÉÒÔÓÃÁ÷³Ìͼ½øÐÐ˵Ã÷ʵÑé¹ý³Ì¡£Á÷³ÌͼµÄ»­·¨ºÜ¶à£¬ÓÐÎÄ×ÖʽµÄ£¬ÓÐÎÄ×ÖºÍʾÒâͼ½áºÏµÄ£¬²»Í¬ÊµÑéÓв»Í¬×ö·¨¡£Ò»°ãÀ´Ëµ£¬¿ÉÄܺóÕß¶àһЩ£¨ÊµÑéÐÔѧ¿ÆÓÈÆäÈç´Ë£©£¬ÒòΪÕâÑùÄÜʹÆÀÉóÈ˶ÔʵÑé¹ý³ÌһĿÁËÈ»¡£Èç¹ûʾÒâͼ»­µÃƯÁÁ£¬»¹¿ÉÒÔÔö¼ÓһЩӡÏó·Ö¡£ÃèÊöʱҪÓÐÏÊÃ÷µÄ²ã´Î¸Ð£¬¶Ôÿ¸ö²½ÖèÖ®¼äµÄ˳ÐòºÍ¹ØÁªÒªÃèÊöÇå³þ£¬²»ÒªÔì³ÉʵÑé¹ý³Ì»ìÂÒ²»¿°µÄÓ¡Ïó¡£ T g{UK  
£¨5£©²»ÒªÖظ´ÃèÊö¡£ Otxa<M+"  
4.ÂÛÎÄÖг£´æÔÚͳ¼Æ·½·¨Ñ¡Ôñ²»µ±ºÍÓ¦Óò»ÕýÈ·µÈÎÊÌâ zU b8NOi  
£¨1£©Í³¼Æ·½·¨ÃèÊö²»Ç壬½áÂÛÇ·¿ÆÑ§¡£ÎÄÖÐδ½»´ýËùÓÃͳ¼Æ·½·¨»òͳ¼Æ·½·¨½»´ú²»Çå»ò¸ù±¾²»Óè½»´ú£¬Ê¹¶ÁÕß¶ÔÂÛÎĵÄÕýÈ·Óë·ñÎÞ·¨Åжϡ£ÓеÄ×÷ÕßÖ»ÌáÒ»¾ä¡°¾­Í³¼ÆÑ§´¦Àí¡±ºó£¬¾Íд³ö½áÂÛ¡£ÓеÄÉõÖÁÖ±½ÓÓÃPֵ˵Ã÷ÎÊÌ⣬ÁýͳµØÒÔP£¾0.05»òP£¼0.05¡¢P£¼0.01±ã³Æ½á¹û²îÒìÓÐÎÞÏÔÖøÐÔ£¬PÖµµÄ´óС²»ËµÃ÷²îÖµµÄ´óС£¬Ëü»¹Óë³éÑùÎó²î´óСÓйء£Òò´Ë£¬»¹Ó¦¸ÃдÃ÷¾ßÌåµÄͳ¼Æ·½·¨£¬ÈçÓÐÌØÊâÇé¿ö£¬»¹Ó¦¸Ã˵Ã÷ÊÇ·ñ²ÉÓÃÁËУÕý£¬Ó¦Ð´³öÃèÊöÐÔͳ¼ÆÁ¿µÄ¿ÉÐÅÇø¼ä£¬×¢Ã÷¾«È·Í³¼ÆÖµ£¨ÈçtÖµ¡¢FÖµºÍuÖµµÈ£©ºÍPÖµ£¬È»ºó¸ù¾ÝPÖµ´óС×ö³öͳ¼ÆÑ§ÍƲ⣬²¢×ö³öÏàÓ¦µÄרҵ½áÂÛ¡£ ;.AV;C"  
£¨2£©©~ͳ¼Æ¼ìÑé·½·¨²»ÕýÈ·¡£¾ßÌå±íÏÖÔÚ£º p>&S7M/9  
¡òtÖµ¼ìÑéÓÃÓÚ¶à×é×ÊÁϱȽϡ£ 4]IKh,jT  
¡ò³É×ét¼ìÑéÓëÅä¶Ôt¼ìÑéÎóÓᣠM2L0c?  
¡ò¶ÔÓÚÆ«Ì¬·Ö²¼µÄÊý¾Ý²ÉÓÃt¼ìÑé»ò·½²î·ÖÎö¡£ DUhT>,~]  
¡òËĸñ±íµÄ¼ìÑéÎóÓ㬹¹³É±ÈÓëÂʵÄÎóÓ㬷ÇÕý̬·ÖÎö×ÊÁÏÓáÀSM·½Ê½À´ÃèÊö¡£ @ 'Q%Jc(  
ÕâЩ´íÎóµÄ·½·¨±ØÈ»µ¼Ö´íÎóµÄ½áÂÛ¡£ÕýÈ·µÄ×ö·¨ÊÇÅä¶ÔÉè¼ÆµÄ¼ÆÁ¿×ÊÁÏÒËÑ¡ÓÃt¼ìÑé¡£t¼ìÑéºÍ·½²î¼ìÑéÖ»ÄÜÓÃÓÚÕý̬·Ö²¼µÄÊý¾ÝÖС£µ±·½²î²»Æëʱ£¬Ó¦Ñ¡ÓýüËÆµÄt¼ìÑ飬ÈôΪ´óÑù±¾£¨n£¾50£©£¬¿ÉÑ¡ÓÃu¼ìÑé¡£¶à×é¼ä¾ùÊý±È½Ïʱ£¬Èç¹û×ÊÁϳÊÕý̬·Ö²¼£¬ÇÒ·½²î³ÊÆëÐÔʱ£¬Ó¦¸ÃÓ÷½²î·ÖÎö£¨Ò²½ÐANOVA·ÖÎö£¬»òF¼ìÑ飩¡£ÒªÑо¿Ä³Á½¸ö»òij¼¸¸ö×ÜÌå¾ùÊýÊÇ·ñÏàµÈ£¬»¹ÒªÔÚ·½²î·ÖÎöµÄ»ù´¡ÉÏ£¬½øÒ»²½×öÁ½Á½±È½ÏµÄq¼ìÑ飨Ҳ½ÐStudent-Newman-Keuls¼ìÑé·¨£©¡£µ±¶à¸ö¹Û²ì×éÓëÒ»¸ö¶ÔÕÕ×é½øÐоùÊý¼ä±È½Ïʱ£¬Ó¦×÷Dunnett t¼ìÑé¡£ d{3I.$ThH  
5.²ÄÁϺͷ½·¨Ð´×÷ʱ̬µÄÓ¦Óà YLigP"*~^  
£¨1£©ÈôÃèÊöµÄÄÚÈÝΪ²»ÊÜʱ¼äÓ°ÏìµÄÊÂʵ£¬Ôò²ÅÓÃÒ»°ãÏÖÔÚʱ¡£ ]Cr]Pvab{  
£¨2£©ÈçÃèÊöµÄÄÚÈÝÎªÌØ¶¨¡¢¹ýÈ¥µÄÐÐΪ»òʼþ£¬Ôò²ÉÓùýȥʱ¡£ boIVU`F-!  
£¨3£©·½·¨Õ½ڵĽ¹µãÔÚÓÚÃèÊöʵÑéÖÐËù½øÐеÄÿ¸ö²½ÖèÒÔ¼°Ëù²ÉÓõIJÄÁÏ¡£ÓÉÓÚËùÉæ¼°µÄÐÐΪÓë²ÄÁÏÊÇÌÖÂ۵Ľ¹µã£¬¶øÇÒ¶ÁÕßÒÑÖ¸µ¼½øÐÐÕâЩÐÐΪºÍ²ÉÓÃÕâЩ²ÄÁϵÄÈ˾ÍÊÇ×÷Õß×Ô¼º£¬Òò¶øÒ»°ã¶¼Ï°¹ß²ÉÓñ»¶¯Óï̬¡£ }`#B f  
£¨4£©Èç¹ûÉæ¼°±í´ï×÷ÕߵĹ۵ã»ò¿´·¨£¬ÔòÓ¦²ÉÓÃÖ÷¶¯Óï̬¡£ I0(8 Z ]x  
£¨5£©Á¦ÇóÓï·¨ÕýÈ·¡¢ÃèÊö׼ȷ¡£ÓÉÓÚ²ÄÁϺͷ½·¨²¿·Öͨ³£ÐèÒª²ÉÓúܼò½àµÄÓïÑÔ£¬Ê¹Óþ«È·µÄÓ¢ÓïÃèÊö²ÄÁϺͷ½·¨ÊÇÊ®·ÖÖØÒªµÄ¡£ÐèҪעÒâµÄ·½ÃæÍ¨³£ÓУº u,\xok"  
¨S²»ÒªÒÅ©¶¯×÷µÄÖ´ÐÐÕß¡£ 8| Sba<d  
¨SÔÚ¼òµ¥±í´ïµÄͬʱҪעÒâÄÚÈÝ·½ÃæµÄÂß¼­ÐÔ¡£ 1-/ 4Y5?}  
¨SÈç¹ûÓжàÖֿɹ©Ñ¡ÔñµÄ·½·¨ÄܲÉÓã¬ÔÚÒýÓÃÎÄÏ×ʱÌἰһϾßÌåµÄ·½·¨¡£ D? %e"*>  
¨SÆÕͨ¡¢¼òµ¥µÄ¹ý³Ì²»±ØÏêÊö¡£ tgc@7  
¨S±ÜÃâʹÓú¬ºý²»ÇåµÄÃèÊö¡£ b~F!.^7Q  

kaobook 2011-08-17 22:34
µÚ10ÕÂÈçºÎÊéдSCIÂÛÎĵÄÑо¿½á¹û O-?z' @5cI  
Ñо¿½á¹û£¨Results£©ÊÇһƪÂÛÎĵĺËÐÄ£¨the core of the paper£©,Æäˮƽ±êÖ¾×ÅÂÛÎĵÄѧÊõ»áƽ»ò¼¼Êõ´´Ðµij̶ȣ¬ÊÇÂÛÎĵÄÖ÷Ì岿·Ö¡£×ܵÄÒªÇóÊDZØÐëʵÊÂÇóÊÇ¡¢¿Í¹ÛÕæÊµ¡¢×¼È·µÄÓÃ˵Ã÷ÐÔ²ÄÁÏ£¨Í¼ºÍ±í£©ÃèÊöÖ÷Òª³É¹û»òÕß·¢ÏÖ¡£ÎÄ×ÖÃèÊöÒªºÏºõÂß¼­¡¢²ã´Î·ÖÃ÷¡¢¼òÁ·¿É¶Á¡£ÓÐÈ˰ÑResultsºÍDiscussion·ÅÔÚÒ»Æðд£¬µ«ÊÇ´ó¶àÊýÂÛÎÄÒªÇó·Ö¿ªÐðÊö¡£ÕâÁ½ÖÖ×ö·¨È¡¾öÓÚÂÛÎĵÄÀàÐÍ£¬±ÈÈçÊÇresearch article»¹ÊÇrapid communication¡£ÓÐһЩSCIÆÚ¿¯µÄrapid communicationÒªÇóresultÓëdiscussionºÏ²¢¡£ "i}Z(_7yr  
1.Ñо¿½á¹ûµÄд×÷Òªµã #%;<FFu\  
£¨1£©ÑÔ¼òÒâêࣨbe concise£©¡£¶ÔʵÑé»ò¹Û²ì½á¹ûµÄ±í´ïÒª¸ß¶È¸ÅÀ¨ºÍÌáÁ¶¡£²»Äܼòµ¥µØ¶ÔʵÑé¼Ç¼Êý¾Ý»ò¹Û²ìÊÂʵ¶Ñ»ýµ½ÂÛÎÄÖУ¬ÓÈÆäÊÇҪͻ³öÓпÆÑ§ÒâÒåºÍ¾ßÓдú±íÐÔµÄÊý¾Ý¡£ 2n _T2{  
£¨2£©±ÜÃâÖØ¸´£¨avoid repetition£©¡£¾ö¶¨ÄÄһЩÄÉÈë½á¹ûÕ½ڣ¬ÄÄÒ»Ð©Ç¨ÒÆµ½ÌÖÂÛÕ½ڡ£ÔÚ½á¹ûÕ½ڣ¬ÄãÖ»ÃèÊö½á¹û£¬Ò»°ã×ö²»×ö½âÊÍ¡£ÔÚÌÖÂÛÕ½ڽøÐнâÊÍ£¬²¢ÓëÒÑÖªµÄ±¨µÀ±È½Ï£¬²»ÒªÖظ´ËùÓнá¹û¡£ 1k*n1t):  
£¨3£©¶ÔʵÑé»ò¹Û²ì½á¹ûÒª¿Í¹ÛµØÆÀ¼Û¡£Äã¹Û²ìµ½Ê²Ã´»òÄã·¢ÏÖÁËʲô£¿¶Ôÿ¸öʵÑé»ò³ÌÐòÒª£º x_]",2 W'  
¨S¼òÊöʵÑ飨£©¡£ÀýÈ磬¡°By Western bolt abnaiysis,we found that¡­¡±¡£ {_": / A  
¨S±¨¸æµÄÖ÷Òª½á¹û£¨mains results£©°üÀ¨Ô¤ÆÚ½á¹û£¨positive results£©ºÍÒõÐÔ½á¹û£¨negative results£©¡£ W<Bxm|  
¨SµäÐÍʵÀý£º×î³£¼ûµÄ£¨most common£©¡£ ;jp6 }zfI  
¨S×î¼Ñ°¸Àý£º×îÀíÏëµÄÀýÖ¤£¨best example of ideal or exception£©¡£ c1gz #,  
£¨4£©Ñо¿½á¹ûÊDZí´ï×÷Õß˼Ïë¹Ûµã×îÖØÒªµÄ²¿·Ö¡£Îª±í´ïÇå³þ£¬¶àÑо¿¹ý±ØÐë·Ö³ÉÈô¸É¸ö²ã´ÎÀ´Ð´¡£ÓеÄÑо¿½á¹ûÖ»·Ö³ÉÈô¸É¸ö×ÔÈ»¶Î¡£×¢ÒâÒ»¸ö×ÔÈ»¶ÎÖ»Äܱíʾһ¸öÖÐÐÄ˼Ïë¡£Ò²¿ÉÒÔ·Ö³ÉÈô¸É¸öС±êÌâ½øÐзֲã±íÊö£¬¶¼Òª×¢Òâ²ã´ÎÖ®¼äµÄÂß¼­¹ØÏµ¡£¶à½á¹ûµÄÂß¼­ÅÅÁУ¬Ó¦×ñÑ­ÒÔÏÂÔ­Ôò£º {yGZc3e1j  
¨S´Ó×îÖØÒªµ½×î²»ÖØÒª£¨from most to least impirtant£©¡£  aOaF&6'j  
¨S´Ó¼òµ¥µ½¸´ÔÓ£¨from simple to complex£©¡£ _%AJmt}  
¨S°´ÏàͬÀàÅÅÁУ¬Èçorgan by organ¡¢chemical class by chemical class¡£ 3s88#_eT  
¨Sд×÷Ó¦°´Ñо¿ÎÊÌâµÄÂß¼­¹ØÏµÀ´Ð´£¬²»Ó¦°´ÊµÑé»òʱ¼ä˳ÐòÀ´Ð´¡£ -wPuml!hZ|  
£¨5£©Êý¾Ý±í´ï¿É²ÉÓÃÎÄ×ÖÓëͼ±íÏà½áºÏµÄÐÎʽ¡£Èç¹ûÖ»ÓÐÒ»¸ö»òÕߺÜÉٵIJⶨ½á¹û£¬ÔÚÕýÎÄÖÐÓÃÎÄ×ÖÃèÊö¼´¿É£»Èç¹ûÊý¾Ý½Ï¶à£¬¿É²ÉÓÃͼ±íÐÎʽÀ´ÍêÕû¡¢ÏêϸµØ±íÊö¡£ÎÄ×Ö²¿·ÖÔòÓÃÀ´Ö¸³öͼ±íÖÐ×ÊÁϵÄÖØÒªÐÔÌØÕ÷»òÇ÷ÊÆ¡£ :Vu7,o  
£¨6£©Ò»°ã²»½âÊÍԭʼÊý¾Ý£¨do not interpret the data£©¡£Èç¹ûÂÛÎÄÖл¹°üÀ¨¶ÀÁ¢µÄDiscussionÕ½ڣ¬Ó¦½«¶ÔÓÚÑо¿½á¹ûµÄÏêϸÌÖÂÛÁôµ½¸Ã²¿·Ö¡£ 2@"0} po#  
ʾÀýÒ» l5 ":[C$  
½á¹ûûÓнâÊÍ£º¡°The duration of exposure to running water had a pronounced effect on cumulative seed grermination percentages.Seeds exposured to the 2-day treatment had the highest cumulative germination(84%), 1.25times that of the 12-h or 5-day groups and 4 times that of controls¡±¡£ +?4*,8Tmmz  
´øÓнâÊÍÐÔ£º¡°The results of the germination experiment suggest that the optimal time for running-water treatment is 2-days.This group showed the highest cumulative germination(84%),with longer(5d) or shorter(12h) exposures producing smaller gains in germination when compared to the control group¡±¡£ jQH5$  
£¨7£©ÎÄ×Ö±í´ïӦ׼ȷ¡¢¼ò½à¡¢Çå³þ¡£±ÜÃâʹÓÃÈß³¤µÄ´Ê»ã»ò¾ä×ÓÀ´½éÉÜ»ò½âÊÍͼ±í¡£Îª¼ò½à¡¢Çå³þÆð¼û£¬²»Òª°Ñͼ±íµÄÐòºÅ×÷Ϊ¶ÎÂäµÄÖ÷Ìâ¾ä£¬Ó¦ÔÚ¾ä×ÓÖÐÖ¸³öͼ±êËù½ÒʾµÄÀíÂÛ£¬°Ñͼ±íÖеÄÐòºÅ·ÅÈëÀ¨ºÅÖС£ uFA|r X  
ÈçʾÀý A>&>6O4  
[²»ÍƼö]Figure 2 shows that neurons were distinguished from astrocytes by the selectivelabeling of astrocytes with SR-101. F3H:I"4  
¡¾ÍƼö¡¿Neurons were distinguished from astrocytes by the selective labeling of astrocytes with SR-101(Fig.2). C+Fh$  
[²»ÍƼö]The results are given in Figure 1. sqMNon`5  
¡¾ÍƼö¡¿Temperature was directly proportional to metabolic rate(Fig.1). FrAqTz  
£¨8£©±ÜÃâ׸Êö¡£±ÜÃâͬÑùµÄÊý¾Ý³öÏÖÔÚͼºÍ±íÖС£ qxg7cj2  
£¨9£©¾¡Á¿ÓþùÖµ¡¢°Ù·ÖÊýµÈ¸ÅÀ¨Ô­Ê¼Êý¾ÝÖµ£¨raw data£©¡£ 2F*Dkv  
£¨10£©°üÀ¨Êý¾Ý»òͳ¼Æ×ÊÁÏʱ£¬Ó¦¸Ã¸³ÓèÊʵ±µÄµ¥Î»£¨appropriate units£©¡£ %$9)1"T0Y  
ʾÀýÈçÏ£º )N%1%bg^-  
µ¥¸öÊý¾Ý¡°The maximum time was 140 min¡±¡£ x1&b@u  
¶àλÊý¾ÝÐèÒª¼ÓÉÏÎó²î£¨error value£©Èç¡°¡­was 10¡À2.3h¡±. .SKNIct M  
һϵÁеÄÊý×Ö¶¼ÓÐÏàͬµÄµ¥Î»£¬ÔÚβÊý¼Óµ¥Î»£¨units£©£¬Èç¡°No differences were observed after 2,4,6,or 8h of incubation¡±¡£ j4 &  
2.Ñо¿½á¹ûд×÷ʱ̬µÄÓ¦Óà )W}/k$S  
£¨1£©ÐðÊöÑо¿½á¹ûµÄÄÚÈÝ£¬Í¨³£²ÉÓùýȥʽ¡£ 0[$Mo3c+'  
£¨2£©Í¼¡¢±íΪÖ÷Óïʱ£¬³£ÓÃÒ»°ãÏÖÔÚʱ¡£ w7*b}D@65\  
£¨3£©¶ÔÑо¿½á¹û½øÐÐ˵Ã÷»òÓÉÆäµÃ³öÒ»°ãÐÔÍÆÂÛʱ£¬¶àÓÃÏÖÔÚʱ¡£ e$ xv[9  
£¨4£©²»Í¬½á¹ûÖ®¼ä»òʵÑéÊý¾ÝÓëÀíÂÛÄ£ÐÍÖ®¼ä½øÐбȽÏʱ£¬¶à²ÉÓÃÒ»°ãÏÖÔÚʱ£¨ÕâÖֱȽϹØÏµ¶àΪ²»ÊÜʱ¼äÓ°ÏìµÄÂß¼­ÉϵÄÊÂʵ£©¡£ .xc/2:m9  
3.Ñо¿½á¹ûµÄд×÷Óï̬ p *W ZY=Q  
½á¹û²¿·ÖÒÔ±»¶¯Óï̬ΪÖ÷¡£¿ÉÒԲβåÖ÷¶¯Óï̬¡£ %]:vT&M  

kaobook 2011-08-17 22:34
µÚ11Õ ÈçºÎÕýÈ·±í´ïSCIÂÛÎÄÖеÄͼºÍ±í +|w~j#j9`  
ËäÈ»ÎÄ×ÖÊÇSCIÆÚ¿¯±í´ïµÄÖ÷ÒªÊֶΣ¬µ«ÔÚ±í´ï½á¹û·½Ã棬ͼºÍ±í£¨figures and tables£©±ÈÎÄ×Ö¸ü¾ßÓÐÖ±¹ÛÐÔ£¬ÇÒ¼òµ¥Ã÷ÁË£¬±ÜÃâÁËÈß³¤µÄÎÄ×ÖÐðÊö¡£ËüÄܹ»ÒÔ½ÏСµÄ¿Õ¼ä³ÐÔØ×Ž϶àµÄÐÅÏ¢£¬Ö±¹Û¡¢¸ßЧµØ±í´ï¸´ÔÓµÄÊý¾ÝºÍ¹Ûµã£¬Ê¹¶ÁÕßÀí½âÎÄÕÂËùÐðÊöÊÂÎïµÄÐÎ̬¼°±ä»¯¹æÂÉ£¬²¹³äÎÄ×ÖÐðÊöµÄ²»×ã¡£ÓÈÆäÊÇÔÚÃèÊö±äÁ¿¼äµÄÏ໥×÷Óûò·ÇÏßÐÔ¹ØÏµÊ±£¬ËüÒ²Äܹ»°ÑÓÃÎÄ×ÖÓïÑÔÄÑÒÔ±íÊöÇå³þµÄÄÚÈÝ£¬¼òÃ÷µØ³ÊÏÖ³öÀ´£¬Ê¹ÂÛÎĵÄÄÚÈݱí´ïµÄ¸üºÏÀí¡¢¸üÍêÉÆ¡£Òª¼Çס£º¡°A picture is worth a thousand words¡±¡£ J)& +y;.  
1.²åͼµÄÀàÐÍ SCIÂÛÎÄÖеIJåͼÖÖÀàºÜ¶à£¬³£ÓõÄÓУº c{P`oB8  
£¨1£©ÏßÐÎͼ£¨line graphs£©¡£ÓÃÓÚ˵Ã÷Á½¸ö±äÁ¿£¨two variables£©Ö®¼äµÄ¹ØÏµºÍÇ÷ÊÆ(trends and relationships between data)¡£×Ô±äÁ¿£¨independent variable£©±êÔÚX-ÖáÉÏ£¨X-axis£©£¬Òò±äÁ¿(dependents variable)±êÔÚY-ÖáÉÏ(Y-axis)¡£³£ÓÃÓÚÏÔʾÁ¬ÐøÐԱ仯¡£ÏßÐÎͼÖеÄÏßÌõÊýĿһ°ã²»³¬¹ý5Ìõ£¬µ«ÎÞÂÛ¼¸Ìõ£¬¶¼Ó¦ÒÔÄܹ»ÇåÎú·Ö±æÎªÔ­Ôò¡£ÏßÐÎͼҪÇó£º jJnBwHp  
¨SÏßÌõÇåÎú¼ò½à¡£ JEkVj']?  
¨SͼÐÎÖеÄÎÄ×Ö¡¢±êÖµÓ¦Ò×ÓÚ±æÈÏ¡£ ~ ?_Z!eS  
¨S×ø±êÖáÅԵıêĿӦ°üº¬²âÁ¿µ¥Î»¡£ z,P7b]KVe  
¨S±íʾ²»Í¬±äÁ¿µÄ·ûºÅÈÝÒ×Çø·Ö¡£ ^aoLry&i=  
¨S×Ý×ø±ê±êÄ¿µÄÎÄ×Ö·½ÏòÓë×ø±êÖáÏò´¹Ö±¡£ 2DQC)Pe+z  
£¨2£©ÌõÐÎͼ»òÖ±·½Í¼£¨bar graphs or histograms£©¡£ ) O^08]Y g  
µ±×Ô±äÁ¿ÊÇ·ÖÀàÊý¾Ýʱ£¬¿ÉÒÔ²ÉÓÃÌõÐÎͼ»òÖ±·½Í¼À´ËµÃ÷×Ô±äÁ¿µÄ¹ØÁª¡£ÌõÐÎͼ»òÖ±·½Í¼Ö÷ÒªÓÃÓÚ½ÒʾÁ˱仯·ù¶È£¨change in magnitude£©£¬¶øÏßÐÎͼÖ÷ÒªÊÇÓÃÀ´ÏÔʾ¸Ä±ä·½Ïò»òÕßÇ÷ÊÆ£¨change in direction£©¡£ÌõÐÎͼ»òÖ±·½Í¼¿ÉÒÔÊÇ×ÝÏò»òºáÏò¡£Ã¿Ìõ´ú±íÒ»ÀàÊý¾Ý£¬ÌõµÄ³¤¶Ì±íʾÊý¾ÝµÄ´óС¡£ÓÐʱһÀà±äÁ¿ÓÖ·ÖΪ¼¸¸öˮƽ£¬¾ÍÐèÒªÓÃÏàÓ¦ÊýÁ¿µÄÌõÀ´±íʾ¡£³£¼ûÌõÐÎͼ¾ßÓÐÏÂÁÐÀàÐÍ£º Q{-r4n|b  
¨SÊúʽÌõÐÎͼ£¨vertical bar graphs£©¡£ oOz6Er[KO  
¨SµþʽÌõÐÎͼ£¨stacked bar graphs£©¡£ (8R M|&  
¨SµãʽÌõÐÎͼ£¨dot graphs£©¡£ |Ay#0uQ5Y  
ÌõÐÎͼ»òÖ±·½Í¼ÒªÇó£º ]x\wP7x  
¨S²»Í¬µÄÌõÓÐÃ÷ÏÔÇø·Ö¡£ S22; g  
¨SÖáÉϵĿ̶ÈÒ×ÓÚ±æÈÏ£¬×Ý×ø±êµÄ±êÄ¿°üº¬²âÁ¿µ¥Î»¡£ 9-SXu lgu  
¨S×Ý×ø±êµÄ³¤¶ÈÖÁÉÙºÍ×µÄÌõµÄ³¤¶ÈÏàµÈ¡£ fok#D>q  
¨SͼÖеÄÎÄ×Ö¡¢Êý×ÖÓ¦Ò×ÓÚ±æÈÏ¡£ KS_d5NvYl  
¨S×Ý×ø±ê±êÄ¿µÄÎÄ×Ö·½ÏòÓë×ø±êÖáÏà´¹Ö±¡£ "k/@tX1: R  
£¨3£©±ýÐÎͼ»ò°Ù·Ö±Èͼ£¨pie or percentage graphs£©¡£ 6qf`P!7d]M  
ÓÃÀ´ÏÔʾ¸÷ÖÖÊý×Ö±ÈÀý¹ØÏµµÄͳ¼ÆÍ¼¡£°Ñµ¥Î»Ô²ÊÓΪ100%£¬¸÷ÖֳɷֵÄÊýÁ¿°´ÔÚÕûÌåÖÐËùÕ¼µÄ·Ý¶îÔÚÔ²ÐÎÖÐÏÔʾ¡£ÔÚÓÃÓڶԱȼ¸¸öÊý¾ÝÔÚÆäÐγɵÄ×ÛºÏÖÐËùÕ¼°Ù·Ö±Èֵʱ×îÓÐÓ᣾¡¹Ü±ýÐÎͼÒ×ѧºÃÓ㬵«ÔÚʵ¼Ê¹¤×÷ÖÐʹÓñȽÏÉÙ¡£ÆäÔ­Òò£ºÊ×ÏÈ£¬±È½ÏµÄÏîĿһ°ã²»Äܳ¬¹ý6¸ö¡£·ñÔòͼÐλáÌ«¸´ÔÓÄÑÒÔÀí½â¡£Æä´Î£¬µµ±È½ÏµÄÊý¾ÝºÜ½Ó½üʱ£¬¾ÍºÜÄÑ¿´µ½¸÷²¿·ÖµÄ²îÒ졣ͻ³ö¸÷²¿·Ö½ÏºÃµÄ·½·¨Ö®Ò»ÊÇ´ÓÃ÷µ½°µÓò»Í¬µÄÑÕÉ«»òµã¸ø¸÷¸ö²¿·ÖͼÉÏÒõÓ°£¬×îСµÄ²¿·Ö×îºÚ¡£»òÕßÓò»Í¬µÄÑÕÉ«À´±íʾ¡£ÖÆÍ¼µÄ¼ÆËã·½·¨£º°Ù·Ö±È¡Â100¡Á360¡ã=¡Á¡Á¡Á¡ã 7Cjrh"al"  
£¨4£©É¢µãͼ£¨scatter graphs, scatterplot£©¡£ÓÉÈô¸É¸öµã×é³É£¬ÕâЩµã¶ÔÓ¦ÓÚÆ½ÃæÖ±½Ç×ø±êϵÖеÄ×ݺáÖáÁ½¸ö±äÁ¿£¬±íʾij¸öʼþµÄÊýÖµ¡£Í¨³£ÓÃÓڱȽϿçÀà±ðµÄ·ÇÖØ¸´Öµ¡£¿É´ÓµãµÄλÖÃÅжϲâÁ¿ÖµµÄ¸ßµÍ¡¢´óС¡¢±ä¶¯Ç÷ÊÆ»ò±ä»¯·¶Î§¡£É¢µãͼ¼ÓÈëÇúÏߣ¬¿ÉÒÔ¿´µ½Ç÷ÊÆ¡£Èç¹ûËùÓеĵ㹹³ÉÒ»¸öÌõÐΣ¬Ôò˵Ã÷´æÔÚÏà¹Ø¹ØÏµ¡£ÀýÈç£¬ÑØ×ÅбÏßÉϵÄÒ»µãÒâζ×ÅÏßÐÔÏà¹Ø£¬Èç¹ûËùÓе㶼ÂäÔÚÒ»ÌõбÏßÉÏ£¬ÄÇôÆäÏà¹ØÏµÊýΪ1.00¡£ NKws;/u  
£¨5£©½á¹¹Í¼»òÁ÷³Ìͼ£¨structure graph or flow chart£©Äܹ»ÃèÊö²Ù×÷¹ý³ÌµÄ²½ÖèÖ®¼ä¡¢Ð¡×éÄÚ¸÷²¿·ÖÖ®¼äµÄ¹ØÏµ¡£½á¹¹Í¼¾­³£ÊÇ·½¿é»òԲȦÓëÏßÁ¬Óá£ÀýÈ磬×éÖ¯½á¹¹Í¼¿ÉÒÔÏÔʾ³ö³ÉÔ±¼äµÄµÈ¼¶£»Á÷³Ì½á¹¹Í¼ÏÔʾһ¸ö¹ý³ÌÖеĸ÷¸ö²½Ö裻ģÐͽṹͼ¿ÉÒÔÏÔʾ²»Í¬±äÁ¿Ö®¼äµÄ¹ØÏµ¡£ 40XI\yE_?  
½á¹¹Í¼ÒªÇó£º *XuzTGa"  
¨SͬһÐÔÖʱäÁ¿ËùÓõķ½¿ò»òԲȦӦ´óСÏàͬ£¬ÏßÐÎÒ»Ö¡£ KtE`L4tW6  
¨SËùÓеÄÏßÌõµÄ´Öϸ¡¢¼ýÍ·µÄÐÎ×´Ó¦Ò»Ö¡£ QPn c "!  
£¨6£©ÕÕÆ¬Í¼£¨£©ÓÃÓÚÏÔʾÏÔ΢¾µÏÂ×éÖ¯ÇÐÆ¬Ïà¡¢·ÅÉäÓ°Ïñ¡¢´óÌå±ê±¾¼°ÐÎÌ¬Ñ§ÌØÕ÷£¬ÕæÊÇ¡¢Ö±¹Û¡¢ÐÅÏ¢Á¿´ó¡£ÕÕÆ¬Í¼ÖÊÁ¿µÄºÃ»µÊǾö¶¨ÂÛÎÄÄÜ·ñ·¢±íµÄÒ»¸öÖØÒªÒòËØ¡£ Aj_}B.  
ÕÕÆ¬Í¼ÒªÇó£º aU @z\sQ  
¨SÇåÎú¶È¸ß£¬¶Ô±È¶ÈºÃ¡£ ,7aqrg  
¨S×éÖ¯ÇÐÆ¬ÕÕÆ¬Ó¦±êÃ÷±ÈÀý³ßºÍȾɫ·½·¨¡£ A}8U;<\I g  
¨SʵÎïÕÕÆ¬Îª±íÃ÷ʵÎï´óС£¬²¢½«±ÈÀý³ßͬʱÅÄÔÚÕÕÆ¬ÉÏ¡£ P+xZaf H  
¨SÒª¶Ô±ÈÇ¿ÁÒ¡¢ÖصãÍ»³ö¡£ Q5ux**(Wr  
2.²åͼµÄÌØÕ÷ Rp#SqRy`  
SCIÂÛÎĵIJåͼÆäÌØÕ÷ÓУº !u"Hf7/  
¨SͼÐεÄʾÒâÐÔ¡£´ÓͼÖеóö¸÷Á¿ÖµÖ®¼äµÄ¾«È·¹ØÏµ¡£ 9iUw7-)  
¨SÄÚÈݵÄдʵÐÔ¡£·´Ó¦±ä»¯¹æÂÉ£¬¸÷Á¿ÖµÖ®¼äµÄÏ໥±ä»¯¹ØÏµ¡£ D~<GVp5T  
¨S±í´ïµÄ¹æ·¶ÐÔ¡£Í¼ÖеÄÏßÐΡ¢ÎÄ×Ö¡¢·ûºÅµÈÓ¦·ûºÏÓйرê×¼µÄ¹æ¶¨ºÍ¹«ÈϵÄϰ¹ß¡£ÔÚͬһƪÎÄÕÂÖУ¬Í¬Ò»ÐÔÖʲåͼµÄ×ÖÌå¡¢×ֺš¢Ö÷¸¨ÏßÌõ´Öϸ¡¢µ¥Î»·ûºÅµÈÒªÏàͬ¡£ P VPwYmte  
3.²åͼҪÇó pT <H&  
ͼÒ×ÓڱȽϡ¢ËµÃ÷ÎÊÌâ¡£²àÖØ±íÏÖ¹ØÁª¡¢Ç÷ÊÆ¡¢Òò¹û¹ØÏµµÈ¡£Ê¹ÓÃʱӦÉÙ¶ø¾«£¬Òª»æÖƵÄÇåÎú¡¢¼òÃ÷¡¢´ó·½¡¢ÃÀ¹Û£¬Ê¹ÈËͨ¹ý¿´Í¼Äܹ»¼ÓÉî¶ÔÄÚÈݵÄÀí½â¡£ +{s^"M2`  
£¨1£©Í¼±íÓ¦¾ßÓÐ×ÔÃ÷ÐÔ£¨£©£¬¼´Ö»¿´Í¼¡¢Í¼½âºÍͼÀý¡¢²»ÔĶÁÕýÎÄ£¬¾Í¿ÉÒÔÀí½âͼÒâ¡£ r=vE0;7  
£¨2£©²¹³ä¶ø²»ÊÇÖØ¸´ÎÄ×ÖµÄÃèÊö¡£ 8/=2N  
£¨3£©ÃèÊö×î»ù±¾¡¢×îÖØÒªµÄÊÂʵ¡£  :sf;Fq  
£¨4£©¼òÃ÷£¬Ê¡ÂÔ²»±ØÒªµÄϸ½Ú¡£ )}EwEM  
£¨5£©²åͼӦ¸ÃÓÐͼÐòºÍͼÌ⡣һƪÎÄÕÂÖ»ÓÐÒ»¸ö²åͼÕßÒ²Ó¦ÓÐÐòºÅ£¬ÈçFigure 1(Fig 1)¡£Í¼ÌâÓ¦¼ò¶Ì¡¢×¼È·¡£ 4B |f}7%\  
£¨6£©ÏßÌõͼӦÏßÌõÇåÎú£¬´Öϸ¾ùÔÈ£¬±ÈÀýÊʵ±¡£ giPyo"SD  
£¨7£©ÕÕÆ¬Í¼Ó¦Í¼ÏñÇåÎú£¬²ã´Î·ÖÃ÷£¬·´²îÊʶȡ£ cD 1p5U  
£¨8£©²åͼ¾ùÁíÖ½¸½ÓÚÎĺó£¨submission by mail£©»òÕßÁí´æÎªJPEG»òÕßTIFFÎļþ£¨online submission£©£¬²¢ÔÚÎÄÕÂÖÐÏàÓ¦¶ÎÂäºó±êʾÆäλÖᣠAam2Y,B  
4.²åͼµÄÉè¼Æ )!0>2,R1  
ÀûÓòåͼÀ´±í´ï½á¹û£¬Ó¦¶Ô²åͼ½øÐо«ÐÄÉè¼Æ£¬Ê¹Í¼ÃæµÄ±ÈÀýÊʵ±£¬ÇåÎúÃÀ¹Û¡£ S-im o  
£¨1£©±êÄ¿ÊÇÓÃÀ´ËµÃ÷×ø±êÖáµÄº¬ÒåµÄ£¬Ó¦¸ÃÓë±»±ê×¢µÄ×ø±êÖáÆ½ÐУ¬¾ÓÖÐÅÅÓ¦ÔÚ×ø±êÖáºÍ±êÖµµÄÍâ²à£¬ÎÄ×Ö·½ÏòÓ¦¸ÃÓë×ø±êÖá·½Ïò´¹Ö±¡£Í¼ÖеÄ×Ö£¨±ê¼ÇÖáµÈ£©Ó¦¸ÃÊÇСдÀàÐÍ£¬µÚÒ»×Öĸ´óд£¬Ã»ÓоäºÅ¡£ \=w|Zeu{l  
£¨2£©±êÖµÊÇ×ø±ê¶¨Á¿±íÊöµÄ³ß¶È¡£±êÖµÓ¦·ÀÖ¹±ê×¢¹ý·ÖÃܼ¯ÒÔÖÁÓÚÊýÂëǰºóÁ¬½Ó£¬±æÊ¶²»Çå¡£±êÖµÅÅÓ¦ÔÚ×ø±êÖáÍâ²à£¬½ô¿¿±êÖµ¶ÌÏߵĵط½¡£ÎªÁËÇåÎú£¬±êÖµµÄÊý×ÖÓ¦¾¡Á¿²»³¬¹ý3λÊý¡£Òò´Ë£¬ÒªÈÏÕæÑ¡È¡±êÄ¿Öеĵ¥Î»£¬ÈçÓÃ3kg´úÌæ3000g¡¢ÓÃ5ug´úÌæ0.005mgµÈ¡£×ø±êÖáÉϵıêÖµ·¶Î§ÊǸù¾ÝͼÐεÄÊý¾ÝÈ·¶¨£¬µ«×ø±êÖáÉϱêÖµµÄ¼ä¾àÔòÊÇÈÎÑ¡µÄ£¬²»Í¬µÄÑ¡Ôñ½«Ê¹Í¬Ò»ÌõÇúÏßÓв»Í¬µÄÐÎ×´¡£Òò´Ë£¬±êÖµµÄÈ·¶¨Ó¦¿¼ÂÇÒÔϼ¸µã£º AH;h#dT  
¨SÑ¡ÔñÊʵ±µÄ±êÖµ£¬ÒÔ±ãËùÃè»æµÄÇúÏßÄܺ­¸ÇÕû¸öÊý¾Ý¡£ 1>n@`M8}  
¨SÑ¡ÔñÊʵ±µÄ±êÖµ¼ä¾à£¬ÒÔ±ãËùÃè»æµÄÇúÏßÄÜÕýÈ·µØ·´Ó³Êý¾Ý¡£ÒòΪÁ½×ø±êÖáµÄ±êÖµ¼ä¾à²»Êʵ±½«»áŤÇúÊý¾ÝµÄÏÔʾ¡£ O5E\#*<K  
¨SÈç¹ûÔÚ×ø±êÖáÉϵIJâÁ¿µ¥Î»²»ÊÇ´Ó0¿ªÊ¼£¬ÄÇôÓá°//¡±·ûºÅÔÚ×ø±êÖáÉÏ·Ö¼¸¶Î¡£ |A"zxNeS"  
£¨3£©±äÁ¿ÏàͬµÄ¼¸ÌõÇúÏßÓ¦»æÖÆÔÚͬһ·ùͼÄÚ¡£ ]c*&5c$  
£¨4£©¶ÔÓÚͬһƪÂÛÎÄÖеĶà·ù²åͼÀ´Ëµ£¬Ó¦¾¡Á¿Ê¹ÓòåͼµÄ¸÷ÒªËØÏ໥ͳһ£¬ÓÈÆäÊÇʹÓÃÏàͬ±äÁ¿µÄ±êÄ¿¡¢±êÖµ¡¢Í¼ÀýµÈÓ¦Ï໥һÖ¡£ KZ&{Ya  
£¨5£©ÕÕÆ¬Í¼»òÉè¼ÆÍ¼£¬Ó¦×¢Ã÷³ß´ç´óС¼°³¤¶Èµ¥Î»¡£ x2 l~aw#?  
£¨6£©Í¼Æ¬ÖеÄËõÂÔÓï¡¢·ûºÅ±ØÐëÓëÕýÎÄÖÐÒ»Ö¡£ &S/KR$^ %  
£¨7£©ÂÛÎĵIJåͼÓ븽±í²»ÒËÌ«¶à£¬Ö»¸½×î±ØÒªµÄ¡£ K;Fy&p^d  
£¨8£©Í¼·ùµÄ´óСÓëͼÄÚËùÌṩµÄÐÅÏ¢Á¿ÏàÆ¥Å䣬²»ÖÁÓÚÊ¹Í¼Ãæ¸Ðµ½¿Õ¿õ»òÓµ¼·¡£ af.yC [  
£¨9£©²åͼµÄ´óСºÍ±ÈÀý¡£ [$$i1%c%Z<  
¨S²åͼҪ°´ÔÓÖ¾µÄ°æÃæ´óС±ÈÀý½øÐÐѹËõ¡£³ýÌØÊâÒªÇóÍ⣬ͼµÄ´óС±ØÐëÒªÏÞ¶¨ÔÚÆÚ¿¯µÄ°æÐÄÖ®ÄÚ¡£ 54v}iG  
¨SͬÀàÐÍ»òͬµÈÖØÒªµÄͼµÄ´óСӦ¸Ã¾¡¿ÉÄܵر£³ÖÒ»Ö£¬µ¥Î»¿Ì¶ÈÏàͬ¡£ n' &:c}zKO  
¨S¿ÉÒÔ°ÑÀàËÆµÄͼ£¨ÈçÁ½¸öͼµÄ×ø±êÖáÏàͬ£©ºÏ²¢ÆðÀ´¡£ bs/Vn'CE  
£¨10£©Í¼ÄÚµÄÏßÐÎÓë·ûºÅ¡¢Êý×ֵȱÈÀýÊʵ±¡£ qi!+ Ceo}  
£¨11£©Í¼»­Ïß²»Ò˹ýϸ»ò¹ý´Ö£¬¹ýϸÈÝÒ×ÔÚÖÆ°æ¹ý³ÌÖжÏÏߣ¬¹ý´ÖÏԵñ¿´ÖÄÑ¿´¡£ 'a[|'  
£¨12£©Í¼Ó¦°´ÆäÔÚÕýÎÄÖгöÏÖµÄ˳Ðò±êºÅ£¬Ã¿Ò»Í¼Ó¦Óмò¶ÌÈ·ÇеÄÌâÃû¡£ g\:(1oY  
£¨13£©»æÖƲåͼʱ£¬³ý·ÇÌØÊâÐèÒª£¬²»ÒªÎªÁË×·ÇóЧ¹û¶øÔö¼ÓһЩÎÞÒâÒåµÄϸ½Ú£¬Èç°Ñ¶þάµÄÌõÐÎͼ»­³ÉÈýάµÄÖùÐÎͼ¡£ GUSEbIz):  
£¨14£©ÓзûºÏͼʱ£¬Ã¿Ò»Í¼Ó¦¸ÃÇå³þµØ±»±ê¼ÇΪA(a)¡¢B(b)¡¢C(c)µÈ¡£ *> LA30R*v  
£¨15£©°±»ùËáºÍºËÜÕËáÐòÁÐÓ¦¸Ã¿¼ÂÇÓÃFigure,¶ø²»ÊÇTable¡£ x}B3h9]  
5.±í¸ñ ozB2L\D7  
±í¸ñÊǼǼÊý¾Ý»òÊÂÎï·ÖÀàµÄµÈµÄÒ»ÖÖÓÐЧ±í´ï·½Ê½£¬¾ßÓмò½à¡¢ÇåÎú¡¢×¼È·µÄÌØµã¡£Âß¼­ÐԺͶԱÈÐÔÓÖºÜÇ¿£¬Òò¶ø±í¸ñÔÚSCIÂÛÎÄÖб»¹ã·º²ÉÓᣱíµÄÖÖÀà½Ï¶à£¬Ö÷ÒªÓÐʾÒâ±í¡¢Í³¼Æ±í¡¢ËµÃ÷¶ÔÕÕ±íµÈ¡£ÊÊÓÃÓÚ³ÊÏֽ϶àµÄ¾«È·ÊýÖµ»òÎÞÃ÷ÏÔ¹æÂɵĸ´ÔÓ·ÖÀàÊý¾ÝºÍƽÐС¢¶Ô±È¡¢Ïà¹Ø¹ØÏµµÄÃèÊö£¬µ«È±·¦Ç÷ÊÆ¡£ a]\l:r  
¡ò±í¸ñµÄ»ù±¾½á¹¹ #p$iWY>e~  
SCIÆÚ¿¯³£Ê¹ÓÃÈýÏß±í£¨£©£¬¼´Ö»Óбí¸ñ¶¥Ïß¡¢À¸Ä¿ºÍµ×Ïß¡£±íÖÆ°æÈÝÒ×£¬ÏÔʾ¼òÁ·¡£ l$/.B=]  
¨S±íÐòºÍ±íÌ⣺±íÐò¼°±í¸ñµÄÐòºÅ¡£±íÌâ¼´±í¸ñµÄÃû³Æ£¬Ó¦×¼È·µÃÌ壬¼ò¶Ì¾«Á¶µÄÎÄ×ÖÓÃÀ´±í´ï±íÌ⣬Á¬Í¬±íºÅÖÃÓÚ±í¸ñ¶¥ÏßÉÏ·½¡£±íÐòºÍ±íÌâ³£ÓúÚÌå×Ö¡£ eI%9.Cx#I  
¨S±íÍ·£ºÖ¸±í¸ñ¶¥ÏßÓëÀ¸Ä¿ÏßÖ®¼äµÄ²¿·Ö£¬±íÃ÷±í¸ñÄÚµÄÏîÄ¿»ò·´Ó³Á˱íÉíÖиÃÀ¸Ä¿ÐÅÏ¢µÄÌØÕ÷¼°ÊôÐÔ¡£ \:y oS>G  
¨S±íÉí£ºÀ¸Ä¿ÏßÓëµ×ÏßÖ®¼äΪ±íÉí£¬ÊDZí¸ñµÄÖ÷Ìâ¡£ XCvL`  
¨S±í×¢£º±ØÒªÊ±£¬Ó¦½«±íÖеķûºÅ¡¢±ê¼Ç¡¢´úÂ룬ÒÔ¼°ÐèҪ˵Ã÷µÄÊÂÏÒÔ×î¼òÁ·µÄÎÄ×Ö£¬×÷Ϊ±í×¢ºáÅŵ×ÏßÏ·½¡£ [8jIu&tJf  
¡ò±í¸ñÒªÇó i/|}#yw8A  
¨SһƪÎÄÕÂÖв»ÊDZí¸ñÔ½¶àÔ½ºÃ£¬¶øÊÇÒª¸ù¾ÝÆä±ØÒªÐÔ½øÐо«Ñ¡¡£Èç¹ûÓÃÒ»Á½¾ä»°¼´¿É˵Ã÷µÄÄÚÈݾͲ»±ØÁбí¸ñ£»Èç¹û²ÉÓöà×éÊý¾Ý±í˵Ã÷ͬһÏÖÏó£¬Ôì³ÉÁ˱í¸ñ±¾ÉíµÄÖØ¸´£¬Ó¦¸ÃÑ¡ÔñÒ»×é×î׼ȷ¡¢×îÓÐ˵·þÁ¦µÄ±í¸ñ£¬¶ø½«Öظ´µÄ±í¸ñɾ³ý¡£Èç¹ûÎÄ×ÖÐðÊöÓëͼºÍ±íÏàÖØ¸´£¬Ò²Ó¦¸ÃÖ»±£ÁôÈýÕâÖÖ×îºÏÊʵÄÒ»ÖÖ±íÊö·½Ê½£¬ÕâÑù²ÅÄÜʹÎÄÕ¼ò½à¡¢¾«Á·¡£ FdGnNDl*e  
¨S±í¸ñµÄÉè¼ÆÓ¦¸Ã¿ÆÑ§¡¢Ã÷È·¡¢¼ò½à¡¢ÖصãÍ»³ö¡¢±í´ï¹æ·¶¡£±í¸ñÓ¦°´ÆäÔÚÕýÎÄÖгöÏÖµÄ˳Ðò±êºÅ£¬ÐòºÅÓð¢À­²®Êý×Ö±íʾ£¬ÈçTable1,Table2¡£¼´Ê¹Ö»ÓÐÒ»·Ý±í¸ñÒ²Òª±êTable1¡£ Ahk q  
¨S±í¸ñÖеÄËõÂÔ´ÊÓë·ûºÅ£¬±ØÐëÓëÕýÎÄÖÐÒ»Ö¡£ QZ& 4W  
¨S±íÄÚͬһÀ¸µÄÊý×Ö±ØÐëÉÏÏß¶ÔÆë¡£±íÄÚ²»ÒËʹÓá°¡±ºÍÀàËÆ´Ê£¬Ò»ÂÉÌîÈë¾ßÌåÊý×Ö»òÎÄ×Ö¡£Èç¡°N/A¡±´ú±íδ²â»òÎÞ´ËÏ¡°¡ª¡±´ú±íδ·¢ÏÖ£¬¡°0¡±´ú±íʵ²â½á¹ûȷΪÁã¡£ Y[!s:3\f  
¨S±í¸ñÖеIJÎÊýÓ¦±êÃ÷Á¿ºÍµ¥Î»·ûºÅ¡£ÈôËùÓÐÀ¸Ä¿»ò´ó²¿·ÖÀ¸Ä¿µÄµ¥Î»Ïàͬ£¬¿É½«¸Ãµ¥Î»±ê×¢ÔÚÏàÓ¦µÄÀ¸ÄÚ¡£ 7?ICXhu9  
¨S±í¸ñÄÚ£¬Ó¦¸ÃʹÓÃÏàͬµÄСÊýλ¡£ÀýÈç3.4ºÍ2.56ºÍ1µÄÕýÈ·±í´ïÓ¦¸ÃÊÇ3.40¡¢2.56ºÍ1.00¡£¡ò±í¸ñ±à¼­  I9Lt>*  
±í¸ñÒª×÷Ϊһ¸ö¶ÀÁ¢µÄÐÅÏ¢µ¥Î»ÁîÒ³´òÓ¡¡£ÔÚÕýÎÄÄÚ£¬Ã¿·ùͼ»ò±í¸ñÓ¦°´ÆÚ³öÏÖµÄ˳Ðò±êºÅ¡£ CT?4A1[aD  
6.Figure LegendsÒªÇó AZ>F+@d  
£¨1£©Figure LegendsÒªÁíҳ˫ÐдòÓ¡¡£ÅÅÔÚ±í¸ñ»ò²Î¿¼ÎÄÏ׺óÃæ¡£Ò²¾ÍÊÇ˵Figure LegendsÅÅÂÛÎĵÄ×îºó¡£.Figure Legends²»ÒªÅÅÔÚ²åͼÏÂÃæ¡£ i&^]qL|J  
£¨2£©Í¼Ðò¼´²åͼµÄÐòºÅ¡£¸ù¾Ý²åͼÔÚÕýÎÄÖб»Ìá¼°µÄ˳Ðò£¬Óð¢À­²®Êý×Ö½øÐÐÅÅÐò£¬ÈçFigure 1¡¢Figure 2µÈ¡£²¢¾¡Á¿°Ñͼ°²ÅÅÔÚ¿¿½üµÚÒ»´ÎÌá¼°ËüµÄλÖᣠA01PEVd@A  
£¨3£©Figure Legends²»Ó¦¸Ã°üº¬·½·¨Ï¸½Ú£¬»òÕß²»³¬³ö100¸ö×Ö¡£Èç¹ûSCIÂÛÎÄûÓз½·¨²¿·Ö£¬Figure LegendsÓ¦¸ÃÉÙÓÚ300¸ö×Ö¡£ u-M Td  
£¨4£©Í¼Ìâ¼´²åͼµÄ±êÌ⣬ҪÇó¼òÃ÷׼ȷ£¬ÒªÓнϺõÄ˵Ã÷ÐÔºÍרָÐÔ£¬²»ÒªÎª×·ÇóÐÎʽÉϵļò½à¶øÑ¡ÓùýÓÚ·ºÖ¸µÄͼÌâ¡£ /Z~5bb (  
£¨5£©Í¼ÖÐδÄܱí´ïÓÖ±ØÐëÒªÇó±í´ïµÄÐÅÏ¢Ó¦¸ÃÔÚͼעÖÐ˵Ã÷£¬ÈçÐèÒª½âÊ͵ĶÈÁ¿µ¥Î»¡¢·ûºÅÒÔ¼°ËõÂԴʵȡ£²»Ó¦¸ÃÈöÁÕßÈ¥²Î¿¼Õ÷ÎIJÅÄÜÀí½â²åͼµÄÐÅÏ¢¡£Èç¹ûÄãµÄ²åͼ°üÀ¨Îó²îÏߣ¬ÄÇô»¹ÐèҪ˵Ã÷ËûÃÇÊDZê×¼Îó¡¢±ê×¼²î¡¢ÐŶȱ߽绹ÊÇÊýÖµ·¶Î§£¬ÕâÓÐÖúÓÚ¶¨ÒåËù²ÉÓõÄÑù±¾´óС¡£Èç¹ûÔÚͼÖбê³öÁËÏÔÖøÐÔµÄÖµ£¬ÄÇôÔÚͼעÖоÍҪ˵Ã÷¡£ vM?,#:5  
£¨6£©µ±²åͼÖÐÓмýÍ·£¨arrow£©¡¢·ûºÅ£¨symbol£©¡¢Êý×Ö£¨number£©»ò×Öĸ£¨letter£©Ê±£¬ÒªÔÚÕⲿ·Ö£¨²»ÊÇÔÚ²åͼҳÉÏ£©¶ÔÆä·½Ïò¡¢Î»ÖõÈ×ö³ö·Ç³£Ã÷È·µÄ˵Ã÷¡£ CC)Mws+2  
7.ÔõÑùÕýÈ·µØÊ¹ÓÃͼºÍ±í []do Lt;J  
ÄãÐèҪעÒ⼸¸ö·½ÃæµÄÎÊÌ⣺ ?)gc;K  
£¨1£©Í¼¡¢±í»¹ÊÇÎÄ×ÖÄĸöʹÓøüÓÐЧ?Èç¹ûÓëÎÄ×Ö²ÄÁÏÖØ¸´£¬ÄÇô¾ÍûÓбØÒªÊ¹ÓÃͼºÍ±í¡£Èç¹ûÄܹ»²¹³ä˵Ã÷ÎÄ×Ö²ÄÁÏ»òÕßÄܹ»Ëõ¶ÌÌÖÂ۵ij¤¶È£¬ÄÇô²åͼ¾ÍÊdzÊÏÖÐÅÏ¢µÄÓÐЧ·½Ê½¡£ i0u`J  
£¨2£©ÄÄÖÖͼ¡¢±í×îÊʺÏÄãµÄÄ¿µÄ£¿ÊÇ·ñÐèÒªÖÆ×÷ÏêϸµÄ¡¢¸ß·Ö±æÂʵIJåͼ£¿ÄÜ·ñÓÃÒ»·ù¼òµ¥µÄ½öÓÃÏßÌõ»òµã¾ÍÄܱíʾµÄ²åͼ£¿Á½Õß±í´ïµÄÐÅÏ¢ÊÇ·ñÒ»Ñù£¿ 8=)9ZjfD  
£¨3£©Í¼¡¢±íÊÇ·ñÕæÊµ¡¢ÓÐЧ¡¢¿Í¹ÛµØÕ¹Ê¾ÁËÊý¾Ý£¿ =gC% =  
£¨4£©Í¼¡¢±íÊÇ·ñչʾÁËÊý¾ÝµÄ±¾Öʺ͹æÂÉ£¿ M?5voV*  
£¨5£©Í¼¡¢±íÊÇ·ñ±í´ïÁËÂÛÎĵÄÖ÷Ìâ»ò¹Ûµã£¿ drvz [ 9;  
8.²åͼµÄºË²éÇåµ¥ \E 6 0  
£¨1£©Õâ¸ö²åͼÓбØÒªÂð£¿Óë±í¸ñ»òÕýÎÄÊÇ·ñÖØ¸´£¿ xt6%[)  
£¨2£©ÓÐͼÐòºÍͼÌâÂ𣿠MO? }$j  
£¨3£©Õâ¸ö²åͼ¼ò½àÂ𣿻¹ÓÐûÓÐɾȥµÄÎÞ¹ØÏ¸½Ú£¿ ]F"P3':  
£¨4£©×ø±êÖáµÄ±êÖµÊÇ·ñºÏÊÊ£¿ ( G~ME>  
£¨5£©ÀàËÆµÄ²åͼ»òÕßÖØÒªÐÔÏà·ÂµÄ²åͼÊÇÒÔͬÑùµÄ×ø±êϵ»­µÄÂ𣿠nchpD@'t  
£¨6£©ËùÓеÄÊõÓïÆ´Ð´ÊÇ·ñÕýÈ·£¿ Tkn8W j  
£¨7£©²åͼÖеķûºÅ¼°Ëõд¶¼ÔÚͼעÖÐÓÐËù˵Ã÷Âð£¿ÕâЩ·ûºÅ¡¢ËõдÓë±êÌâÊÇ·ñÒ»Ö£¿ÔÚÆäËû²åͼ»òÕýÎÄÖÐÊÇ·ñ±£³ÖÒ»Ö£¿ !}5+hj!6  
£¨8£©ËùÓеIJåͼÔÚÕýÎĵÄÏàӦλÖô¦ÊÇ·ñ±»Ìá¼°£¿ @vL0gzE?nB  
ÔÚÒ»°ãÇé¿öÏ£¬Ðí¶àSCIÆÚ¿¯¶Ô²åͼºÍ±í¸ñÒªÇóÓÐÃ÷È·µÄ˵Ã÷¡£²»Í¬µÄÆÚ¿¯¶Ô²åͼºÍ±í¸ñÓв»Í¬µÄÒªÇó¡£Òò´ËҪȷ¶¨ÔÙ½»ÄúµÄÂÛÎÄ֮ǰͨ¶Á×÷ÕßµÄÖ¸ÄÏ¡£°´ÕÕ¸ÃÆÚ¿¯µÄÒªÇó½øÐÐÕýÈ·µÄ¸ñʽ»¯¡£ 7q:;3;"9  
9.ͼ±íÔÚÂÛÎÄÊÖ¸åÖеÄλÖà L 3\( <[  
¨Sͼ£ºÔÚͼעºóÃæ£¬Ã¿¸öͼһҳ£¨submission by mail£©¡£Èç¹ûon line submission,ÔòͼΪÁí´æ¡£ og_ylCh:  
¨Sͼע£ºÍ¼×¢ÅÅÔÚ±í¸ñºóÃæ£¬ÁíÆðÒ»Ò³¡£ 7q{yLcC"  
¨S±í¸ñ£ºÅÅÔÚÕýÎÄÖвο¼ÎÄÏ׵ĺóÃæ£¬Ã¿¸ö±í¸ñÒ»Ò³¡£ >;#rK@*&  
10.SCIÂÛÎÄͼ±íÉè¼ÆÖг£¼ûµÄ´íÎó 'Hgk $Im+  
£¨1£©Í¼¡¢±í¸ñÄÚÈÝÓëÎÄ×ÖÖØ¸´¡£ÔÚSCIÂÛÎÄÖУ¬ÏàͬÄÚÈݲ»ÒËÓÃÎÄ×Ö¡¢±í¸ñºÍͳ¼ÆÍ¼Öظ´±í´ï£¬Ó¦¸ù¾ÝÄÚÈݵÄÐèҪѡÔñÒ»ÖÖ±í´ï·½Ê½¼´¿É¡£Õâ·½ÃæµÄÔ­ÔòÓ¦ÊÇ£º·²ÊÇÓüò½àµÄÎÄ×ÖÄܹ»±í´ïÇå³þµÄ¾Í²»ÓÃͼºÍ±í¸ñ±í´ï£¬£»·²ÊÇÓñíÄܹ»Ò»Ä¿ÁËÈ»±íʾµÄ¾Í²»ÓÃͼ¡£ÎªÊ¹¶ÁÕß±ãÓÚ¶ÔÕձȽϺÍÁ˽⾫ȷ½á¹ûʱ£¬ÒÔ±í¸ñÐÎʽΪÒË¡£ "yl6WG# J  
£¨2£©±í¸ñÖÐÊý¾Ý¼ÆËã²»¾«È·£¬±£ÁôλÊý²»Ò»Ö¡£±íÖÐÊýÖµ¾«È·Óë·ñÊǾö¶¨Í³¼Æ±íÖÊÁ¿µÄ¹Ø¼üÒòËØ£¬Ò²ÊÇ¿ÆÑ§ÊµÑé½á¹ûÊÇ·ñÑÏÃܵľßÌåÌåÏÖ¡£ÓÉÓÚ±í¸ñÖеÄÊý¾ÝÊǾ­¹ýԭʼÊý¾Ý¼ÆËãµÃ³ö£¬Òò´ËÍùÍù²»ÊÇÕûÊý¡£Ó¦¸ÃʹÓÃÏàͬµÄСÊýλ¡£±í¸ñÖÐͬһָ±êÊý×ÖµÄÓÐЧλÊýÓ¦Ò»Ö£¬²»×ãÕßÒÔ¡°0¡±²¹×ã¡£¼ÆËã°Ù·Ö±Èʱ£¬Ó¦×¢Òâ¸÷°Ù·Ö±ÈÏà¼ÓӦΪ100%¡£ 6G(K8Q{>  
£¨3£©ËõÂÔÓï¼°Á¿ºÍµ¥Î»²»¹æ·¶¡£±í¸ñÖÐËùÁеÄÖ¸±êÃû³Æ²»ÒËËæÒâ¶ø¶¨£¬Ó¦Ê¹Óù̶¨µÄËõÂÔÓï¡£ÌØÊâÇé¿öÏÂʹÓò»³£Óõĵ¥Î»ºÍËõд´Êʱ£¬ÐèÔÚ±í×¢ÖÐ˵Ã÷¡£µ¥Î»Ó¦¸Ã×ñÑ­¹ú¼Ê±ê×¼ÃüÃûÔ­Ôò¡£ÔÚÊý×ֺ͵¥Î»Ö®¼äÓ¦¸ÃÓÐÒ»¸öµ¥Ò»¿Õ¸ñ¡£Ç§¼Æµ¥Î»Ó¦¸ÃÓöººÅ·ÖÀ루1,000£©¡£ tv2k&\1  
£¨4£©±íÖзÖ×é±äÁ¿Óë¹Û²âÖ¸±êµÄλÖõߵ¹¼°Êý¾ÝÅÅÁв»µ±¡£±íÖÐÊý¾ÝµÄÅÅÁÐÓ¦°´Í¬ÀàÊý¾Ý×ÝÅŵÄÔ­Ôò°²ÅÅ£¬ÅÅÁв»µ±Ôòµ¼Ö¶Á±í·ÑÁ¦£¬²»Ò×¶ÔÕձȽϺʹÓÖÐÁ˽â±ä»¯¹æÂÉ¡£ r9<#R=r)}J  
£¨5£©±íע˵Ã÷¹ý·±¡£±í×¢ÊǶԱíÖÐÓйØÄÚÈݵıØÒª²¹³äºÍ˵Ã÷£¬Ó¦¼òÃ÷¶óÒª¡£ÈçÐèҪ˵Ã÷µÄÄÚÈݽ϶àʱ£¬Ó¦ÒÆÈë±íǰµÄÕýÎÄÖÐÓÃÎÄ×Ö½éÉܱíÖÐÊý¾ÝµÄ¼ÆË㹫ʽ£¬Ó¦ÔÚÂÛÎĵġ°Materials and Methods¡±²¿·Ö½éÉÜ£¬²»ÒËÁÐÈë±í×¢¡£ s#aane  
£¨6£©ÂÞÁÐԭʼ¼Ç¼Êý¾Ý¡£µäÐ͵ıíºÍͼʾ¶Ô½á¹ûµÄ×ܽᣬÑо¿¹ý³ÌÖеÄԭʼÊý¾Ý£¬²»±ØÈ«²¿ÂÞÁÐÓÚ±íÖС£±í¸ñÖеÄÊý¾ÝÒ»°ãÓ¦ÊǾ­¹ýͳ¼ÆÑ§´¦ÀíµÄ¡£ 5g;mc.Cvt  
£¨7£©ÎÞ±íÌâ»ò±íÌⲻȷÇлòÖØµã²»Í»³ö¡£±íÌâÊDZí¸ñµÄÖØÒª×é³É²¿·Ö£¬ÊǶԱíÖÐÄÚÈݵĸÅÀ¨£¬±íÌâÓ¦¸ÃÖ÷νÓÐÐò£¬¼ò½à¡¢×¼È·¡£ >.H}(!  
£¨8£©Í¼¡¢±íÖеÄÊõÓï¡¢·ûºÅ¡¢µ¥Î»ÓëÎÄÖÐÎÄ×ÖÐðÊö²»Ò»Ö»òÕßÕýÎÄûÓÐÌἰͼºÍ±í¡£Í¼±íÖгöÏÖµÄÊõÓï¡¢·ûºÅ¡¢µ¥¡¢Ó¦ÓëÎÄ×ÖÐðÊöÏàÒ»Ö£¬ÒÔÏÔʾÕû¸öÂÛÎĵÄÍêÕûÓëͳһ¡£ 9j}Q~v\  
£¨9£©Í³¼ÆÍ¼±íÉè¼Æ²»¹æ·¶¡£Èç±íÖÐÏßÌõ¹ý¶à¡£ QyrB"_dm  
11.³£¼ûµÄ´íÎóÇé¿ö PG @C5Rnu  
¨S×ø±êÖáÉϱêÖµ²»µ± O7od2fV(i7  
¨Sȱµ¥Î»£¬×ø±êÖáµßµ¹£¬¾â³ÝÐÎÏßµÄÁ¬½ÓûÓиù¾Ý£¬Í¼Ìå²»Ã÷È·£¨¸ü¶àÄÚÈÝ¿ÉÒÔ¼ûhttp//:www.ruf.rice.edu/~bioslabs/tools/tools.html£© F^lau f  
¨S´æÔÚÎÊÌ⣺Ñù±¾Ì«ÉÙ \5a;_N[Ed  
¨S´æÔÚÎÊÌ⣺×ÊÁÏûÓÐåàÑ¡ J<9}) m  
¨S´æÔÚÎÊÌ⣺±í¸ñ²»¹æ·¶£¬Ã»Óбí¸ñ±êÌâ hVCxwTg^X  

kaobook 2011-08-17 22:35
µÚ12 ÕÂÈçºÎÊéдSCIÂÛÎĵÄÌÖÂÛ _^$F^}{&  
ÌÖÂÛ£¨Discussion£©ÊÇһƪÎÄÕµľ«»ª¡¢È«ÎĵÄÁé»ê£¬Ò²ÊÇ×îÄÑдµÄ²¿·Ö¡£DiscussionÖ®ËùÒÔÄÑд£¬ÊÇÒòΪÌÖÂÛ²¿·Ö×îÄÜ·´Ó³×÷Õߵĸ´Ï°µÄÎÄÏ×Á¿ºÍ¶Ôij¸öѧÊõÎÊÌâÁ˽âÒÔ¼°Àí½âµÄÉî¶ÈºÍ¹ã¶È¡£Éî¶È¾ÍÊÇÂÛÎĶÔÓÚÌá³öÎÊÌâµÄÑо¿µ½ÁËÒ»¸öʲôÑùµÄ³Ì¶È£¬¹ã¶ÈÖ¸ÊÇ·ñÄܹ»´Ó¶à¸ö½Ç¶ÈÀ´·ÖÎö½âÊÍʵÑé½á¹û¡£ er@.<Dc  
1.ÌÖÂÛ²¿·ÖµÄÖØÒªÐÔ %wGQu;re  
ÒªÈÃÉó¸åÈ˺ͶÁÕßÁ˽âÄãµÄÂÛÎÄΪʲôֵµÃÒýÆðÖØÊÓ£º 6kONuG7Yv  
£¨1£©ÄãµÄ½á¹ûÓÖÓÐʲôÀíÂÛÒâÒ壿 sD6vHX%  
£¨2£©ÄãµÄ½á¹ûÓÐʲôʵ¼ÊÓ¦ÓüÛÖµ£¿ ,fhwDqR ?  
£¨3£©ÄãµÄ·¢ÏÖÊÇ·ñ¿ÉÒÔÀ©Õ¹µ½ÆäËûÁìÓò£¿ `0=j,54cx  
£¨4£©ÄãµÄ½á¹ûÊÇ·ñÓÐÖúÓÚÎÒÃÇÀí½â¸ü¹ã·ºÁìÓò£¨a broader topic£©£¿ Vp8!-[R  
2.ÌÖÂÛµÄÄÚÈÝ #-PUm0|  
ÔÚDiscussionÕâÒ»Õ½ڣ¬ÄãÓ¦¸Ã½âÊÍÄãµÄ½á¹û¡£Òò´Ë£¬ÌÖÂÛµÄÄÚÈÝÖ÷ÒªÓУº kcP&''  
£¨1£©¸ÅÊö×îÖØÒªµÄ½á¹û¡£ÄãµÄ½á¹ûÓÐʲôÒâ˼£¿Êý¾ÝÊÇ·ñ·ûºÏÄãµÄ×î³õ¼ÙÉ裿Èç¹ûûÓеϰ£¬ÎªÊ²Ã´£¿ÄãÊÇ·ñÐèÒªÐ޸ļÙ˵£¿ OjK+`D_C  
£¨2£©Ö¸³öÆäÊÇ·ñÄܹ»Ö§³ÖÏÈǰµÄ¼ÙÉèÒÔ¼°ÊÇ·ñÓëÆäËûѧÕߵĽá¹ûÏ໥һÖ£»Èç¹û²»Êǵϰ£¬ÎªÊ²Ã´£¿ÊÇ·ñËûÃǵÄÉè¼ÆÓÐȱÏÝ£¿ QQ99sy  
£¨3£©¶Ô½á¹ûÌá³ö˵Ã÷¡¢½âÊÍ»ò²Â²â£¬¸ù¾ÝÕâЩ½á¹û£¬ÄܵóöºÎÖÖ½áÂÛºÍÍÆ¶Ï£¿ Ft@ZK!'@  
£¨4£©ËµÃ÷Ñо¿µÄ¾ÖÏÞÐÔÒÔ¼°ÕâЩÏÞÖÆ¶ÔÑо¿½á¹ûµÄÓ°Ïì¡£ÓÐʲô½øÒ»²½µÄʵÑéÐèÒª½øÐУ¿Èç¹ûÄãµÄ½á¹ûÄ£ÀâÁ½¿É£¬»¹ÐèҪʲôʵÑéÄÜʹ½á¹û¸ü¼ÓÃ÷È·£¿ zKf0 :X  
£¨5£©Ö¸³ö½á¹ûµÄÀíÂÛÒâÒåºÍʵ¼ÊÓ¦ÓüÛÖµ¡£ )!sjXiC!h  
3.ÌÖÂÛ²¿·Öд×÷µÄ»ù±¾ÒªÇó X- SR0x  
DiscussionµÄÖØµãÔÚÓÚ¶ÔÑо¿µÄ½á¹ûµÄ½âÊͺÍÍÆ¶Ï£¬²¢ËµÃ÷×÷ÕߵĽá¹ûÊÇ·ñÖ§³Ö»òÕß·´¶ÔijÖֹ۵㣬ÊÇ·ñÌá³öÁËеÄÎÊÌâ»ò¹ÛµãµÈ¡£Òò´Ë׫дÌÖÂÛʱҪ±ÜÃ⺬Ð¾¡Á¿Ö±½Ó¡¢Ã÷È·µØ×ö³öÍêÕûµÄ½âÊÍ¡£ËµÀíÒªÓиù¾Ý£¬ÎÊÌâÒª½²Çå³þ¡¢½²Í¸³¹¡£Òò´Ë£¬Ã¿¸ö½áÂÛ¶¼ÒªÓÐÖ¤¾Ý¡£×ÜÊǾ۽¹ÔÚÄãµÄ½á¹ûÉÏ£¬²»ÒªÌÖÂÛÓëÄãÏÖÔڵŤ×÷Î޹صϰÌâ¡£ Rts}y:44  
4.ÌÖÂÛ²¿·ÖµÄд×÷½á¹¹ vARZwIu^D  
Ò»°ãʵÑéÐÔSCIÂÛÎĵÄÌÖÂÛ²¿·ÖµÄд×÷½á¹¹ÈçÏ£º o H]FT{  
µÚÒ»¶Î£¨first paragraph£© #3-hE  
²ûÊö·¢ÏÖ¡£¿ÉÒÔ´ÓÕªÒª¸Äд£¬ÀýÈ磺 U> {CG+X  
In this study, we have shown that tumor cells organize a mitochondrial chaperone network,, which involves Hsp90, its related molecule, TRAP-1, and the immunophilin CypD. This complex maintains mitochondrial homeostasis and antagonizes the function of CypD in permeability transition. Conversely, inhibition of mitochondrial Hsp90 chaperones with a novel class of mitochondria-directed ATPase antagonists cause sudden loss of mitochondrial membrane potential, release of cytochrome c, and massive death of tumor but not normal cells. ;Y$d !an0  
Öмä¶ÎÂ䣨middle paragraph£© D^w<V%] .  
¶ÎÂäµÄ¶àÉÙ¸ù¾Ý½á¹û¶àÉÙ¶ø¶¨£¬¿ÉÒÔÊDz¢ÁйØÏµ»òÕßÊǵݽø¹ØÏµ¡£µ«Òª±£Ö¤Ã¿Ò»¶Î¶¼Ò»¸öÖ÷Ìâ¡£¶øÇÒÿһ¶ÎÖÐҪ˵Ã÷ÒÔϼ¸µã£º > V@,K z1  
£¨1£©ÄãµÄÑо¿½á¹ûÊÇʲô£¿ÓÐʲôÒâÒ壿ÀýÈ磺 oRl@AhS  
The results presented here demonstrate an involvement of Shh signaling in the regulation of SVZ stem cells, leading to sustained neurogenesis, in the postnatal and adult mouse brain. Taken together , the gene expression and analyses and the in vitro and in vivo experiment indicate that Shh signaling is critical for the proliferation of the number of cells with stem cell properties, for the proliferation of early precursors and consequently $)7Af6xD  
for the production of new neurons. _B\X&!G.  
£¨2£©ÄãµÄÑо¿½á¹ûºÍ±ðÈ˵ĵÄÀàËÆÑо¿ÓÐʲôÒìͬ£¿Èç¹û²»Í¬£¬¿ÉÒÔÌÖÂÛһЩ²úÉú²îÒìµÄ¿ÉÄÜÔ­Òò¡£ÀýÈ磺 =L}$#Y8?  
In contrast to other data(ref), we show that Shh is sufficient to increase the number of neurospheres derived from SVZ cultures grown over quiescent astrocytes. This difference might relate to the method used:it is possible that the astrocytes in the in the feeder layer produce enough cofactors but at low enough levels for Shh to act, whereas saturating levels of EGF mask the effects of Shh(ref). GoG_4:^#h  
£¨3£©Èç¹ûÄãÔÚÑо¿½á¹ûÖгöÏַdz£ÐµĶ«Î÷£¬ÓÃÒÔǰ±ðÈ˵ÄÀíÂÛºÜÄѽâÊÍ£¬ÄÇôÄã¿ÉÒÔÌá³öÄãµÄ¼ÙÉèÀíÂÛÀ´½âÊÍÊÇÑÏÖØÀ´½âÊÍʵÑéÖзdz£ÐµĶ«Î÷£¬Ò»¶¨Òª×öµ½ÄÜ×ÔÔ²Æä˵¡£ #pX+~ {  
Ä©¶Î£¨last paragraph£© K# plSD^f=  
ÔÚDiscussion µÄ×îºóÒª×ܽáһϣ¬¸æËß±ðÈËÄãÕâ¸öÑо¿µÄ¼¸¸öÖ÷Òª½á¹û£¨Á½Èý¾ä»°£©¡£ÀýÈ磺 l,1.6  
In summary, Hsp90-directed protein folding/refolding functions as a novel regulatory mechanism of mitochondrial permeability transition (reference).Although this pathway is selectively exploited in tumor cells to elevate an antiapoptotic threshold, the development of Hsp90 antagonists competent to accumulate in mitochondria may provide a new class of potent and selective anticancer agents,potentially devoid of side effects for normal tissues. ZQrgYeQl"  
5.ÌÖÂÛ²¿·Öд×÷µÄ³£¼ûÎÊÌâ *wJ'Z4_5F  
£¨1£©Ã»ÓÐÑ¡ÔñÉîÈëÌÖÂÛµÄÎÊÌ⡣ѡÔñºÏÊʵĽá¹ûÔÚDiscussion²¿·Ö½øÐÐÉîÈëÌÖÂÛ£¬ÊÇдºÃ¸Ã²¿·ÖÊ×ÏÈÒªÃæÁÙµÄÎÊÌâ¡£ÒªÒÔÿһ¸öÖØ´ó½á¹ûΪ»ùµã¡£Ò»°ãÀ´Ëµ£¬¿É¸ù¾ÝÒÔÏÂÔ­ÔòÀ´ÅжϣºÈç¹ûÄãµÄ½á¹ûÌåÑéÁËʵÑéµÄ¶ÀÌØÐÔ£¬ÊÇÆäËûÑо¿¾ÍÖÐûÓеõ½µÄ£¬ÄÇôÕâ¸öÑо¿½á¹û¾ÍÊÇÒªÖØµãÌÖÂÛµÄÎÊÌ⣻ÓÐЩ½á¹ûºÍǰÈ˵ÄÑо¿½á¹ûÒ»Ö£¬²¢Ã»ÓÐÏÔÖøÐÔ²îÒ죬¾ÍÓ¦¸ÃÒ»±Ê´ø¹ýÎÞÐèÉîÈëÌÖÂÛ¡£DiscussionµÄÒ»¸öÖØÒª×÷ÓþÍÊÇҪͻ³ö×Ô¼ºÑо¿µÄ´´ÐÂÐÔ£¬²¢ÌåÏÖ³öÏÔÖøÇø±ðÓÚËûÈ˵ÄÌØµã£¬Çø±ð´óºÍСÊÇÁíÍâÒ»¸öÎÊÌâ£¬ÖØÒªµÄÊÇÓÐÇø±ð£¬Çø±ð¾ÍÊÇ´´Ð¡£ pXHeUBY.  
£¨2£©Ã»ÓжÔÑ¡ÖеÄÎÊÌâ°´Ò»¶¨²ã´Î´Ó¶à¸ö½Ç¶È½øÐÐÌÖÂÛ¡£Ñ¡ÔñµÄÎÊÌâÓÐʱ²»Ö¹Ò»¸ö£¨¶àÊýÇé¿öÊÇÁ½¸öÒÔÉÏ£©£¬Òò´Ë£¬Òª°´Ò»¶¨²ã´ÎÃèÊöÇå³þ¡£ÎÊÌâÎÞÂÛ´óС¡¢ÊÇ·ñÖØÒª£¬¶¼Òª´Ó¶à¸ö½Ç¶ÈÕ¹¿ªÉîÈëÌÖÂÛ¡£ =_H)5I_\  
¨SÊ×ÏÈÒªÓÐÀàËÆ½á¹ûµÄ¶Ô±È£¬ËµÃ÷×Ô¼º½áÂ۵ĶÀÌØÐÔ¡£ w^QqYUL${  
¨SÆä´ÎҪϵͳ²ûÊöΪʲô»áÓÐÒìͬ¡£·½·¨ÓжàÖÖ£¨´ÓʵÑéÉè¼Æ½Ç¶È¡¢´ÓÀíÂÛÔ­Àí½Ç¶È¡¢´Ó·ÖÎö·½·¨½Ç¶È»ò½è¼ø±ðÈË·ÖÎö·½·¨µÈ£©¡£ÖØÒªµÄÊǽ«ÕâÎÊÌâÉîÈë²ûÊöÇå³þ£¬²»ÄÜÈÃÈËÓÐÒâÓÌδ¾¡Ö®¸Ð£¨So What£¿£©¡££¨3£©ÓëResultsµÄ²»Ò»ÖÂÐÔ¡£¾ÍÊǽá¹ûºÍÌÖÂÛûÓÐÒ»Ò»¶ÔÓ¦¡£ÉÙÊý³öÏÖÌÖÂÛµÄÄÚÈÝ¿ÉÒÔÍÆ³öÓëʵÑéÏà·´µÄ½áÂÛ¡£ l ~ /y  
£¨4£©×÷ÕßÔÚÌÖÂÛʱ²»ÒýÓûòûÓÐϵͳÒýÓÃÏà¹ØÎÄÏס£·¢ÉúÕâÖÖÇé¿öµÄÖ÷ÒªÔ­ÒòΪ£º×÷ÕßûÓÐÒâʶµ½²éÕÒºÍÒýÓÃÏà¹ØÎÄÏ׵ıØÒªÐÔ£»×÷ÕßÒòÌõ¼þËùÏÞ£¬ÎÞ·¨²éµ½»ò²éÈ«Ïà¹ØÎÄÏ×£»ÉÙÊý×÷Õß¹ÊÒâ²»ÒýÓÃÏà¹ØÎÄÏ×£¬ÒÔÍ»ÏÔ×Ô¼ºÑо¿µÄ"ÐÂÓ±"Óë"¼ÛÖµ"¡£ =6+j Po{F  
£¨5£©×÷ÕßËäÒýÓÃÏà¹ØÎÄÏ×£¬µ«Ã»ÓнáºÏ×ÔÉíµÄÑо¿ÌÖÂÛ£¬Ò²¾ÍÊÇ˵£¬×÷ÕßËäÈ»²éµ½²¢ÒýÓÃÁËÏà¹ØÎÄÏ×£¬µ«Ã»ÓаÑÒÔǰµÄ½á¹ûºÍ×Ô¼ºµÄ½á¹ûÈÚºÏÔÚÒ»ÆðÌÖÂÛ¡£ÕâÁ½ÖÖÂÛÎÄ·Ö¸îµÄ½á¹û¶¼Ò»Ñù£¬¾ÍÊÇʹ¶ÁÕß¿´ÍêÂÛÎĺó£¬ÈÔ¶Ô¸ÃÑо¿È±·¦ÏµÍ³¡¢ÍêÕû¡¢ÉîÈëµÄÁ˽âºÍÀí½â¡£ %uhhQ<zs%  
£¨6£©¼òµ¥Öظ´IntroductionµÄÄÚÈÝ¡£ËäÈ»ÌÖÂÛ×ÜÓëIntroductionÖÐÄúÔ®ÒýµÄÎÊÌâ»ò¼Ù˵ÏàÁ¬¡£µ«²»ÊǼòµ¥µÄÖØ¸´£¬¶øÊÇIntroductionµÄÕ¹¿ª¡£ MBH/,Yd  
£¨7£©Öظ´ResultsµÄÄÚÈÝ¡£²»ÒªÔÚÌÖÂÛÖÐÖØ¸´ÉêÃ÷ÄãµÄ½á¹û¡£ËäÈ»Äã¿ÉÒÔż¶ûÔÚDiscussion²¿·ÖÀïÌἰͼºÍ±í¸ñ°ïÖú½âÊÍijÊ£¬µ«²»Äܰüº¬ÐµÄÊý¾Ý¡£¿ÉÒÔÓÃÁ÷³Ìͼ˵Ã÷¡£Èç¹ûÄãÐèÒªÌáÐѶÁÕßÌÖÂ۵Ľá¹û£¬¿ÉÒÔÓÃbridge sentenceÀ´½øÐÐÁ¬½Ó¡£ÀýÈ磬The increased expression of neuroglobin in the damaged region after focal isechemia suggests that¡­(½âÊÍ)¡£ "n=Ih_J  
6.ÌÖÂÛ²¿·Öд×÷µÄÈ˳ƺÍÓï̬ g edk  
ÔÚÕâÒ»½Ú¾¡¿ÉÄÜʹÓÃÖ÷¶¯Óï̬¡£É÷·ÀÂÞà´ʾ䣬Ҫ¼ò½à¡£¿ÉÒÔʹÓõÚÒ»È˳ÆÃèÊö×Ô¼ºµÄ½á¹û¡£ÏÖÔÚʱºÍ¼òµ¥µÄ¹ýȥʱ¿ÉÒÔÓÃÓÚÌÖÂۺͽáÂÛÕ½ڣ¨Present and simple past tenses may both be correct for results discussion and conclusions£©¡£

kaobook 2011-08-17 22:35
µÚ13ÕÂÈçºÎÊéдSCIÂÛÎĵĽáÂÛ 8?7:sfc  
½áÂÛ£¨Conclusion»òSummary£©ÓֳƽáÊøÓï¡¢½áÓï¡£ËüÊÇÕû¸ö¿ÎÌâÑо¿µÄ×ܽᣬȫƪÎÄÕµĹé½á¡£Ò»°ãÀ´Ëµ£¬½áÂÛÖгöÏÖµÄÎÊÌⲻ̫¶à¡£ÓÐЩSCIÆÚ¿¯ÒªÇóÓнáÂÛÎÄÕ£¨¶ÎÂ䣩£¬Î»ÓÚÂÛÎĽáÂÛ½áÊøÊ±¡£ }~28UXb23  
1.½áÂÛд×÷µÄÄÚÈÝ q<cpU'-#  
£¨1£©½á¹ûÒªµã¡£±¾Ñо¿½á¹ûÓÐʲôз¢ÏÖ£¬µÃ³öÁËʲô¹æÂÉÐÔ½áÂÛ£¬½â¾ö»òÍêÉÆÁËʲôÀíÂÛ£¬ÊÊÓÃÓÚʲôÑùµÄ·¶Î§¡£¶ÔǰÈËÓйر¾ÎÊÌâµÄÀíÂÛ¡¢·½·¨»ò¼¼Êõ×öÁËÄÄЩ¼ìÑ飬ÄÄЩÓë±¾Ñо¿½á¹ûÒ»Ö£¬ÄÇЩÓë±¾Ñо¿²»Ò»Ö£¬×÷³öÁËÄÄЩÐÞÕý¡¢²¹³ä¡¢·¢Õ¹»ò·ñ¶¨¡£ d\ Z#XzI8  
£¨2£©ÒâÒå»òʵÓÃÐÔ¼ÛÖµ¡¢Íƹãǰ¾°¡£ I:aG(8Bi)H  
2.½áÂÛд×÷ÒªÇó h&6x.ps@  
£¨1£©¸ÅÀ¨×¼È·£¬´ë´ÇÑϽ÷¡£×¼È·¡¢ÍêÕûµØ¸ÅÀ¨ÂÛÎÄÖд´ÐµÄÄÚÈÝ¡£ dj76YK  
£¨2£©Ã÷È·¾ßÌå¡¢¼ò¶Ì¾«Á¶¡£½áÂÛÓ¦ÌṩÃ÷È·¡¢¾ßÌåµÄ¶¨ÐÔÓ붨Á¿µÄÐÅÏ¢¡£¶ÔÒªµãÒª¾ßÌåÂÛÊö£¬²»ÄÜÓóéÏóºÍÁýͳµÄÓïÑÔ¡£ X7]vXo*  
£¨3£©×ۺϷÖÎö£¬¿Í¹ÛÆÀ¹À£¬Å¨Ëõ±í´ï¡£±ÜÃâÒÔ¼ÙÉèÀ´¡°Ö¤Ã÷¡±¼ÙÉ裬ÒÔδ֪À´ËµÃ÷δ֪£¬²¢ÒÀ´ÎÑ­»·ÍÆÂÛ¡£²»Òª°ÑǰÑÔ²¿·ÖµÄÄÚÈÝ£¬ÈçÁ¢ÌâÒÀ¾Ý¡¢Ñо¿Ä¿µÄµÈдÔÚ½áβ²¿·ÖÀ´ÌÖÂÛ¡£ *7I=vro  
3.½áÂÛд×÷·½·¨ :8aIj_qds  
£¨1£©ÓÉÓÚMS Word µÈÎÄ×Ö´¦ÀíÈí¼þÌṩµÄ¿½±´£¨copy£©¡¢Õ³Ìù£¨paste£©¹¦ÄÜ£¬ÂÛÎÄÕªÒªÖеÄһЩ»°¿É±»¿½±´µ½½áÂÛÖС£µ«Òª×¢Òâ¸Ä±äʱ̬¡£ J)n g,i  
£¨2£©½áÂÛÒ»°ã¿ÉÒÔÓü¸¾ä»°À´±íÊö¡£ÓÐʱҲ¿ÉÒ԰ѽáÂÛ·Ö³ÉÈô¸ÉÌõÀ´Ð´£¬µ«²»³£¼û¡£ Q=9S?p M  
£¨3£©½áÂÛҪǡÈçÆä·Ö¡£ U9xFQ=$ 2  
£¨4£©±¾Ñо¿ÉÐδ½â¾öµÄÎÊÌâ¼°½ñºóÑо¿·½ÏòµÄÉèÏë»ò½¨ÒéºÍÓ¦Óü¼ÊõÓÐÄÄЩ¸Ä½øµÄ½¨ÒéÒ»°ã²»·ÅÔÚ½áÂÛÖС£µ«ÓÐЩSCIÆÚ¿¯ÒªÇóÔÚ½áÂÛÖмÓÈëÕâЩÉèÏë»ò½¨Òé¡£ËùÒÔͨ¶ÁSCIÆÚ¿¯µÄ×÷ÕßÖ¸ÄÏÊ®·ÖÖØÒª¡£ mHo x  
4.½áÂÛÈ˳ƺÍд×÷ʱ̬µÄд×÷ 8L 9;VY^Y  
дËûÈËÑо¿½á¹ûÓÃÏÖÔÚʱ»òÏÖÔÚÍê³Éʱ£»ÃèÊö±¾ÎĵÄÑо¿½á¹ûÓùýȥʱ£»ÆÕͨʵÓõĽáÂÛÊÇÏÖÔÚʱ¡£½áÂÛÖв»Ê¹ÓõÚÒ»È˳Ƶ¥ÊýÖ÷¸ñ¡°I¡±£¬¶ø½Ï¶àʵÓõÚÒ»È˳Ƹ´ÊýÖ÷¸ñ¡°We¡±£¬ÒÔ˵Ã÷¸Ã¹¤×÷ÊÇÓɶàÈËÍê³ÉµÄ¡£

kaobook 2011-08-17 22:36
µÚ14ÕÂÈçºÎÊéдSCIÂÛÎĵÄÖÂл =3|pHc hJ4  
1.ÖÂлÄÚÈÝ efjO8J[uk-  
ÖÂлÄÚÈÝÖ÷Òª·ÖΪÁ½·½Ã棺 _1sMYhI  
£¨1£©±íÃ÷¸ÃÑо¿ÊÇʲô×ʽð»ò»ù½ð×ÊÖúµÄÇé¿öÏÂÍê³ÉµÄ¡£ÖйúÒ»°ã¶¼Êǹú¼Ò×ÔÈ»¿ÆÑ§»ù½ð£¨Nature Science Foundation of China, NSFC£©¡£ÃÀ¹ú´ó¶àÊÇÃÀ¹ú¹ú¼ÒÎÀÉúÑо¿Ôº£¨National Institute of Health, NIH£©ºÍÃÀ¹ú¹ú¼Ò¿ÆÑ§»ù½ð£¨National Science Foundation, NSF£©¡£Ð´»ù½ðʱһ°ãÒª±ê×¢Çå³þ»ù½ðºÅÂë£*****rant number£©£¬Ö»ÓÐÕâÑù²ÅËãÊǸÃÏî»ù½ðµÄÑо¿³É¹û£¬Ò²¿ÉÒÔËã×÷ʵÑéÊÒµÄÑо¿³É¹û¡£ [5Fd P0  
£¨2£©¶Ô²ÎÓëÈËÔ±ºÍµ¥Î»±íʾ¸Ðл¡£Ó¦¶ÔÕû¸öÑо¿¹ý³ÌÖУ¬ÓÈÆäÊDzÎÓ벿·ÖÑо¿¹¤×÷£¬°üÀ¨ÌṩʵÑéÉè¼Æ»òʵÑé²ÄÁÏ£¬µ«Ã»ÓÐÁÐÔÚ×÷ÕßÖеÄÑо¿ÈËÔ±£¬Òª¿Ï¶¨ËûµÄ¹±Ï×£¬ÓèÒÔÖÂл¡£ÓÐЩÉó¸åÈËÒ²ºÜ¿´ÖØÕâЩ·½Ãæ¡£Òò´Ë£¬ÒªÒýÆðÖØÊÓ¡£ qO-C%p [5  
µ«ÊÇ£¬Èç¹ûÌṩ°ïÖúµÄ¹ý¶à£¬¾Í²»±ØÒ»Ò»ÌáÃû£¬³ýÖ±½Ó²ÎÓ빤×÷¡¢°ïÖúºÜ´óµÄÈËÔ±ÁÐÃûÖÂл£¬Ò»°ãÈ˾ùÁýͳ±íʾлÒâ¡£Èç¹ûÓеĵ¥Î»»ò¸öÈËȷʵ¸øÓè°ïÖúºÍÖ¸µ¼£¬ÉõÖÁÑо¿·½·¨¶¼ÊÇ´ÓÈ˼ÒÄÇÀïѧµ½µÄ£¬Ò²Ö»×ÖδÌᣬÊDz»Ó¦¸ÃµÄ¡£Èç¹ûдÉÏһЩ´Óδ¸øÓè°ïÖúºÍÖ¸µ¼µÄÈË£¬ÎªÕչ˹ØÏµ£¬Ìá³öÖÂлҲÊDz»Ö÷ÕÅ¡£ CV&zi6  
2.ÖÂлÔÚÂÛÎÄÊÖ¸åÖеÄλÖà dL_QX,X-]  
ÖÂлͨ³£Î»ÓÚÂÛÎĽáÊøÖ®ºó»ò½áÊøÊ±¡£µ«ÉÙÊýSCIÆÚ¿¯ÒªÇó°ÑÂÞÁÐÖÂл·ÅÔڲο¼×ÊÁÏ֮ǰ£¬»òÕßÔÚµÚÒ»½Ú¡£ ATXF,o1  
3.ÀûÒæ³åÍ» :N@U[Wx0A  
ÓÐЩSCIÆÚ¿¯ÒªÇóÔÚÖÂлÕ½ÚÄÚ˵Ã÷¡°Any clarification regarding conflicts of interest of the authors¡±¡£Èç¹ûûÓУ¬Äã¿ÉÒÔдÉÏ¡°The authors indicate no potential conflicts of interest¡±»òÕß¡°The authors declare that they have no competing financial interests¡±¡£ `c"4PU^  
4.ÊéдÖÂл³£¼ûµÄ´íÎó gYatsFyL  
£¨1£©Êéд»ù½ðÀ´Ô´Ê±£¬Ã»Óбê×¢»ù½ðºÅÂë¡£µ±È»£¬ÓÐЩ»ù½ðûÓлù½ðºÅÂë¡£ -J,Q;tj   
£¨2£©ÓÐÈË»ùÓÚÀñò£¬ÌíÉ϶ÔeditorºÍanonymous reviewersµÄ¸Ðл£¬ÕâÊÇûÓбØÒªµÄ¡£ $PSY:Zz  
£¨3£©ÓÐЩÃû¼Ò¡¢Ñ§Õß»ò½ÌÊÚ£¬´Óδָµ¼£¬Ò²Ã»ÓÐÔĶÁ¹ýÂÛÎÄ£¬½è¡°ÖÂл¡±À´Ôö¼ÓÂÛÎÄ·¢±íµÄ¿ÉÄÜÐÔ£¬ÊDz»¶ÔµÄ¡£ÖÂл´ÊºÍÖÂл·½Ê½±ØÐëÕ÷µÃÊÜлÈ˺͵¥Î»µÄͬÒâ¡£

kaobook 2011-08-17 22:36
µÚ15Õ ÈçºÎÒýÓòο¼ÎÄÏ× A&?}w_|9  
1.²Î¿¼ÎÄÏ×µÄÄ¿µÄ GQN98Y+h  
±ãÓÚ¶ÁÕß²éÔÄԭʼÎÄÏ××ÊÁÏ£¬±ãÓÚ×Ô¼º½øÒ»²½Ñо¿Ê±²Î¿¼¡£Ó¦¸Ã×¢ÒâµÄÊÇ£¬·²ÁÐÈë²Î¿¼ÎÄÏ×£¬×÷Õß¶¼Ó¦ÏêϸÔĶÁ¹ý£¬²»ÄÜÁÐÈëÎ´ÔøÔĶÁµÄÎÄÕ¡£ :l+_ja&o  
2.ÊÕ¼²Î¿¼ÎÄÏ×µÄÔ­Ôò =fl%8"%N&  
£¨1£©Ö÷ÒªµÄÎÄÏ×£¨Primary literature£©¡£ %}C9  
¨S¸ÃÑо¿ÓÉË­´´Ê¼µÄ£¿£¨Who first laid the basic idea?£© }A|))Ao|  
¨SÊÇË­×öÁË×îÖØÒªµÄ¹¤×÷£¿£¨Who did the most important work before?£© ->\N_|_  
¨S»¹ÓÐË­¹±Ï׺ܴ󣿣¨Who else contributed significantly?£© Qyz>ZPu}sz  
£¨2£©ÊÕ¼Õýʽ·¢±íµÄÎÄÏס£ =7 VCtd/  
£¨3£©¹æ·¶µÄÊÕ¼¸ñʽ¡£ IAI(Ix  
3.ÊÕ¼²Î¿¼ÎÄÏ×ӦעÒâÊÂÏî !.EcP=S  
£¨1£©×îºÃÒýÓÃԭʼÎÄÏ×£¬²»Òª¶þ´ÎÒýÓᣠ[Tb\woU  
£¨2£©×¢ÒâÎÄÏ×±àÅŸñʽ£¬ÓëÄãҪͶµÄ¿¯ÎïÒªÒ»Ö¡£ÒòΪ£¬²»Í¬µÄSCIÆÚ¿¯Óв»Í¬µÄÎÄÏ×±àÅŸñʽ¡£Í¶¸åǰ£¬Ê×ÏÈÒªÁ˽â¸ÃÆÚ¿¯µÄͶ¸åÖ¸ÄÏ¡£ Wr5Q5s)c  
£¨3£©¾¡Á¿²»ÒªÒÅÂ©ÖØÒª²Î¿¼ÎÄÏס£ _gW{gLYyJ  
£¨4£©ÒýÓÃÎÄÏ×ʱ£¬²»ÒªÍêÈ«ÒÀÀµÓÚ×ÛÊö¡£ .+yW%~0  
£¨5£©¾¡Á¿ÒýÓÃÔ­´´ÕßµÄÎÄÏס£  7^MX l  
£¨6£©µ±ÒýÓÃ×Ô¼ºÒѾ­Í¶¸å£¬µ«»¹Ã»ÓнÓÊܵÄÂÛÎÄʱ£¬¿ÉÒÔд³Ésubmitted¡£Èç¹ûÄãµÄÂÛÎÄÒѾ­±»½ÓÊÜ£¬µ«»¹Ã»Óгö°æÊ±£¬¿ÉÒÔд³Éin press¡£ G2]^F Y  
£¨7£©²Î¿¼ÎÄÏ×µÄÒýÓÃÒª¸ù¾ÝÊÕ¼²Î¿¼ÎÄÏ×µÄÔ­Ôò¡£ÒòΪ£¬±à¼­²¿Ò»°ãÑ¡ÓøÃÁìÓòÖеÄר¼ÒÀ´ÆÀÉó¡£Èç¹ûÆÀÉóר¼Ò·¢ÏÖËûµÄÂÛÎÄûÓб»ÒýÓ㬿ÉÄÜ»áÔì³ÉÒ»¶¨µÄ¸ºÃæÓ°Ïì¡£ÖÁÉÙÆÀÉóר¼Ò»áÈÏΪÄã¶Ô¸ÃѧÊõÎÊÌâµÄÁ˽âºÍÀí½âµÄÉî¶ÈÒÔ¼°¹ã¶È²»¹»¡£ )11W)G`w  
4.²Î¿¼ÎÄÏ׵ĸñʽ )TU<:V  
£¨1£©×÷ÕßµÄд·¨£ºÓеÄÊǼòдÔÚǰ£»ÓеÄÊǼòдÔÚºó£»ÓеļòдÓе㣻ÓеļòдûÓе㡣 DyfsTx  
£¨2£©ÎÄÕµÄÃû×Ö£ºÓеÄÒª¼ÓÉÏÒýºÅ£¬ÓеÄÔò²»±Ø¼Ó¡£ \dcdw* v@  
£¨3£©ÆÚ¿¯µÄд·¨£ºÓеÄÒª¼òд£¬ÓеÄҪȫ³Æ£¬ÓеÄҪбÌ壬ÓеÄÔò²»ÐèÒª¡£ SfW}"#L>5  
£¨4£©ÄêºÍÆÚ¾íºÅµÄ˳Ðò£ºÓеÄÊÇÄê·ÝÔÚǰ£¬ÓеÄÊÇÄê·ÝÔÚºó¡£ "MnSJ 2  
£¨5£©ÎÄÏ×µÄÅÅÁÐ˳Ðò£ºÓеÄÊǰ´ÕÕ×ÖĸµÄ˳Ðò£¬ÓеÄÔòÊǰ´ÕÕÔÚÂÛÎÄÖгöÏÖµÄ˳ÐòÓð¢À­²®Êý×ÖÅÅÁС£ & Kmy}q  

kaobook 2011-08-17 22:37
µÚ15Õ ÈçºÎÒýÓòο¼ÎÄÏ× gnLn7?  
1.²Î¿¼ÎÄÏ×µÄÄ¿µÄ iW;i!,  
±ãÓÚ¶ÁÕß²éÔÄԭʼÎÄÏ××ÊÁÏ£¬±ãÓÚ×Ô¼º½øÒ»²½Ñо¿Ê±²Î¿¼¡£Ó¦¸Ã×¢ÒâµÄÊÇ£¬·²ÁÐÈë²Î¿¼ÎÄÏ×£¬×÷Õß¶¼Ó¦ÏêϸÔĶÁ¹ý£¬²»ÄÜÁÐÈëÎ´ÔøÔĶÁµÄÎÄÕ¡£ 7I}P*%(f  
2.ÊÕ¼²Î¿¼ÎÄÏ×µÄÔ­Ôò g97]Y1g  
£¨1£©Ö÷ÒªµÄÎÄÏ×£¨Primary literature£©¡£ pQWHG#?7  
¨S¸ÃÑо¿ÓÉË­´´Ê¼µÄ£¿£¨Who first laid the basic idea?£© Qi9-z'  
¨SÊÇË­×öÁË×îÖØÒªµÄ¹¤×÷£¿£¨Who did the most important work before?£© sx 9uV  
¨S»¹ÓÐË­¹±Ï׺ܴ󣿣¨Who else contributed significantly?£© `rb>K  
£¨2£©ÊÕ¼Õýʽ·¢±íµÄÎÄÏס£ Z4hLdHo_  
£¨3£©¹æ·¶µÄÊÕ¼¸ñʽ¡£ Br5o7(AE  
3.ÊÕ¼²Î¿¼ÎÄÏ×ӦעÒâÊÂÏî ,gx) w^WTm  
£¨1£©×îºÃÒýÓÃԭʼÎÄÏ×£¬²»Òª¶þ´ÎÒýÓᣠ#0"~G][#  
£¨2£©×¢ÒâÎÄÏ×±àÅŸñʽ£¬ÓëÄãҪͶµÄ¿¯ÎïÒªÒ»Ö¡£ÒòΪ£¬²»Í¬µÄSCIÆÚ¿¯Óв»Í¬µÄÎÄÏ×±àÅŸñʽ¡£Í¶¸åǰ£¬Ê×ÏÈÒªÁ˽â¸ÃÆÚ¿¯µÄͶ¸åÖ¸ÄÏ¡£ U \oy8FZ  
£¨3£©¾¡Á¿²»ÒªÒÅÂ©ÖØÒª²Î¿¼ÎÄÏס£ aeP[+I9  
£¨4£©ÒýÓÃÎÄÏ×ʱ£¬²»ÒªÍêÈ«ÒÀÀµÓÚ×ÛÊö¡£ S%mfs!E>  
£¨5£©¾¡Á¿ÒýÓÃÔ­´´ÕßµÄÎÄÏס£ 6bO~/mpWT~  
£¨6£©µ±ÒýÓÃ×Ô¼ºÒѾ­Í¶¸å£¬µ«»¹Ã»ÓнÓÊܵÄÂÛÎÄʱ£¬¿ÉÒÔд³Ésubmitted¡£Èç¹ûÄãµÄÂÛÎÄÒѾ­±»½ÓÊÜ£¬µ«»¹Ã»Óгö°æÊ±£¬¿ÉÒÔд³Éin press¡£ 'g)n1 {  
£¨7£©²Î¿¼ÎÄÏ×µÄÒýÓÃÒª¸ù¾ÝÊÕ¼²Î¿¼ÎÄÏ×µÄÔ­Ôò¡£ÒòΪ£¬±à¼­²¿Ò»°ãÑ¡ÓøÃÁìÓòÖеÄר¼ÒÀ´ÆÀÉó¡£Èç¹ûÆÀÉóר¼Ò·¢ÏÖËûµÄÂÛÎÄûÓб»ÒýÓ㬿ÉÄÜ»áÔì³ÉÒ»¶¨µÄ¸ºÃæÓ°Ïì¡£ÖÁÉÙÆÀÉóר¼Ò»áÈÏΪÄã¶Ô¸ÃѧÊõÎÊÌâµÄÁ˽âºÍÀí½âµÄÉî¶ÈÒÔ¼°¹ã¶È²»¹»¡£ E167=BD9<  
4.²Î¿¼ÎÄÏ׵ĸñʽ izZ=d5+K  
£¨1£©×÷ÕßµÄд·¨£ºÓеÄÊǼòдÔÚǰ£»ÓеÄÊǼòдÔÚºó£»ÓеļòдÓе㣻ÓеļòдûÓе㡣 K@u&(}  
£¨2£©ÎÄÕµÄÃû×Ö£ºÓеÄÒª¼ÓÉÏÒýºÅ£¬ÓеÄÔò²»±Ø¼Ó¡£ )9v`f9X){  
£¨3£©ÆÚ¿¯µÄд·¨£ºÓеÄÒª¼òд£¬ÓеÄҪȫ³Æ£¬ÓеÄҪбÌ壬ÓеÄÔò²»ÐèÒª¡£ uQqWew8l+  
£¨4£©ÄêºÍÆÚ¾íºÅµÄ˳Ðò£ºÓеÄÊÇÄê·ÝÔÚǰ£¬ÓеÄÊÇÄê·ÝÔÚºó¡£ S* R,FKg  
£¨5£©ÎÄÏ×µÄÅÅÁÐ˳Ðò£ºÓеÄÊǰ´ÕÕ×ÖĸµÄ˳Ðò£¬ÓеÄÔòÊǰ´ÕÕÔÚÂÛÎÄÖгöÏÖµÄ˳ÐòÓð¢À­²®Êý×ÖÅÅÁС£ y$W|~ H   

kaobook 2011-08-17 22:37
µÚ17Õ ÈçºÎÑ¡Óø½Â¼ 4QHS{tj  
1.¸½Â¼µÄÄÚÈÝ e Y $qV}  
¸½Â¼£¨appendix¡¢supporting information¡¢supplemental data£©°üº¬SCIÂÛÎĵIJ¹³äÐÅÏ¢¡£¶ÔÑо¿ÂÛÎı¾ÉíÓÐÓ㬵«²»Êǹؼü½á¹û¡£¿ÉÒÔ°üÀ¨½á¹ûµÄÏêϸÊý¾Ý¡¢Í¼±ê¡¢Í¼±íµÈ¡£ 1B=>_3_  
2.¸½Â¼µÄÓ¦Óà "3CJUr:Q  
£¨1£©¸½Â¼²¢·Ç°üº¬¶ÔÕýÎÄÀí½âµÄ±ØÐëÐÅÏ¢£¬µ«Ò²Ðí¶ÔSCIÂÛÎÄÖÐijһЩ¹Ûµã¿ÉÒÔ½øÐнøÒ»²½³ÎÇå²¢ÓÐÀûÓÚ¶ÁÕßÀí½âÂÛÎĵÄÄÚÈÝ¡£¸½Â¼Ê®¶ÔÕ÷ÎÄijЩ²¿·ÖµÄ²¹³ä˵Ã÷[¿ÉÑ¡£¨optional£©],ºÜÉÙÓÃÓÚSCIÆÚ¿¯¡£Ö»ÊÇÔÚÂÛÎÄ×ÖÊýÊܵ½ÏÞÖÆµÄSCIÆÚ¿¯ÈçNatureºÍScienceÖвŻáʹÓᣠD=r))  
£¨2£©ÓÐЩÄÚÈݲ»ÄÜÌåÏÖÓÚÓ¡Ë¢ÆÚ¿¯£¬Èçµç×ÓÊÓÌýÎļþ£¨E-component£©¡¢¶Ì¼ÏñƬ£¨video clip£©¡¢¶¯»­£¨short cartoon£©µÈ¡£µ«¿ÉÒÔÔÚÍøÉÏ·¢±í¡£ tt_o$D ~kg  
3.×¢ÒâÊÂÏî - y AQ  
£¨1£©¸½Â¼×ÊÁÏÈÔ°´ÕÕÕý³£Éó¸å³ÌÐòÉó¸å¡£ Nw_@A8-r  
£¨2£©Ö»ÓÐÕýÎÄÖÐÌáµ½µÄ²Å¿ÉÒÔÁÐÈ븽¼¡£ m#!=3P7T  
£¨3£©Èç¹ûÄãʹÓöà¸ö¸½Â¼Ê±£¬Ó¦¸Ã°´Êý×Ö˳ÐòÅÅÁУ¬¼´¸½Â¼I¡¢¸½Â¼II»ò¸½Â¼1¡¢¸½Â¼2µÈ¡£ÎļþµÄÃüÃûÓ¦¸ÃÊÇOne word,ûÓпոñ£¬Èçmovielink¡¢mov¡¢movie2.qt¡¢table1.xls¡£ Qdk6Qubi!  
£¨4£©Ã¿¸ö¸½Â¼Ó¦¸Ã°üº¬²»Í¬µÄ²ÄÁÏ¡£ *Zk>2<^R  
£¨5£©ÎªÁ˱ÜÃâÏÂÔØÎļþÀ§ÄÑ£¬ÊÓÆµ²»Ó¦¸Ã³¬¹ý5MbµÄ´óСºÍ30-60sµÄ³¤¶È¡£¹ÄÀøÊ¹ÓÃQuickTimeÀ´¡°Ñ¹Ëõ¡±ÊÓÆµ¡£ K2)!h.W  
4.¸½Â¼µÄ¸ñʽ uQ1@b-e`5  
¸½Â¼µÄ¸ñʽ°´ÏàÓ¦µÄSCIÆÚ¿¯³ö°æÎïµÄÖ¸ÄÏ×¼±¸¡£

kaobook 2011-08-17 22:38
µÚ17Õ ÈçºÎÑ¡Óø½Â¼ `>C<}xO  
1.¸½Â¼µÄÄÚÈÝ ~uWOdm-"[  
¸½Â¼£¨appendix¡¢supporting information¡¢supplemental data£©°üº¬SCIÂÛÎĵIJ¹³äÐÅÏ¢¡£¶ÔÑо¿ÂÛÎı¾ÉíÓÐÓ㬵«²»Êǹؼü½á¹û¡£¿ÉÒÔ°üÀ¨½á¹ûµÄÏêϸÊý¾Ý¡¢Í¼±ê¡¢Í¼±íµÈ¡£ }yn0IWVa  
2.¸½Â¼µÄÓ¦Óà '9p@vi{\  
£¨1£©¸½Â¼²¢·Ç°üº¬¶ÔÕýÎÄÀí½âµÄ±ØÐëÐÅÏ¢£¬µ«Ò²Ðí¶ÔSCIÂÛÎÄÖÐijһЩ¹Ûµã¿ÉÒÔ½øÐнøÒ»²½³ÎÇå²¢ÓÐÀûÓÚ¶ÁÕßÀí½âÂÛÎĵÄÄÚÈÝ¡£¸½Â¼Ê®¶ÔÕ÷ÎÄijЩ²¿·ÖµÄ²¹³ä˵Ã÷[¿ÉÑ¡£¨optional£©],ºÜÉÙÓÃÓÚSCIÆÚ¿¯¡£Ö»ÊÇÔÚÂÛÎÄ×ÖÊýÊܵ½ÏÞÖÆµÄSCIÆÚ¿¯ÈçNatureºÍScienceÖвŻáʹÓᣠ"r4AY  
£¨2£©ÓÐЩÄÚÈݲ»ÄÜÌåÏÖÓÚÓ¡Ë¢ÆÚ¿¯£¬Èçµç×ÓÊÓÌýÎļþ£¨E-component£©¡¢¶Ì¼ÏñƬ£¨video clip£©¡¢¶¯»­£¨short cartoon£©µÈ¡£µ«¿ÉÒÔÔÚÍøÉÏ·¢±í¡£ uN*KHE+h  
3.×¢ÒâÊÂÏî 2F{hg%  
£¨1£©¸½Â¼×ÊÁÏÈÔ°´ÕÕÕý³£Éó¸å³ÌÐòÉó¸å¡£ e}Vw!w  
£¨2£©Ö»ÓÐÕýÎÄÖÐÌáµ½µÄ²Å¿ÉÒÔÁÐÈ븽¼¡£ !|hoYU>@2L  
£¨3£©Èç¹ûÄãʹÓöà¸ö¸½Â¼Ê±£¬Ó¦¸Ã°´Êý×Ö˳ÐòÅÅÁУ¬¼´¸½Â¼I¡¢¸½Â¼II»ò¸½Â¼1¡¢¸½Â¼2µÈ¡£ÎļþµÄÃüÃûÓ¦¸ÃÊÇOne word,ûÓпոñ£¬Èçmovielink¡¢mov¡¢movie2.qt¡¢table1.xls¡£ /*FH:T<V  
£¨4£©Ã¿¸ö¸½Â¼Ó¦¸Ã°üº¬²»Í¬µÄ²ÄÁÏ¡£ d[^KL;b?6  
£¨5£©ÎªÁ˱ÜÃâÏÂÔØÎļþÀ§ÄÑ£¬ÊÓÆµ²»Ó¦¸Ã³¬¹ý5MbµÄ´óСºÍ30-60sµÄ³¤¶È¡£¹ÄÀøÊ¹ÓÃQuickTimeÀ´¡°Ñ¹Ëõ¡±ÊÓÆµ¡£ ipnV$!z  
4.¸½Â¼µÄ¸ñʽ |077Sf|  
¸½Â¼µÄ¸ñʽ°´ÏàÓ¦µÄSCIÆÚ¿¯³ö°æÎïµÄÖ¸ÄÏ×¼±¸¡£

kaobook 2011-08-17 22:38
µÚ19ÕÂÈçºÎÏòSCIÆÚ¿¯Í¶¸å 5>3}_  
1.×¼±¸Í¶¸åÐÅ u p.Q>28r  
SCIÆÚ¿¯µÄ±à¼­ÍùÍùÐèҪһЩÓйØ×÷Õß¼°ÆäÂÛÎĵÄÐÅÏ¢£¬¶ø×÷ÕßҲϣÍû¸ø±à¼­ÌṩһЩÓÐÖúÓÚÆäÈ«ÎÄËÍÉó¼°¾ö²ßµÄÐÅÏ¢¡£ÕâЩÐÅÏ¢¶¼Ó¦¸Ã°üÀ¨ÔÚͶ¸åÐÅ£¨covering letter£©ÖС£Í¶¸åÐÅÓ¦°üÀ¨ÒÔϼ¸·½ÃæµÄÄÚÈÝ£º Hsih[f  
£¨1£©ÂÛÎĵÄÌâÄ¿ºÍËùÓÐ×÷ÕßµÄÐÕÃûÒÔ¼°µØÖ·¡£ }I 3gU  
£¨2£©ÉêÃ÷ÎĸåȨתÈᣠM02uO`Y9  
£¨3£©ÎÞÒ»¸å¶àͶ¡£ t+5E#!y  
£¨4£©ËùÓÐÁгö×÷Õß¾ù¶ÔÎĸåÓÐÈ·Çй±Ïס£ j4?@(u9;j  
£¨5£©ÎĸåÄÚÈÝÕæÊµ£¬ÎÞαÔì¡£ \V9Z #>  
£¨6£©ËùÓÐ×÷Õß¾ùÒÑÔĶÁÎĸ壬ÇÒͬÒâË͸塣 NCxqh<  
£¨7£©½¨ÒéÉó¸åÈ˼°Òò´æÔÚ¾ºÕù¹ØÏµ¶ø²»ÒË×öÉó¸åÈ˵ÄÃûµ¥¡£ 0|R# Tb;Y  
£¨8£©Í¨ÐÅ×÷Õߣ¨corresponding author£©µÄÐÕÃû£¬ÏêϸµØÖ·£¬µç»°ºÍ´«ÕæºÅÂ룬E-mailµØÖ·¡£ +/#Ei'do  
£¨9£©Í¨ÐÅ×÷ÕßÇ©Ãû¡£ M?=;JJ:  
Science¶ÔͶ¸åÐÅÒªÇó¹ý¶à£º GN KF&M  
¡òThe title of paper and a statement of its main point. 2H.654  
¡òAny information needed to ensure a fair review process. 763+uFx^  
¡òNames of colleagues who have reviewed the paper. 2X:4CC%5  
¡òAlso required for submission are the following: Names, telephone, and E-mail addresses for all authors. -(O-%  
¡òA statement that none of the material has been published or is under consideration elsewhere, including the Internet. {Fzs@,|W.  
¡òNames, affiliations, and E-mail addresses of five potential referees. !"e5~7  
¡òFor investigations on humans, a statement indicating that informed consent was obtained after the nature and possible consequences of the studies were explained. dt~YW  
¡òFor investigations on humans, a statement indicating that informed consent was obtained after the nature and possible consequences of the studies were explained. ]skkoM  
¡òFor authors using experimental animals, a statement that the animals¡¯ care was in accordance with institutional guidelines. mxb06u _  
¡òCopies of any paper by you or your coauthors that is in press or under consideration elsewhere that relates to the work submitted to sciences, or of any paper that is cited in your paper as in press. These materials should be sent as attached PDF files in an E-mail to science_editors@aass.org. h3T9"w[  
¡òWritten permissions from any authors who is not an author of your manuscript but whose work is cited as a personal communication or in press. Permission must allow distribution of in press manuscripts or relevant data to reviewers or any interested reader upon publication. `"qP  
Ͷ¸åÐÅʾÀý1 {.yStB. T  
Dear Editor: E*#]**  
Enclosed for your consideration is an original research article, entitled ¡°X X X X X¡±. VUI|.76g  
1.All authors of this research paper have directly participated in the planning, execution, or analysis of this study. upeU52@\  
2.All authors of this research paper have read and approved the final version submitted. zG e'*Qei  
3.The contents of this manuscript are not been copyrighted or published previously. !QDQ_  
4.The contents of this manuscript are not now under consideration for publication elsewhere.  JHf  
5.The contents of this manuscript will not be copyrighted, submitted ,or published elsewhere ,while acceptance by the Journal is under consideration. q~o,WZG  
6.There are no directly related manuscripts or abstracts ,published or unpublished, by any authors of this paper. XQ4G)  
We believe the paper may be of particular interest to the readers of your Journal because the study reports that ¡­. %*#n d  
Correspondence and phone calls about the paper should be directed to X X X X X at the following address, phone and fax number ,and E-mail address: 'R&uD~Q  
(your name and address here) /m!Cc/Hv  
Thanks very much for your attention to our paper. f]7M'sy|  
Sincerely yours, = waA`I d  
(your name here) Q[+ac*F=Y  
Ðí¶àÂÛÎÄÒòSCIÆÚ¿¯±à¼­²¿ÍùÍùÕÒ²»µ½ºÏÊʵÄÉó¸åÈË£¬ÖÂʹ¸å¼þÒ»ÔÙÍÏÑÓ¡£ÌṩÉó¸åÈËÃûµ¥ºÍÏêϸͨѶµØÖ·£¬»á¼Ó¿ìÉó¸åÈËËÙ¶È¡£Òò´Ë£¬ÔÚͶ¸åµÄͬʱ£¬ÌṩһЩÊìϤÂÛÎÄÄÚÈݵÄÉó¸åÈËÊDZØÐèµÄ¡£ RZ1 /#;  
Ͷ¸åÐÅʾÀý2 ZNYH#mJX*  
Dear Dr. XXX, 9<K j6t_  
I would like to submit the attached manuscript,¡°XXX¡±,for consideration for possible publication in the Research Articles section of JCI. w&xDOyW]  
My two nominees for associate editor are Dr. Smith and Dr. XXX.. Dr. Smith is well versed in the topic of the paper, while Dr. XXX has used a methodology in his own research that is related to the methodology in the paper being submitted. :_Eqf8T  
Reguarding the option of nominating up to four reviewers, my nominees are: O LI$1d_  
Name-1,E-mail adderess-1 ^Q&u0;OJ  
Name-2,E-mail adderess-2 4e;QiTj  
Name-3,E-mail adderess-3 QM?#{%31  
Name-4,E-mail adderess-4 o!Rd ^  
The nominees for associate editor and reviewers have no conflict of interest with any of the authors of the paper being submitted. si4don  
This paper (or closely related research) has not been published or accepted for publication. It is not under consideration at another journal. No other papers using the same data set have been published.(NONE: If other papers using the data set have been published, please indicate the differences between the submitted paper and the other published papers.) r=c<--_@  
Sincerely, ;;A2!w{}[i  
(your name and address here) s|y:UgD  
2.ÔĶÁͶ¸åÐëÖª ':R,53tjl  
´ÓÏàÓ¦µÄSCIÆÚ¿¯ÍøÕ¾µÄhomepageÏÂÔØInstruction for Author,²¢ÇÒ°´ÕÕÒªÇó×¼±¸ºÃÔ­¸åËùÓÐÎļþ£¬ÈçͶ¸å·ÝÊý¡¢ÂÛÎĸñʽ¡¢³¤¶È¡¢Í¼±í¡¢²Î¿¼ÎÄÏ׸ñʽ¡¢Åäͼ˵Ã÷£¨Figure legends£©µÈ£¬ÖðÌõ×ñÑ­¡£Ò»°ãSCIÂÛÎĿɷÖΪ»Ø¹ËÐÔÎÄÕ£¨review article£©¡¢ÆÕͨÂÛÎÄ£¨regular/research article£©¡¢¿ìѶ£¨short communication£©µÈ¡£²»Í¬µÄѧ¿Æ£¬ÕýÎĵÄÄÚÈݺÍÐÎʽ»áÓÐËùÔö¼õ£»Í¼±í¡¢¹«Ê½µÄÊýÁ¿Ò²»áÓÐËù²»Í¬¡£´ËÍ⣬²»µ«Ô­¸æµÄÄÚÈÝÒª·ûºÏSCIÆÚ¿¯µÄµÄÒªÇ󣬶øÇÒÔÚÊý×Ö¡¢Ò³Êý¡¢¸ñʽ¡¢Îļþ´¢´æÐÎʽµÈ·½Ã棬¾ùÐèÓëͶ¸åµÄµÄSCIÆÚ¿¯ÒªÇóÒ»Ö¡£·ñÔò£¬ÂÛÎÄÔÚ³õÑ¡½×¶Î»áºÜ¿ìÂäÑ¡¡£ f-n z{U  
3.ÏòSCIÆÚ¿¯Í¶¸åµÄ·½Ê½ t#!yrQ..'G  
£¨1£©ÓʼÄÐÎʽ¡£¼´Í¨¹ý¹ú¼Ê¿ì¼þ»òº½¿Õ½«ÂÛÎĵÄÔ­¸åÓʼĸøÆÚ¿¯µÄÖ÷±à»ò±à¼­²¿¡£ 2 1PFR:lP7  
a£©¸å¼þ°ü×°£ºÒ»°ãÓ¦°´ÒÔÏÂ˳Ðò±¸Æë×ÊÁÏ£º (@WA1oNG  
¨SͶ¸åÐÅ¡£ n<B<93f/  
¨SÂÛÎĸ忽±´·ÝÊý¡£ÒÔ´òÓ¡¸å£¨hard copy£©Í¶¸å¡£ 'EFyIVezg9  
¨S°æÈ¨×ªÈÃÉêÃ÷£¨¿ÉÒÔÔÚÂÛÎĽÓÊܺó×·¼Ó£©¡£ "`[!Lz  
b£©¸å¼þÓʼġ£Óʼĸå¼þӦעÒ⣺ )!tK[K?5  
¨SÕýÈ·µÄͶ¸åµØÖ·¼°ÊÕ¸åÈË£¨¼û¡°Í¶¸åÐëÖª¡±£©¡£ÓеÄSCIÆÚ¿¯ÔÚ¡°Í¶¸åÐëÖª¡±ÖÐÌØ±ðÖ¸³öͶ¸åµØÖ·Ó붨¿¯»ò¶©µ¥Ðб¾µØÖ·²»Ò»Ñù£¬ÒÔÃâÔì³Éʱ¼äµ¢¸é¡£ ;E ec5w1  
Óʼĸå¼þµÄÐÎÊ½Ôø¾­ÊÇSCIÂÛÎÄͶ¸å½üºõΨһµÄ·½Ê½£¬ÏÖÔÚ²ÉÓÃÕâÖÖ·½Ê½½ÓÊÜÀ´¸åµÄSCIÆÚ¿¯Ô½À´Ô½ÉÙÁË¡£ ~zHg[X*  
£¨2£©µç×ÓÓʼþÐÎʽ¡£¼´×÷Õß½«SCIÂÛÎÄE-mail±à¼­²¿¡£ÏÖÔÚÓÐÐí¶àSCIÆÚ¿¯ÒѾ­¸æ±ðÁËÓʼĺ͵ç×ÓÓʼþµÄʱ´ú£¬¿ªÊ¼Ö»ÊÜÀíÍøÉÏͶ¸å¡£Ä³Ð©ÆÚ¿¯½öÔÊÐíһЩûÓÐͼ±íµÄ¶ÌÎÄ¡¢ÌØÑûÂÛÎÄ£¨reviewer£¬book chapter£©»ò¡°¸ø±à¼­µÄÐÅ¡±Í¨¹ýE-mailͶ¸å¡£¼¸ºõËùÓеÄSCIÆÚ¿¯¾ù²»½ÓÊÜfaxͶ¸å¡£ E\;ikX&1  
£¨3£©ÍøÉÏͶ¸å£¨online submission£©¡£ÍøÉÏͶ¸å·½Ê½Ëٶȸü¿ì£¬¶øÇÒ¸å¼þ²»»á¶ªÊ§¡£ÍøÉÏͶ¸å³£ÐèÒª×÷Õßonline×¢²á¡£Ò»µ©×÷ÕßÔÚÍøÉϵǼÇ×¢²áͶ¸å£¬Ã¿¸öÖ÷Òª²½Öè¶¼ÓмǼ£¬ºÜÊÜSCIÆÚ¿¯×÷Õߵ϶ӭ¡£ 81*M= ?  
4.ÍøÉÏͶ¸å M# 18H<]  
£¨1£©ÍøÉÏ×¢²á£¨online registration£©£¬Ò²½Ð×÷Õß×¢²á¡£ÍøÉÏͶ¸å£¨online submission£©Ê±£¬Òª°Ñ×Ô¼ºµÄÐÕÃû¡¢µ¥Î»¡¢ÁªÏµµØÖ·£¬°üÀ¨µç»°¡¢´«ÕæºÍµç×ÓÓÊÏäµÈµÇ¼Ç׼ȷÎÞÎó¡£×¢²á³É¹¦ºó£¬×÷Õß»áÊÕµ½E-mail»ØÖ´¡£ NzKUtwnIz  
×¢²á³É¹¦ÊÂÀý <5=JE*s$NS  
Dear Dr .XXX, >R/$1e1Y  
Thank you for registering for the Elsevier Editorial System online submission and peer review tracking system for Neurobiology of Disease. #.[AK_S5&  
Here is your username and confidential password, which you need to acess the Elsevier Editorial System :http://ees.elsevier.com/ynbdi/ m5G\}8|  
Your username is: XXX and Your password is: XXX *Ei|fe$sa  
You can change your password and other personal information at: http://ees.elsevier.com/ynbdi/ c#N<"cy>  
info_update.asp 6 n1rL  
Editorial Office t:LcNlN|  
£¨2£©°´²¿¾Í°àµÄÊäÈëÂÛÎĵĸ÷¸öÖ÷Òª²¿·Ö¡£ÈçÌâÄ¿¡¢×÷Õß¡¢ÕªÒª¡¢¹Ø¼ü´Ê¡¢ÕýÎÄ¡¢Í¼±íµÈ¡£ÔÚÊäÈëÿ¸ö²¿·ÖµÄʱºò£¬Ò»ÊÇҪͨ¹ý¸Ã²¿·ÖµÄÓйØÒªÇó£¬ÔÙ´ÎҪȷÈÏ×Ô¼ºÊäÈëµÄÎļþÊÇ·ñ·ûºÏÒªÇó¡£ÕâÌýÆðÀ´²¢²»ÄÑ£¬µ«Êµ¼ÊÉÏ×÷ÕßÔÚÕâ·½ÃæµÄÊèºöÈ´ºÜ¶à¡£ ;IK[Y{W/  
£¨3£©È·ÈÏÿ¸ö²¿·ÖÊäÈëµÄÍêÕûÐÔ¡£ÓÐЩ×÷ÕßÔÚÊäÈëÎļþʱ¹ýÓÚ´Òæ£¬Ê®¸öͼֻÊäÈëÒ»°ë£¬ÕâÑùµÄ¸å¼þ¼´Ê¹Äܵ½Á˱༭²¿Ò²²»ÄÜËÍÉó£¬Ö»ÄÜ·µ»Ø×÷Õß²¹Â©¡£Èç¹ûÉóУԱһʱÊèºö»òÖ÷±àûÓвì¾õ£¬½«ËùÓÐǷȱµÄÎÄÕ·¢³öËÍÉó£¬ÔòÉó¸åÈËÒòΪȱͼ£¬²»ÄÜÕý³£ÉóÔÄÎÄÕ¡£ÕâÑùÔì³ÉµÄÂé·³Ëùµ¢ÎóµÄʱ¼ä»á¸ü¶à¡£ $hxN hI  
£¨4£©ÊäÈëÎļþÍê±Ïºó£¬Ò²¾ÍÊÇËùÓеIJ¿·Ö³É¹¦µØÊäÈëºó£¬²»ÒªÍü¼Çµã»÷Ͷ¸å·¢Ëͼü£¨¡¾Sending¡¿»ò¡¾submitting¡¿£©¡£·ñÔò£¬¸å¼þÖ»»á´æ´¢ÔÚ×÷Õß×Ô¼ºµÄÎļþ¼ÐÖУ¬¶ø²»ÊÇ·¢Ë͵½±à¼­²¿µÄÎļþ¼ÐÀï¡£ÂÛÎÄÌá½»³É¹¦ºó£¬×÷Õß»áÊÕµ½E-mail»ØÖ´¡£ 7k Ky\W  
Ͷ¸å·¢Ëͳɹ¦Ê¾Àý .lhn;*Yi  
Dear DrXXX£¬ !QmzrX}h  
This is confirm that the above-mentioned manuscript has been received for consideration $>U # W:  
in Neurobiology of Disease. A|}l)!%  
You will be able to check on the progress of your manuscript by logging on to the Elsevier Editorial System for Neurobiology of Disease as an author. M\b")Tu{0  
You will be given a manuscript number shortly and you will soon receive an E-mail AGA`fRVx  
with this number for your reference. ECa$vvK m  
Thank you for submitting your manuscript to Neurobiology of Disese. Should you have iAMtejw  
any questions, please feel free to contact our office. b{DiM098  
Kind regards, S~$'WA  
Editorial Office !e#xx]v3  
Ŀǰ£¬Ðí¶àSCIÆÚ¿¯ÍøÉÏͶ¸å£¬Ðè°ÑÎļþÓÐÒ»ÖÖ´æ´¢ÐÎʽת»»µ½ÁíÍâÒ»ÖÖ´æ´¢ÐÎʽ£¬±ÈÈçWordÎļþ±ä³ÉPDFÎļþ¡£ÔÚÕâ¸öת»»¹ý³ÌÖУ¬¼ÆËã»úÆÁÄ»ÉÏ»áÏÔʾͣÖÍ״̬£¬¿´ÉÏÈ¥ºÃÏñËÀ»úÁË¡£Æäʵ²»È»£¬Ö»ÐèÄÍÐĵȴý¡£Èç¹ûÓÐÎÊÌ⣬ÆÁÄ»ÉÏÔò»á³öÏÖÎÊÌâÔ¤¾¯»ò½â¾öÎÊÌâµÄÌáʾ¡£Èç¹û×÷Õß²»ÄÜ×ÔÐнâ¾ö¹ÊÕÏ»òÎÊÌâ·´¸´³öÏÖ£¬×÷Õß¿ÉÓë³ö°æÉçµÄÔÚÏßͶ¸åÖ§³ÖϵͳµÄÏà¹Ø²¿ÃÅ£¨online submission support team £©ÁªÏµ£¬ÇóµÃ°ïÖú¡£´ËÍâÖµµÃÒ»ÌáµÄÊÇ£¬²¿·ÖÖøÃû³ö°æÉçµÄÍøÒ³Éϳý¸½ÓÐͶ¸åÐëÖªÍ⣬»¹ÓÐרÃÅÉè¼ÆÁËÕë¶ÔÍøÉÏͶ¸åµÄÖ¸µ¼Ê¾·¶Îļþ£¨£©¡£×ÜÖ®£¬ÍøÉÏͶ¸å²¢²»ÄÑ£¬¹Ø¼üÊÇ×¼±¸³ä·Ö£¬¶øÇÒÔÚʵ¼ÊÉÏ»ú²Ù×÷ʱ°´²¿¾Í°à£¬²»Äܵ¥´¿Çó¿ì£¬·ñÔòÓûËÙ¶ø²»´ï¡£ *p ? e.%nd  
ÍøÉÏͶ¸åºó£¬±à¼­²¿»¹»á¸øÄãÒ»¸öÕýʽµÄ»ØÖ´ºÍ¸å¼þ±àºÅ¡£ gJ2 H=#M  
£¨5£©¸å¼þ±àºÅ¿ÉÓÃÓÚ¸å¼þ×·×Ù£¨following-up£©¡£Òò´Ë£¬Òª±£´æºÃ¡£ j*T]HaM  
Ͷ¸åÊÕÌõʾÀý 0@1:M  
Dear Authors£¬ :&'{mJW*{t  
This is to inform you that the following manuscript has been submitted to the JCB. T#:F]=  
Manuscript Number: F-00555-2008 xSpC'"   
Manuscript Title: X X£Ø.Author list:XXX V'Y{v  
You can track the status of the manuscript in your author center at http://mc.manuscriptcentral.com/JCN. %IpSK 0<Sp  
If you have received this message in error, or if one of your co-authors did not receive this message, please contact the corresponding author:Dr.XXX. Tc ZnmN  
Regards, [UPNd!sy  
Peer Review Manager 6(56,i<#/  
5.ÍøÉÏͶ¸å³£¼ûÎÊÌâ w`yx=i#  
ÍøÉÏͶ¸åͨ³£ÊÇ¿ìËÙ²¢Ïà¶ÔµØÈÝÒס£È»¶ø£¬Èç¹û×÷ÕßÊèºö×ñÊØÆÚ¿¯µÄÒªÇ󣬿ÉÄÜÑÓ³Ù»òÍ£Ö¹·¢ËͺÍÉó¸å¹ý³Ì£¨The submission and peer-review process£©¡£ÍøÉÏͶ¸å³£¼ûµÄÎÊÌâÓУº m^!Sv?hV  
£¨1£©ÂÛÎÄ×ÖÊdz¬¹ý¹æ¶¨µÄÒªÇó¡£ {ctwo X[;  
±ÈÈç°´ÒªÇó£¬Ô­¸å²»Äܳ¬¹ý3000×Ö£¬¿ÉÓеÄÔ­¸å³¤´ï3200×Ö£¬ÉõÖÁ¸ü¶à¡£ l%"`{   
£¨2£©Í¼²»¹æ·¶¡£ 3\!F\tqD \  
¨SµÝ½»Í¼Îļþ£¨Figure file£©·½Ê½²»ÕýÈ·¡£¶àÊýSCIÆÚ¿¯ÒªÇóÿµ¥¶Àͼ×÷Ϊһ¸öµ¥¶ÀÎļþµÝ½»£¬¶ø²»ÊǰÑËùÓеÄfigure fileºÏ³ÉÒ»¸öÎļþÔٵݽ»¡£ 5ouQQ)vA  
¨SͼµÄ·Ö±æÂÊÌ«µÍ¡£Ó¦¸ÃÓø߷ֱæÂʵÄͼ£¨300dots per inch£©¡£ R lg#z4m  
¨SͼµÄ¸ñʽ£¨format£©²»¶Ô¡£³£ÓÃͼµÄÖ¸¶¨¸ñʽΪGIF¡¢JPEG¡¢TIFF¡£²»ÒªÓ÷ÇÖ¸¶¨¸ñʽ£¬ÀýÈ磬PDF¡¢WBMP¡¢Word.doc¡¢RLEºÍPowerPoint¡£ =Q?f96T  
¨SûÓÐͼ½â£¨Figure legend£©¡£ dt-K  
£¨3£©Ã»Óеݽ»¡°A conflict of interest disclosure¡±¡£ 9={N4}<  
ÓÐЩSCIÆÚ¿¯ÒªÇó×÷ÕßÔÚͶ¸åµÄͬʱ£¬ÒªµÝ½»¡°A conflict of interest disclosure¡±¡£ N^$9;CKP=  
£¨4£©È±Title page¡£ ;QidDi_s>  
£¨5£©È±ÕªÒª¡£ } J;~P 9Y  
£¨6£©È±Í¶¸åÐÅ¡£ $xcv>  
£¨7£©¶¯ÎïºÍÈËÌåÊÔÑéûÓб»Â×ÀíίԱ»áÅú×¼¡£ 1 ;Ju]  
£¨8£©ÂÛÎĵĸñʽ²»·ûºÏËùͶSCIÆÚ¿¯µÄÒªÇó¡£

kaobook 2011-08-17 22:39
µÚ20ÕÂSCIÂÛÎÄÉó¸å¹ý³Ì WE7>?H*Ro  
1.±à¼­²¿³õÉó y. %i  
³õÉó°üÀ¨£º QZz&1n  
£¨1£©×î»ù±¾µÄ¼¼Êõ¼ì²é¡£Ö÷ÒªÊǼì²ìÔ­¸åÊÇ·ñ°üº¬ÁËÓ¦¸ÃÓеĻù±¾ÄÚÈÝ¡£°üÀ¨ÎļþÐÎʽ¡¢ÄÚÈÝ¡¢×÷ÕßÁªÏµ·½Ê½ÒÔ¼°ÂÛÎÄÊÇ·ñÊôÓÚÖØ¸´ÐÔͶ¸åµÈ¡£ "_ Zh5 g  
£¨2£©ÂÛÎĵÄÓ¢ÎÄÊÇ·ñ»ù±¾¹ý¹Ø£¨·ÇÓ¢Óï¹ú¼Ò£©¡£  hgNY[,  
£¨3£©ÂÛÎĵÄÄÚÈÝÊÇ·ñ·ûºÏ¸ÃÆÚ¿¯ÒªÇó¡£ ;Kt'S it  
£¨4£©ÂÛÎĵÄˮƽÊÇ·ñ·ûºÏ¸ÃÆÚ¿¯ÒªÇó¡£ N" 8*FiZ|  
2.±à¼­²¿³õÉóºóµÄ½á¹û .`b4h"g:  
£¨1£©½øÒ»²½ËÍÉó¡£ :A,O(   
£¨2£©Ðè²¹³äºÍÐ޸ġ£Ò»µ©¼¼Êõ·¢ÏÖÎÊÌ⣬±ÈÈçÔ­¸å¹ý³¤µÈ£¬Ô­¸å»áÂíÉÏ·µ»Ø×÷Õߣ¬½øÐбØÒªµÄ²¹³äºÍÐ޸ġ£Ô­¸æÒ»µ©ÍË»Ø×÷Õߣ¬Îļþ±ã»áÖØÐ»ص½×÷Õß×Ô¼ºÔÚÍøÉϵÄͶ¸åÎļþ¼ÐÀµÈºòÐ޸ġ£Óë´Ëͬʱ£¬×÷Õߵĵç×ÓÐÅÏäÄÚͬÑù»áÊÕµ½Ò»·â±à¼­²¿µÄÀ´ÐÅ£¬Ã÷È·¸æÖª¸å¼þÓ¦¸Ã½øÐÐÐ޸Ļò²¹³äµÄµØ·½¡£×÷ÕßÖ»ÐèÉÏÍø´Ó×Ô¼ºµÄÎļþÖе÷³öÎļþÐ޸ļ´¿É¡£Ò»µ©ÎļþÐÞ¸ÄÍê±Ï£¬×÷ÕßÓÖÒª¸ù¾Ý³ö°æÉçÐź¯µÄÌáʾ£¬ÉÏÍø°´²½Öè»á×ßÔÙ½«Ô­¸å·¢»ØSCIÆÚ¿¯µÄ±à¼­²¿¡£Õâ¸ö²Ù×÷¹ý³ÌÓë×î³õµÄͶ¸å³ÌÐò´óͬСÒì¡£ USH@:c#t  
£¨3£©Ö±½Ó±»¾Ü¾ø¡£ LNWqgIq  
Ö±½Ó±»¾Ü¾øµÄÔ­ÒòÖ÷ÒªÓУº `" i^'VL,  
µÚÒ»£¬ÂÛÎĵÄˮƽûÓзûºÏ¿¯ÎïÒªÇó¡£ÀýÈ磬Nature´óÖÂµÄÆÀÑ¡»úÖÆ£º±à¼­Ê×ÏȾö¶¨ÕâÆªÂÛÎĵ½µ×ÓжàÉÙ·ÖÁ¿£¬Õâ¸ö¾ö¶¨ÒªÔÚ¼¸ÌìÄÚ¾ÍÍê³É£¬Èç¹û·ÖÁ¿²»¹»£¬¾ÍÖ±½Ó¾Ü¾ø£¬Ã¿ÄêÈ«Çò´óÔ¼ÓÐ1ÍòƪÂÛÎÄÌá½»£¬60%-70%µÄÂÛÎĵ±¼´·ñ¾öµô£¬´ËºóÇëרҵÆÀÉóÍÅÆÀ¹À£¬´óÔ¼3¸ö×óÓÒ£¬¶¼ÊÇÏàͬÁìÓòµÄר¼Ò£¬Í¨¹ýÆÀÉóÂÊ´óÔ¼ÊÇ20%£»ÔÚÌýÈ¡ÆÀÉóÍÅÒâ¼ûºóÔÙ·ñ¾ö´óÔ¼2000-3000ƪ£¬×îºóֻʣÏÂ1000ƪ·¢±í£¬×îºóµÄ×Ü·¢±íÂÊÊÇ10%¡£ hqdC9?\  
µÚ¶þ£¬ÂÛÎĵÄÄÚÈݲ»·ûºÏ¸ÃÆÚ¿¯µÄµÄ°ì¿¯×ÚÖ¼ºÍ·¶Î§ÒªÇó¡£ vQ?MM&6  
ÂÛÎÄÖ±½Ó±»¾ÜʾÀý Cmp{FN"o  
Dear Dr.XXX $1:}(nO,  
I am writing to you on behalf of the Journal of Clinical Investigation,s Editorial Board to thank you for submitting your manuscript,¡°Xxxx¡± (our reference 5555-RG-1).The Broad has now had a chance to carefully consider your manuscript, but I regret to inform you that we feel the manuscript would not be appropriate for publication in the Journal of Clinical Investigation. gK&5HTo  
More than 4,000 manuscripts are submitted annually to the JCI,of which only a small percentage can be published. To facilitate the review process, we submit all manuscripts to a review by the Editorial Board to determine their appeal to the Journal¡¯s general readership. @2-Hj~  
Although the Board regrets that it cannot offer to publish your manuscript, I would stress that this decision was based on issues relating to the priority assigned to your work relative to the other submissions under consideration. Q"x`+?!  
Thank you for allowing us to review this work.We hope that you will continue to consider sending your work to the Journal in the future. PT 0Qzg  
Sincerely, ;$E~ZT4p  
Editor-in-Chief PE OM1oY)w  
3.±à¼­²¿ËÍÉó B]+7 JB  
¡òÆÀÉóÈ˵ÄÑ¡Ôñ 1Xk{(G<\  
SCIÆÚ¿¯µÄÉó¸åÈË´ó¶àÊǸ÷ÁìÓòר¼Ò£¬ÔÓÖ¾³ö°æÕß¾­³£Õ÷ѯ±àίÒâ¼û£¬Ñ¡Ôñ×î¼ÑÉó¸å¶ÓÎé¡£Éó¸åÈ˵ÄÔðÈÎÊǶÔÂÛÎĵĴ´ÐÂÐÔºÍÕþÈ·¶¨½øÐÐÉó²é£»Éó¸åÒâ¼ûÒ»°ãÓ¦°üÀ¨ÎªÌá¸ß¸å¼þÖÊÁ¿¶øÓ¦×öµÄÐ޸ĵĽ¨Òé¡£Éó¸åÈËÊÇÎÞ±¨³êµÄ£¬Éó¸åÈ˵Ä̬¶È´ó¶à¼«ÆäÈÏÕæ¡£Ã¿Ò»ÂÛÎÄÓÉ2-4λÆÀÉóÈËÀ´ÅÐ¶ÏÆä¼ÛÖµ£¬²¢½¨Òé±à¼­ÊÇ·ñ½ÓÊÜ»ò¾Ü¾ø¸ÃÂÛÎÄ¡£µ«±à¼­×ö³ö×îºóµÄ¾ö¶¨£¬Ò»°ã²»»áÒòΪ±à¼­¸öÈ˵ĺöñ»òÆäËû·Ç¿ÆÑ§ÒòËØ¶øÓ°ÏìÂÛÎĵĽÓÊÜ¡£ÒòΪ£¬±à¼­À´×Ô²»Í¬µÄ¹ú¼ÒºÍµØÇø£¬ÓÐ×Ų»Í¬¿ÆÑ§µÄרҵ±³¾°£¬×Ô¼ºÊ×ÏȾÍÊǸÃÁìÓòµÄר¼Ò£¬ËûÃǵÄÖ°Ôð¾ÍÊǾ¡×Ô¼º×î´ó¿ÉÄÜ£¬Ñ°ÕÒ×îÓÅÐãµÄÂÛÎÄ¡£ OX #eLco  
EditorÑûÇëReviewerÉó¸åµÄÑù¸åÐÅʾÀý hlSB7 D"d  
MS TITLE£ºXXX =H.<"7  
Dear Dr.XXX 0XBBA0t q  
I would appreciate your expert opinion as a reviewer of the above manuscript recently submitted for publication to Science. Given your knoeledge and expertise in the subject areas upon which this manuscript is focused, I hope you will agree to participate in the reviewer process. qY*%p  
Please advise the editorial office in your reply of any relevant relationship that might be reasonably perceived as a real or potienial conflict of interest that could potentially influence or bias your review of this manuscript.  )zk?yY6  
While most relationships are not disqualifyin, if you believe that you have a disqualifying conflict of interest, financial or otherwise, please contact the editorial office immediately. A relationship is ¡°relevant¡± if the relationship or interest relates to the topic of the manuscript in terms of any of the following: the same or similar subject matter or topic; the same, similar or competing drug or device, product or service, intellectual property or asset; a drug or device company or its competitor; or has the reasonable potential to result in financial, professional or other personal gain or loss for you, members of your household or employer. 8S[ <[CH  
To view the abstract and accept/decline this invitation, please go to: http://submit-science.org !DY2{Wb  
Enter your ¡®Reviewer Area¡¯ and click on ¡®Requests for Review¡¯. Please accept or decline via the appropriate alternative reviewers, giving their name(s),institution(s), and E-mail address(es). [7SI<xkv  
Sincerely, F| ,Vw{  
Editor M rH%hRV6R  
Èç¹ûͬÒ⣬Editor»á¸øReviewerÒ»·âÐŲ¢¸æËßReviewerÈçºÎÏÂÔØÂÛÎÄºÍÆÀÉó¡£ SzgY2+Qq  
Editor¸øReviewerµÄÑù¸åÐÅʾÀý E``!-W  
Dear Dr.XXX ')yF0  
Thank you for agreeing to review Manuscript ID-07-555 entitled ¡°XXX¡± for Cell.  HPd+Bd  
In your review, please answer all questions. On the review page, there is a space for ¡°Comments to Editor¡± and a space for ¡°Comments to the Author¡±.Please be sure to put your comments to the author in the appropriate space. u6bB5(s`&  
To access the manuscript, login to Cell-Manuscript Central site at http://mc.manuscriptcentral.com/cell. Once you are logged in, the Main Menu will be displayed.Please click on the Reviewer Centre, where you will find the manuscript listed under ¡°Review and Score¡±.You can click on the ¡°View Details¡± button to begin reviewing the manuscript. It is essential that you click the ¡°Save¡± button if you wish to exit the review before you submit it to the Editor. Otherwise, none of the information that your have completed your review and are ready to submit it to the Editor, click on ¡°Submit¡±. Fm[?@Z&wP  
Thank you for evaluating this manuscript. yW6[Fpw  
Best regards, [jtj~]&mO  
Executive Editor Jj^<:t5{rN  
¡òÂÛÎĽøÈëSCIÆÚ¿¯µÄ×î»ù±¾ÒªÇó }mT%N eS  
Ô­´´ÐÔÊǺܶàSCIÆÚ¿¯ÊÇ·ñ¼ÓÃÂÛÎĵÄ×îÖ÷Òª³ö·¢µã¡£ÈÎºÎÆÚ¿¯¶¼²»Ï£Íû·¢±íÒѾ­¼ûÓÚÆäËûÔÓÖ¾£¬»òÓÉÆäËûÓïÑÔ·¢±í¡¢»òÒÔÉÔÓв»Í¬µÄÐÎʽ·¢±íµÄÂÛÎÄ£¬SCIÆÚ¿¯Ò²ÊÇÈç´Ë¡£ÒªÏëÔÚSCIÆÚ¿¯·¢±íÂÛÎÄ£¬Ô­´´ÐÔ×î»ù±¾µÄÒªÇó¡£ ,[K)E  
¡òÂÛÎÄÆÀÉó±ê×¼ WY. \<$7  
ÏÖ½éÉÜÂÛÎÄÆÀÉó±ê×¼ÈçÏ£º DHujpZXQ  
¨SÂÛÎĵÄÄÚÈÝÊÇ·ñ·ûºÏ¸ÃÆÚ¿¯µÄ·¶Î§£¨aims and scope£©¡£ krnk%ug  
¨SÂÛÎÄÊÇ·ñÌá³öÁËÒ»¸öеÄÎÊÌâ»òÕß¶ÔÒÑÓÐÎÊÌâÌá³öÁËÒ»¸öеĽâ¾ö·½°¸¡£ t U~H@'  
¨SÂÛÎĵÄÔ­´´ÐÔÖÊ£¨°üÀ¨¸ÅÄî¡¢ÖÎÁÆ¡¢·½·¨¡¢Êý¾Ý¡¢½âÊͺÍ/»òÓ¦Óã©»ò½ñºóµÄ¼ÛÖµ»òÒâÒå¡£ `))J8j"  
¨SÂÛÎĵÄÖ÷Òª½á¹û»ò½áÂÛÊÇʲô£¿ÊµÑé½á¹û»ò½áÂÛÊÇ·ñ³ä·Ö£¿ Qmc;s{-r;  
¨SÂÛÎÄËùʹÓõķ½·¨µÄÆÀ¼Û£¿ÂÛÎļ¼Êõº¬Á¿ÈçºÎ£¿ $E@.G1T [  
¨S½á¹û»ò½áÂÛÊÇ·ñ¾ßÓÐÐÂÓ±ÐÔ£¿½áÂÛÊÇ·ñÓëÌá³öµÄ¼Ù˵»òÎÊÌâ¹ØÁª£¿½áÂÛÊÇ·ñ±»Ö¤Ã÷Çå³þ£¿ q!h*3mN m  
¨SÖ÷Òª½á¹û»ò½áÂÛÊÇ·ñÕýÈ·£¿ Px?At5  
¨SÂÛÎÄÊÇ·ñ¶ÔËùÌá³öµÄ¼¼Êõ/½á¹ûµÄÓÐЧÐԺ;ÖÏÞÐÔ½øÐÐÁËÆÀ¼Û£¿ g}og@UY7#  
¨SÂÛÎÄд×÷ÊÇ·ñÇåÎú£¬ÊÇ·ñÄÜÈñ¾ÐÐÒµÄÚ¶àÊýÑо¿ÈËÔ±¶Á¶®£¿ ^)P5(fJ  
¨SÎÊÌâ¡¢¸ÅÄî¡¢¶¨ÒåºÍ/»ò¼Ù˵µÄ³ÂÊöÊÇ·ñÇå³þ£¿ k-PRV8WO  
¨SÂÛÎÄÊÇ·ñÊʵ±µØÒýÓúͽéÉÜÁËÓëÖ®Ïà¹ØµÄÀúÊ·ÎÄÏ×£¿ÒýÓÃÎÄÏ×ÊÇ·ñ³ä·Ö£¿ mt6uW+t/  
¨SÊÇ·ñ¾ßÓÐÒ»ÖÂÐÔ£¨Ç°/ºó£¬ÂÛÊö/½á¹û£©£¿ w0%ex#lkm  
¨SÂÛÎĵÄÓ¢ÎÄÊÇ·ñ¹ý¹Ø£¿ exMPw ;8  
¡ò¸å¼þ×·×Ù Ty`=U>K|  
Ͷ¸åºó¸å¼þ×·×Ù£¨follow-up£©¡£Èç¹ûͶ¸å2ÖܺóÈÔÎÞÈκÎÓйظå¼þÊÕµ½µÄÐÅÏ¢£¬¿ÉÒÔ´òµç»°¡¢·¢E-mail»òдПø±à¼­²¿ºËʵ¸å¼þÊÇ·ñÊÕµ½¡£ÏÖÔÚµÄÓʼþ¶ªÊ§Êdz£ÓеÄÊ£¬¼´Ê¹Í¨¹ýE-mail×÷Ϊ¸½¼þ·¢µÄ£¬Ò²ÓзþÎñÆ÷´íÈÏΪ²¡¶¾¶øÉ¾µôÄãµÄͶ¸å¡£E-mail×îºÃÒԻظ´µÄÐÎʽ£¬±£ÁôÔ­Ðżþ£¬ÌáÐѱ༭²¿ÉÏ´ÎͨÐŵÄʱ¼ä¡¢ÄÚÈݺ͸å¼þ±àºÅ¡£Ñ¯ÎÊÎÄ×ÖÒª¼ò½à£¬¿ªÃżûɽ£¬²»ÓÿÍÌ×»°¡£ %B un@  
¸å¼þ×·×ÙÑù¸åÐÅʾÀý Dq1XZ%8  
Dear Dr.XXX 2X |jq4  
I am just writing to enquire if you have received our manuscript (MS#:55555)? zSufU2  
Best 00x^zu?N  
(your name here) (dnc7KrM  
ËùÓÐͨÐÅÓ¦±£³Ö¼Í¼£¬±ÜÃâÎʵĹýÇÚ¡£¿ÉÒÔÔÚÍøÉϲéѯ¸å¼þ״̬¡£

kaobook 2011-08-17 22:40
µÚ21Õ ÈçºÎÕýÈ·¶Ô´ýÉó¸åÒâ¼ûºÍÍ˸å *G"#.YvE  
1.Ͷ¸åºóµÄ½á¹û W 9MZ  
ͨ³£ÔÚÁ½Öܵ½Á½¸öÔ£¬Äã»áÊÕµ½±à¼­µÄ»Ø¸´£¬°üÀ¨Éó¸åÈ˵ÄÒâ¼û£¨Reviewers, comments£©ºÍÒ»·â±à¼­²¿µÄ¸ÅÀ¨ÐÅ£¨Covering letter£©¡£Ò»°ãÓÐÏÂÁпÉÄÜÐÔ£º l'8wPmy%N  
£¨1£©Ô­¸æ½ÓÊÜ£¬ÎÞÐèÐ޸ģ¨Publish without changes£©¡£º±¼û¡£ `r$WInsDu  
Dear XXX \`5u@Nzx  
On the basis of reviewer¡¯s comments on your manuscript, I am pleased to inform you that your manuscript has been accepted for publication in the ¡°XXX iournal¡±. wA&)y>n-  
For the pre-publication preparation, please read carefully the document of ¡°name of document¡± at ¡°XXX website¡± to access the resources you need for preparing the reference styles and the final complete package. When you same your manuscript into an MS-Word file, please use your Paper ID as the file name. For our production schedule, please submit your complete package to me within 14 calendar days. Y}z?I%zL  
Normally, the pre-publication process takes up to three months. During this period, galley proofs will be sent to you for checking and corrections purposes.The galley proofs must be returned to the production office within 7 callendar days. Furthermore, you are responsible for any error in the published paper due to your oversight. 4'| :SyOm  
I look forward to receiving the electronic file of your final manuscript. .?]_yX  
Best Regards, K7Tell\`  
Editor bUL9*{>G  
£¨2£©¸å¼þÍËÐÞ£¬ÐèÇá΢Ð޸ģ¨Publish with minor changes£©¡£²»¶à¼û¡£ &$im^0`r_  
Dear Dr. XXX S`.-D+.68  
Your manuscript, entitled ¡°title of the paper¡±, has been subjected to a double-blind review process by the reviewers who are experts in the related fields. Enclosed please find the reports from these reviewers. Wb xksh:)Q  
Based on the reviewers, recommendations, I am delighted to inform you that your manuscript has been ACCEPTTED WITH MINOR REVISIONS for the ¡°name of the journal¡±. x*V<afLY[  
Please note that it is imperative for you to revise the manuscript according to reviewers, comments and guidelines. Once you have revised the manuscript, please E-mail it in an MS-Word format to me at ¡°Your E-mail Address¡± on or before MM DD,YYYY, with a cover letter outlining point-by-point the revisions you have made in regards to the reviewers comments and guidelines. _"`h~jB  
Thank you very much for submitting your article to ¡°the name of the journal¡±. I look forward to receiving the revised version of your manuscript. z6(Q 3@iO  
Sincerely, #IDCCD^1=  
Editor )FPbE^ s(  
Enclosures: Referees reports. 4y.[tk5  
£¨3£©¸å¼þÍËÐÞ£¬ÐèÖØ´óÐ޸ģ¨Publish with major changes£©¡£ºÜ³£¼û¡£ K(S/D(\ FL  
Dear Dr. XXX ?Q2pD!L{  
We have now received the reviews of your manuscript referenced above. While the reviewers believe that this paper would ultimately make a significant contribution to the literature and could be acceptable for publication in The Journal of Neuroscience, they have also raised a number of serious concerns. These concerns are outlined in their reviews which have been included below. We invite you to revise and resubmit the manuscript. <^{:K`  
Please carefully address the issues raised in the attached comments, points by points, and make appropriate changes in the manuscript, or provide a suitable rebuttal to any specific request for change that you believe is unwarranted. When the revised manuscript is received, it will be sent for re-review. O6]~5&8U.  
When submitting your revised paper, please include a separate document called ¡°Response to Reviews¡± detailing your responses to the comments of the reviewers, we request that your manuscript text, tables and figure legend be submitted in an editable format(Word or La Tex only), and all figures uploaded individually. TIF or EPS files are the preferred formats for figures; however, Power point, Word, and Excel files will also be accepted. DPI minimums are as follows: R kzBn  
-Line art must be at least 1000dpi. 'o L8Z  
-Line/tone(combination of photographs and lines or labels )must be at least 500dpi. oDa{HP\O]W  
Thank you and we look forward to receiving yopur revised manuscript. wQ T'~'kL  
Kind regards, HenJlo  
Associate Editor -}@9lhS,  
£¨4£©ÂÛÎÄÐèÒªÖØ´óÐ޸ģ¬ÖØÍ¶²¢µ±×÷иå¼þ´¦Àí£¨not publish in its present form, but resubmit after major modifications to then be treated like a new submission£©¡£³£¼û¡£ }T,uw8?f!  
Dear Dr. XXX 3QpT O,  
Your manuscript has been reviewed by referees who specialize in the subject matter addressed by the submitted material. The general and specific comments of the referees are below. I regret to inform you that the reviewers raised serious concerns about the manuscript and submitted low priority ratings. In particular the concern was raised that the work was only a minor advance of the field and that several of the findings are already well established. Accordingly, I must reject your manuscript for publication in The Journal of Clinical Investigator. I hope that the reviewers comments will be of assistance to you if you decide to submit your work elsewhere. eAMT72_  
If you choose to rewrite your manuscript and resubmit it to The Journal of Clinical Investigator, you must resubmit it online as a de novo manuscript where it will be assigned an Associate Editor and expert reviewers. You must be complete all required submission forms and pay the $50 submission fee. No exceptions will be made. ,ME9<3 Ac  
Yours sincerely, a0R]hENC  
Associate Editor q<VhP2R  
£¨5£©ÍêÈ«¾Ü¾ø(Reject)¡£×î³£¼û¡£ {\B!Rjt[T  
SCIÆÚ¿¯±à¼­²¿³ýÁ˸ø×÷Õ߻ظ´ÒÔÍ⣬ͬʸæËßreviewer±à¼­¶ÔÂÛÎĵÄ×îºó´¦ÀíÒâ¼û¡£ ]G:xTv8  
±à¼­Ð´¸øreviewerÑù¸åÐÅ jkq+j^  
Dear Dr. XXX F r~xN!  
Thank you for reviewing manuscript Cell-07-o555 entitled XXX for Cell. )7^jq|  
On behalf of the Editors of Cell, we appreciate the voluntary contribution that each reviewer gives to the Journal. We thank you for your participation in the online review process and hope that we may call upon you again to review future manuscripts. om1 / 9  
To read the Editors decision on this paper, go to your Reviewer Centre an click on View Decision Letter. ?U |lZ~o  
Sincerely, P1t5-q  
Editor ^N]*Zf~N?  
2.×î³£¼ûÍ˸åÔ­Òò 9cLKb  
£¨1£©Ö÷ÌâÔ­Òò£¨Subject£©£º MYjCxy-;A  
¨SÄÚÈݲ»ÊÊºÏ¸ÃÆÚ¿¯£¨Not suitable for journal£©¡£ tm$3ZzP4  
¨S²»ÊÊʱ£¨Not time£©¡£  :z[SI{Y  
£¨2£©ÂÛÎÄÄÚÈÝ£¨coverage£©£º {S?.bT%&  
¨SÒâÒå²»´ó£¨Questionable significance£©¡£ ' {Q L`L  
¨S²»¿ÉÐÅ£¨Questionable validity£©¡£ \|Mz'*  
¨SÉî¶È²»¹»£¨Too shallow£©¡£ Ae"B]Cxb_X  
¨S¹ýÓÚÏ꾡£¨Too exhaustive£©¡£ Qi9SN00F.  
£¨3£©ÂÛÎij¤¶ÈµÄÔ­Òò£¨Length£©£º ` sSI;+  
¨SÂÛÎĹý³¤£¨Too long£©¡£ jN'zNOV~  
¨SÂÛÎĹý¶Ì£¨Too short£©¡£ 0VPa=AW  
£¨4£©ÂÛÎĵıí´ïÔ­Òò£¨Presentation£©£º \QVL%,.%M  
¨S¿ò¼Ü²»ºÃ£¨Bad organization£©¡£ ~MOIrF  
¨S±í´ï²»ÐУ¨Ineffective expression£©¡£ HJDM\j*5  
¨S²åͼÓÐÎÊÌ⣨Ineffective or unusable illustrations£©¡£ {<V{0 s%  
£¨5£©ÂÛÎĵĸñʽÎÊÌ⣨Failure to follow style guide£©¡£ tks1*I$S<  
3.ÈçºÎ´¦Àí±»¾ÜµÄÂÛÎÄ 3qP! (*  
£¨1£©ÒªÀí½â±»SCIÆÚ¿¯¾Ü¸åÊÇÒ»¼þÕý³£µÄÊÂÇ飨70%ÒÔÉϱ»¾Ü£©¡£Òò´Ë£¬Òª±£³ÖÁ¼ºÃÐÄ̬¡£ 3>ytpXUEGx  
£¨2£©¶ÔÍêÈ«¾Ü¾øµÄÂÛÎÄ£¬±à¼­Í¨³£»á±í´ï²»Ô¸ÔÙ¿´µ½¸ÃÎÄ£¬ÔÙ¼ÄËÍÕâÀàÎÄÕÂÊÇûÓÐÒâÒåµÄ¡£Ó¦¸Ã²¹³äÐ޸ĺó¸ÄͶÆäËûSCIÆÚ¿¯¡£ #>}cuC@  
£¨3£©Éó¸åÈËÓÐʱҲ»á·¸´íÎ󣬲»½ö½öÊDZÊÎó£¬Ò²ÓÐרҵ֪ʶÉϵĴíÎó£¬ÒòΪ±à¼­ÈËÕÒµÄÉó¸åÈËδ±ØÊÇÄãÏàͬÁìÓòµÄר¼Ò¡£Èç¹û×÷Õß¶Ô·ñ¶¨µÄÔ­ÒòÓÐÒìÒ飬¿ÉÒÔÏò±à¼­²¿»òÖ÷±àÌá³ö×Ô¼ºµÄÒâ¼û£¬¾ÝÀíÁ¦Õù¡£Ö»Òª×Ô¼ºÊÇÕýÈ·µÄ¾ÍÒª¼á³Ö¡£Ôڻظ´ÖÐίÍñµØ±í´ïÒ»ÏÂÄãµÄÒâ¼û£¬ÂÛÎÄ¿ÉÒÔÖØÐ½øÈëеÄÒ»ÂÖÉó¸å³ÌÐò¡£ÕâÖÖÇé¿öºÜÉÙ¼û¡£³É¹¦µÄ¿ÉÄÜÐԺܵ͡£ >HyZ~M  
£¨4£©Èç¹ûÎÄÕ±»¾ÜµÄÔ­ÒòÊÇÒòΪÊý¾Ý»ò·ÖÎöÓÐÑÏÖØÈ±ÏÝ£¬ÕâÖÖÎÄÕ²»·ÁÏÈ·ÅÒ»·Å£¬µÈÕÒµ½¸ü¹ã·ºµÄÖ¤¾ÝÖ§³Ö»òÓÐÁ˸üÃ÷ÎúµÄ½áÂÛºó£¬ÔÙ½«¾­¹ýÐ޸ĵġ°Ð¡±ÎÄÕ¼ĸøÍ¬Ò»SCIÆÚ¿¯£¬±à¼­Í¨³£»á¿¼ÂÇÖØÐÂÊÜÀí¡£ ,VI2dNst\  
£¨5£©Èç¹û±»¾ÜÂÛÎIJ»ÊÇÓÉÓÚÎĸåÖеĴíÎ󣬶øÊÇÖØÒªÐÔ»ò´´ÐÂÐÔ²»¹»£¬×÷Õß×Ðϸ¿¼ÂÇÉó¸åÈ˵ÄÒâ¼û²¢ÈÏÕæÐÞ¸ÄÎĸåºó£¬¿ÉÒԼĸøÓ°ÏìÒò×Ó½ÏµÍµÄÆäËûSCI¿¯Îï¡£ =nG g k}Z  
4.ÈçºÎÐÞ»ØSCIÂÛÎÄ -a !?%  
¸å¼þÍËÐÞ£¨revised manuscript£©¡£¼¸ºõËùÓеľ­Éó²éѧÊõˮƽ´ïµ½³ö°æÒªÇóµÄSCIÂÛÎÄ£¬ÔÚ·¢±íǰ¶¼ÐèÒªÍ˸ø×÷ÕßÐÞ¸ÄÆä±í´ï·½Ê½¼°±à¼­¸ñʽ£¬ÈçѹËõÎÄÕÂÆª·ù¡¢ÖØÐÂÉè¼Æ±í¸ñ¡¢¸ÄÉÆ²åͼÖÊÁ¿¡¢ÏÞÖÆ²»¹æÔòËõд´ÊʹÓõȡ£È»¶øÍ˸ø×÷Õߵĸå¼þ²¢²»´ú±íÎÄÕÂÒѾ­±»½ÓÊÜ¡£Óеĸå¼þ¸Ä¶¯Ò»´Î¼´¿É±»¿¯Îï²ÉÄÉ£¬µ«Ò²ÓеÄÒª·´¸´Ð޸Ķà´Î²ÅÄܱ»Í¨¹ý¡£ÎÄÕÂ×îÖÕ½ÓÊÜÓë·ñÈ¡¾öÓë×÷Õß¶ÔÎÄÕ¹ؼüÐÔÖØÒªÄÚÈݺͱíÊö·½Ê½µÄÐÞ¸ÄÄÜ·ñ´ïµ½Éó¸åÈ˼°±à¼­µÄÒªÇó¡£È»ºóÓ¦¿¼ÂÇÄÜ·ñ»òÔ¸Òâ½ÓÊÜÉó¸åÈË»ò±à¼­µÄÒâ¼û¡£ 0l;TZf=H  
´ÓÖ÷±à»ò±à¼­µÄ»ØÐźÍÉó¸åÈËÐÞ»áÒâ¼û¿É¿´³öÎÄÕ¼ÓõĿÉÄÜÐÔ¡£Ö÷±àµÄ»ØÐÅ»áÌØ±ðÌáµ½ÄãÎÄÕµĿÆÑ§´´ÐÂÐÔ£»Éó¸åÈ˶ÔÎÄÕÂ×ܵįÀ¼ÛÖлáÌáµ½¶ÔÎÄÕÂÊÇ·ñ¸ÐÐËȤµÈ£»Ðݻ᲻Ҫ²Ö´Ù£¬·´¸´ÔĶÁ¡¢Àí½âÉó¸åÈ˵ÄÎÊÌâ¡£ :pq+SifP  
Èç¹û×÷ÕßÔÚ½Óµ½Ö÷±à»ò±à¼­²¿×ªÀ´µÄÉó¸åÈËÒâ¼ûºó£¬¶ÔÆäÆÀ¼ÛÓкܴóÒìÒé»ò²»Ô¸Òâ¸Ä¶¯×Ô¼ºµÄÂÛÎÄ£¬±ã¿ÉÒÔÖ÷¶¯ÒªÇóÍ˸塣ÊÖÐøºÜ¼òµ¥£¬Ö»ÐèÒªÏò±à¼­²¿·¢¸öE-mail¼´¿É£¬»ò×Ô¼ºÉÏÍø³·¸å¡£Èç¹û×÷ÕßÔ­Òâ¸ù¾ÝÉó¸åÈ˵ÄÒâ¼û¸Ä¶¯ÂÛÎÄ£¬ÔòÐèÈ«Ãæ³¹µ×£¬²¢ÇÒ¶ÔÉó¸åÈËÌá³öµÄÒÉÎÊÒªÒ»Ò»×÷´ð¡£ 3s;^p,9 Y  
5.¸å¼þÍËÐÞʱעÒâÊÂÏî :<hM@>eFn  
£¨1£©¶ÔÉó¸åÒâ¼ûҪʮ·Ö×ðÖØ£¬¶ÔÓÚÿһÌõÅúÆÀºÍ½¨Ò飬¶¼ÒªÈÏÕæ·ÖÎö¡£ËùÓÐÎÊÌâ±ØÐëÖðÌõ»Ø´ð£¨Response to reviewer¡¯s comments1,2,3£©¡£ kntYj}F(  
£¨2£©¶ÔÐ޻ظåÖÐÒÑÐ޸ĵĵط½Òª¾ßÌå±êÃ÷£¨pages, line£©¡£ E6XD n`:  
£¨3£©¾¡Á¿Âú×ãÒâ¼ûÖÐÐèÒª²¹³äµÄʵÑé¡£ iSbPOC7  
£¨4£©Éó¸åÈËÓÉÓÚ֪ʶÏÞÖÆºÍijÖֳɼû£¬ÉõÖÁѧÊõ¹Ûµã²»Í¬£¬ÅжϴíÎó²¢½¨ÒéÍ˸峣·¢Éú¡£Òª¼«ÆäÉ÷ÖØºÍÈÏÕæµØ»Ø´ð£¬ÓÐÀíÓоݵØÓëÉó¸åÈË̽ÌÖ¡£µ«ÒªÎ¯ÍñµØÀñòµØ±í´ïÄãµÄ¹Ûµã¡£ 4( $p8J  
ÀýÈ磬 ^p)#;$6b  
[²»ÍƼö]¡°The reviewer¡¯s comments was wrong, ¡­¡± KT[ZOtu  
[²»ÍƼö]¡°The referee¡¯s idea is bad, but mine is good.¡± :CLWmMC_  
[ÍÆ¼ö]¡°The reviewer¡¯s comments is very interesting. However, we found that ¡­¡± ml@;ngmp.  
[ÍÆ¼ö]¡°It would be very interesting to see ¡­ .However, ¡­¡± pu~b\&^G  
[ÍÆ¼ö]¡°The referee has an interesting notion, but the proposed idea is also good, particularly in light of this or that fact.¡± F/x2}'  
£¨5£©²»ÄÜ×öµÄÒ²²»Òª»Ø±Ü£¬ËµÃ÷ºÏÀíÀíÓÉ¡£ /k8I6  
£¨6£©Éó¸åÈËÊÇÂÛÎĵĵÚÒ»¶ÁÕߣ¬Èç¹ûËû¶¼Ã»ÓжÁ¶®Äã˵µÄijһ·½Ã棬×÷ÕߵĿ¼ÂÇ×Ô¼ºµÄÎÄÕÂÓÐʲôÎÊÌâÈÃÈ˼Ҳ»¶®£¬·ñÔò·¢±íºóÈçºÎÃæ¶Ô¸ü¶àµÄ¶ÁÕߣ¿ÄãÐè¸ÄµÃ¸üÇå³þ¡£ [Do^EJ  
£¨7£©Èç¹ûÄãµÄÂÛÎÄÓÖ±»¾Ü¾øÊÇÒòΪÓÐÒ»¸öÉó¸åÈ˶ÔÄãµÄÂÛÎÄÓÐºÜºÃµÄÆÀ¼Û£¬µ«ÁíÍâÒ»¸öÉó¸åÈ˶ÔÄãµÄÂÛÎÄÆÀ¼ÛºÜ²î¡£´Ëʱ£¬Èç¹ûÓÐÀíÓÉÈÏΪÉó¸åÈ˲»ºÏÀí¶Ô´ýÄãµÄÂÛÎÄ£¬Äã¿ÉÒÔдПø±à¼­²¿ÒªÇó¸ü»»Éó¸åÈË¡£Èç¹ûÕâλÉó¸åÈËÒ²ÆÀ¼ÛºÜ²î£¬ÄÇô£¬Ó¦¸Ã²¹³äÐ޸ĺó¸ÄͶÆäËûSCIÆÚ¿¯¡£ 4%2APvLW  
£¨8£©¸ø±à¼­»ØÐÅ£¬¸Ðл¸øÂÛÎÄÌá³öµÄÐÞ¸ÄÒâ¼û£¬²¢Ö¸³ö°´Ð޸Ľ¨ÒéÒÑ×öµÄÐ޸ģ¬Î´×÷Ð޸ĵĵط½ÒªËµÃ÷ÀíÓÉ¡£ ~7 `,}) d  
6.³£¼ûÎÊÌâ R2v9gz;W  
¨SǧÍò²»ÒªÒ»¸å¶àͶ¡£Ò²²»Òª°ÑÒѾ­·¢±íµÄÖÐÎİæµÄÂÛÎĸijÉΪӢÎÄÔÙͶSCIÆÚ¿¯¡£·´Ö®£¬Ò²²»ÐС£µ«ÊÇһƪ»áÒéÂÛÎľ­¹ýÐ޸ĺó¿ÉÒÔÔÚͶSCIÆÚ¿¯¡£ _V 4O#;%?  
¨SÂÛÎı»Ò»¼ÒSCIÆÚ¿¯¾Ü¾øºó²»¾­Ð޸ģ¬ÓּĸøÁíÒ»¼ÒSCIÆÚ¿¯¡£ fcxg6W'  
7.ÂÛÎı»½ÓÊÜ l]4=W<N  
ÐÞ»ØÂÛÎĸåºó£¨´óÔ¼1¸öÔº󣩣¬×÷Õß»áÊÕµ½±à¼­²¿µÄÐÅ£¬Ò»°ãΪ½ÓÊÜͬÒâ·¢±í¡£ &#L C'  
SCIÂÛÎı»½ÓÊÜÑù¸åÐÅʾÀý md*U  
Dear Dr. XXX ~n- Px)  
We are pleased to inform you that the PNAS Editorial Board has given final approval of your article for publication. The Editor who conducted the initial review of your manuscript [MS#2007-XXX],will also bo informed of the decision. }[Z'Sg]s  
If you have not done so already, please complete and sign the Copyright Assignment from <http: //www.pnas.org/ misc/ copyright. pdf>. If practical, all authors are not available, the corresponding author may sign on their behalf. The form should be faxed to the PNAS office(202-555555).Proofs for your article will not be sent to you until the copyright form is received in our office. hH 5}%/vF  
You will receive reprint order details and an invoice for publication fees with your proofs. Payment of the page charge of $70 per printed page will be assessed from all authors who have funds available for that purpose. Payment by authors of the following additional costs is expected: $325 for each color figure or table and $150 for each replacement or deletion of a color figure or table. Proofs should be returned within 48 hours. VxBBZsZO~  
Sincerely yours, g!R7CRt%  
Editor-in-Chief #m,H1YH M  
ͬʱ£¬×÷ÕßÒ²»áÊܵ½°æÈ¨Ç©×Ö±í¸ñ£¨copyright assignment form£©¡£×÷ÕßÐèÒªÔÚ°æÈ¨Ç©×Ö±í¸ñÉÏÇ©×Öºó£¬ÂÛÎIJÅÄÜ·¢±í¡£Ò»°ãÇé¿öÏ£¬Öйú×÷ÕßÐèÒªÔÚÀ¸Ä¿ºÍµ×²¿Ç©×Ö¾ÍÐС£ "aOs#4N  

kaobook 2011-08-17 22:44
µÚ22Õ ÈçºÎÐÞ¸ÄSCIÂÛÎĵÄÑù¸å IrMH AM5K  
SCIÂÛÎı»½ÓÊܺó£¬×÷Õß²»¾Ã»áÊܵ½ÂÛÎÄÑù¸å£¨proof£©¡£Ò»°ãÅŰæÎªPDFÎĵµ£¬»¹ÓÐTIFFÎĵµ¡£ Az&>.*  
1.ÂÛÎĵÄÑù¸å *?FVLE  
ÂÛÎĵÄÑù¸åÐÅʾÀý ^%r6+ey  
Dear Author /eV)5`V  
We are pleased to inform you that your paper is nearing publication. The page proofs are available at : http://www.spsspitech.com/springer/XXX x3q^}sj%  
The proof shows the paper as it will appear later in print except that: hY`<J]-'`  
-The pages are not numbered but the lines are, to ease reference to any passage to be corrected. L/i'6(="  
-This proof has been optimized for online presentation. Please note that color figures will appear in color in the online version, but not necessarily in the printed edition. See the comment on the proof as to whether they will be printed in black and white. )ros-d p`  
You can help us facilitate rapid publication by returning the corrected proof of this paper within 2 working days. Please first read about the proof produre to learn how to proceed and also to obtain information about online publication. p*Z<DEh#  
Thank you very much. We hope you are pleased with the publication. K(+=V)'Dz  
Sincerely, ]64Pk9z=  
Springer }b456J  
2.ÓÃproof correction marks½øÐÐÑù¸åÐÞ¸Ä f)Qln[/  
Ñù¸å»á¾­³£·¢ÏÖÓм¸´¦´íÎó£¬ÐèÒªÐ޸ġ£Äã¿ÉÒÔÁгöÑù¸åÖÐÒªÐ޸ĵĵط½£¬Ö±½ÓE-mail¸ø±à¼­²¿£¬ËûÃÇ»á°ïÄãÐ޸ĵġ£µ«Ðí¶àÔÓÖ¾ÒªÇó½«ÕýÈ·µÄÎÄ×Ö±êÔÚÑù¸åµÄÁ½±ß£¬¼´Ö±½Ó±ê×¢ÔÚPDFÎļþÉÏ¡£ÕâÊÇÄãÒªÓùú¼ÊͨÓõġ°proof correction marks¡±½øÐбê×¢¡£Ð޸ĺóµÄÑù¸åÖ±½Ó´«Õæ»òÕ߼ĸø±à¼­²¿£¬Ò²¿ÉÒÔɨÃèºó£¬E-mail¸ø±à¼­²¿¡£Ò»°ãÇé¿öÏ£¬SCIÂÛÎĵÄÑù¸åÒªÇóÔÚ24¡ª72СʱÄڼĻء£ ?/.])'&b  
3.Ö±½ÓÓÃAdobe ReaderÈí¼þÔÚPDFÎļþ½øÐÐÐÞ¸Ä JLd%rM\m  
ÏÖÔÚÓÐЩSCIÆÚ¿¯ÒªÇóÖ±½ÓÓÃAdobe ReaderÈí¼þÔÚPDFÎļþ½øÐÐÐÞ¸ÄPDFÎļþÊǶÀÁ¢ÐÔµÄÎļþ¡£°üº¬ËùÓÐÊʵ±µÄ¸ñʽ»¯ºÍËùÓÐ×ÖÌ壬¿ÉÒÔÏÔʾÔÚ¼ÆËã»úÆÁÄ»ºÍ´òÓ¡Ö½ÉÏ¡£Òª²é¿´ºÍÐÞ¸ÄÄãµÄÑù¸å£¬ÐèÒªAdobe Reader°æ±¾7£¨»ò¸ü¸ß£©¡£¸ÃÈí¼þ¿ÉÓÃÓÚPC¡¢MacºÍUNIX¼°Æä£¬ÊÇÈ«ÃæÃâ·ÑµÄ£¬²¢¿ÉÒÔ´Óhttp://www.adobe.com/products/acrobat/readstep2.htm ÏÂÔØ¡£ Ae2N"%Ej  
4.ÈçºÎÓÃAdobe ReaderÈí¼þ½øÐÐÐÞ¸Ä y3efie {J  
£¨1£©´ò¿ªPDFÎļþ£¨open the PDF file£©¡£Òª°ÑPDFÎļþµÄÑù¸å×÷×¢ÊÍ»òÕßÐ޸ģ¬ÏÈ´ò¿ªAdobeÖ÷Òª¹¤¾ßÀ¸¡¾Toolbar¡¿¡£Ò»°ãÀ´Ëµ£¬µ±ÓÃAdobe Reader´ò¿ªPDFÎļþ£¬Ó¦¸Ã×Ô¶¯µØÏÔʾ¡¾Commenting toolbar¡¿¡£Èç¹ûûÓУ¬µã»÷¡¾Tool¡¿£¬Ñ¡¡¾Commenting¡¿£¬È»ºóµã»÷¡¾Commenting toolbar¡¿¡£Èç¹ûÕâЩѡÔñ¶¼²»ÐУ¬ÄÇôÄãµÄAdobe°æ±¾±È°æ±¾7µÍ¡£È»ºó´ò¿ªÄãÒªÐ޸ĵÄPDFÎļþ¡£ I bD u+~)  
£¨2£©²åÈëÎÄ×Ö£¨insert text£©¡£µã»÷¡¾Commenting toolbar¡¿Öеġ¾Text Edits¡¿°´Å¥¡£½«Êó±êλÖÃÒÆµ½ÐèÒªÐ޸ĵĵط½£¬È»ºó¿ªÊ¼¼üÈëÒªÐ޸ĵÄÎÄ×Ö¡£Í¨¹ýµã»÷ÓÒÉϽǡ¾X¡¿¹Ø±Õ¡¾box¡¿¡£Ò²¿ÉÒÔͨ¹ýµã»÷Êó±êÓÒ¼üÑ¡Ôñ¡¾Delete¡¿À´É¾È¥ÊäÈëµÄÎÄ×Ö¡£ >#h,q|B  
£¨3£©Ìæ»»ÎÄ×Ö£¨replace text£©¡£µã»÷¡¾Commenting toolbar¡¿Öеġ¾Text Edits¡¿°´Å¥¡£È»ºóhighlightÒªÌæ»»µÄÎÄ×Ö£¬½«Êó±êÒÆµ½ÒªÌæ»»µÄÎÄ×ÖÉϲ¢µã»÷£¬È»ºóÊäÈëÌæ»»ÎÄ×Ö¡£Èç¹ûÒªÌæ»»Ä³Ð©¸ñʽ»¯µÄÎÄ×Ö£¨ÈçµÈʽ£©£¬Ç븽Îļþ¡£ _g Mr]%Q  
£¨4£©Ïû³ýÎÄ×Ö£¨remove text£©¡£µã»÷¡¾Commenting toolbar¡¿Öеġ¾Text Edits¡¿°´Å¥¡£³¶×§£¨drag over£©Òª±»É¾³ýµÄÎÄ×Ö²¢µã»÷¡£È»ºó°´É¾³ý¼ü¡£ wqG#jC!5  
£¨5£©HighlightÎÄ×Ö/ÆÀ¼Û£¨highlight text/make a comment£©¡£µã»÷¡¾Commenting toolbar¡¿Öеġ¾Highlight¡¿¼ü¡£È»ºóHighlightÏàÓ¦µÄÎÄ×Ö¡£Òª×öÆÀÂÛ£¬Ë«»÷¡¾Highlight¡¿µÄÎÄ×Ö£¬È»ºó¼üÈëÄãµÄcomments¡£ #w''WOk@ZG  
£¨6£©¸½¼þ£¨attach a file£©¡£µã»÷¡¾Commenting toolbar¡¿Öеġ¾Attach a File¡¿¼ü¡£µã»÷Òª±»Ì滻ͼ£¬ÖƱí»òÕßÎÄ×Ö¡£´°¿Ú½«×Ô¶¯µØ´ò¿ª£¬ÔÊÐí¸½ÓÐÎļþ¡£ @x1cV_s[  
£¨7£©ÆÀÂÛ£¨leave a note /comment£©¡£µã»÷¡¾Commenting toolbar¡¿Öеġ¾Note Tool¡¿¼ü¡£½«Êó±êÒÆµ½ÏàÓ¦µÄÎÄ×ÖÉϲ¢µã»÷£¬È»ºó¿ªÊ¼¼üÈëÎÄ×Ö¡£µ«²»ÒªÊ¹ÓÃÕâ¸öÌØµã×öÔ­Îı༭¡£ y{M7kYWtHV  
£¨8£©¸´ÔÄ£¨review£©¡£Òª¸´ÔÄÒÑÓеı䶯£¬µã»÷¡¾Commenting toolbar¡¿Öеġ¾Show¡¿¼ü¡£Ñ¡Ôñ¡¾Show Comments List¡¿¡£ k{r<S|PK0  
5.ʵÀý·ÖÎö *$O5.`]  
¹ú¼ÊÉϳ£ÓõÄproof correction mark =R:O`qdC4e  
Ö÷Òª°üÀ¨Instruction£¬Textual markºÍMargin markÈý²¿·Ö¡£ w7` pbcY,  
Ïà¹ØÍ¼ÎÄ·ûºÅÂÔÈ¥¡£¿ÉÒԲο¼ÍøÖ·Á´½Ó£º http://www.jaggercreative.co.uk/proofingmarks.pdf

kaobook 2011-08-17 22:46
µÚ23Õ SCIÂÛÎÄÖÐÓ¢Óïд×÷µÄÓïÑÔ¼¼ÇÉ Hya.OW{  
ÖÐÎ÷·½ÎÄ»¯µÄ²îÒìµ¼ÖÂÁËÓïÑÔÈÏʶÉϵIJ»Ò»Ö¡£ÖйúѧÕßÔÚSCIÆÚ¿¯ÂÛÎıêÌâÖо­³£»áÓõ½¡°Elementary introduction of ¡­¡±£¨Ç³Ì¸£©¡¢¡°Primary study of ¡­¡±£¨³õ̽£©µÈ×ÔÇ«´Ê£¬¸øÈËÔì³ÉÒ»ÖÖÑо¿²»ÉîµÄ´í¾õ¡£ÕâÖÖÖÐÎ÷ÎÄ»¯²îÒ컹µ¼ÖÂÁËÐí¶àÈËÓÃÓ¢Óïд×÷ʱ£¬Ò²»áÊܵ½ººÓï±í´ïʽµÄÓ°Ï죻¾­³£²ÉÓÃÓ뺺Óï±í´ï·½Ê½ÀàËÆµÄÓ¢Óï¾äÐÍ£¬¶ø²»ÉÆÓÚʹÓõصÀµÄÓ¢Óï¾äÐÍ¡£ Ep(xlHTv  
ÖµµÃÌá³öµÄÊǺܶàÖйúÇàÄê¿ÆÑÐÈËÔ±ºÍÑо¿ÉúÏÈд³öÂÛÎĵÄÖÐÎĸ壬ÔÙÒë³ÉÓ¢Óï¡£µ«ÊǽðÀ¤ÁÖ½ÌÊÚÈÏΪÂÛÎÄÔÚ׫дʱҪ×ÔʼÖÁÖÕ¶¼ÓÃÓ¢Óïд£¬£¬²»ÒªÏÈдÖÐÎÄÔÚÒë³ÉÓ¢ÎÄ¡£Òª²»È»Ð´³öÀ´µÄÎÄÕ¿ÉÄܾÍÊÇÖйúʽӢÓChinglish£©¡£ u3 Z]!l  
½ð½ÌÊÚÈÏΪÖйúʽӢÓïÓ¦·ÖΪÁ½ÖÖÀ´¿´´ý¡£Ò»ÖÖÊÇChineseEnglish£¬Ò»ÖÖÊÇChinaEnglish¡£ÆäÖÐChineseEnglish¾ÍÊÇChinglish£¬ÊÇÓÃÖÐʽµÄÓï·¨ºÍӢʽµÄ´Ê»ã×éºÏ³ÉµÄ£¬ÊôÓÚÓïÑԵIJ»¹æ·¶Ê¹Óᣳ£¼ûChinglishÀàÐÍÓУº dG+$!*6Z  
¡òººÓïÓ²Òë A3.I|/  
ʾÀýÈçÏ£º LL);Ym9d  
¨SGood good study, day day up.£¨ºÃºÃѧϰ£¬ÌìÌìÏòÉÏ¡£) 8g:VfzaHu  
¨SWho two who and who?(ÔÛÁ©Ë­¸úË­£¿) V5-!w0{  
¨SGive you some color see see.(¸øÄãµãÑÕÉ«¿´¿´¡£) )n"0:"Ou  
¨SWatch sister(±í½ã) KaMg [ G  
¡ò ººÓïÖ±Òë _'mC*7+  
ʾÀýÒ» N"<.v6Z  
¨S¡°¶«Ê©Ð§ò­¡±°´ÕÕ×ÖÃæÒâ˼ֱÒë¹ýÀ´¾Í³ÉΪDongshi imitates Xishi.µ«ÊÇÍâ¹úÈ˾ÍÃ÷°×ÊÇÔõô»ØÊÂÁË¡£ÒªÈÃÍâ¹úÈËÃ÷°×±ØÐë·­Òë³É¡°The ugly imitates the beautiful in such a distorted way that the ugliness of the ugly becomes worse¡±¸üÇ¡µ±¡£ x0)=jp '  
¨S¡°ÇéÈËÑÛÀï³öÎ÷Ê©¡±²»ÊÇ¡°Xishi is in the eye of the beholder¡±,¶øÊÇ¡°Beauty is in the eye the beholder¡±¡£ SFh<>J^ 0a  
·ÇÓ¢Óïϰ¹ßÐÔ±í´ïʾÀý Wm"q8-<<  
ChinaEnglishÖ¸µÄÔòÊÇÓÉÖйúÌØÓеĶ«Î÷£¬ÊÇÔÊÐí´æÔڵġ£ÀýÈ磬20ÊÀ¼Í30Äê´úÖð×Ö·­ÒëµÄ¡°Long time no see¡±£¨ºÜ¾Ã²»¼û£©ÒѾ­½øÈëÓ¢ÓïµÄ±ê×¼´Ê×é¡£ÔÚ±ä³ÉÓ¢ÓïдʵÄÖÐʽӢÓïÖкܶàÊÇÖйú¶ÀÓеĴʻã»ò¸ÅÄî¡£ÈçÈå¼Ò˼Ï루Confucianism£©¡¢ËÄÊ飨FourBooks£©¡¢Îå¾­£¨FiveClassics£©¡¢ÖªÊ¶¾­¼Ã£¨knowledgeeconomy£©¡¢ºÍƽáÈÆð£¨peacefulrising£©µÈ¡£ÒòΪº£Íâ¶ÔÖйú¹Ø×¢µÄ³ÖÐøÉýΣ¬ÕâЩ¾ßÓÐÖйúÌØÉ«µÄ´Ê»ã²»¶Ï³öÏÖÔÚº£Íâ¸÷ÖÖýÌåÉÏ£¬³ÉΪ¹Ì¶¨±í´ï¡£ÆäËû¾ßÓÐÖйúÌØÉ«µÄ´Ê»ã¼ûÈçÏÂʾÀý£º "5dke^yk0  
°´×ÊÅű² to assign priority according to seniority 2%fzRXhu%  
°ÚÍÑÆ¶À§ shake off poverty; lift oneself from poverty 8ZbXGQ  
°ëÀ­×Ó¹¤³Ì uncompleted project .|u`s,\  
°àÃÅŪ¸« teach one¡¯s grandma to suck eggs D=vw0Q_3Y3  
±ÆÉÏÁºÉ½ be driven to drastic alternatives ?fP3R':s  
±ßԶƶÀ§µØÇø outlying poverty-stricken areas 8a@k6OZ  
²»ÕýÖ®·ç bad (harmful) practice; unhealthy tendency I6;6x  
²ð¶«Ç½²¹Î÷ǽ rob Peter to pay Paul )N~ p4kp  
¶ÀÉú×ÓÅ® the only child in one¡¯s family 55ec23m  
·´¸¯³«Á® combat corruption and build a clean government Xu~N97\G  
»§¿Ú²¾ residence booklet %E#Ubm !  
451.VI}MR  
×ܶøÑÔÖ®£¬ÔÚSCIÂÛÎÄд×÷ʱ£¬Òª×¢ÒâÓ¢Óï±í´ïµÄÖÐÎ÷·½ÎÄ»¯²îÒì¡£´ËÍ⣬»¹Òª×¢ÒâÒÔϼ¸¸ö·½Ãæ¡£ MYb^G\K  
1.SCIÂÛÎÄд×÷ʱ̬ 4yqYs>  
2.SCIÂÛÎÄÖÐ×îÈÝÒ׳öÏÖµÄÓÃ´Ê h4K Mhr  
3.Ó¢Îıêµã·ûºÅ zRLJ|ejMP  
4.SCIÂÛÎÄÖоä×ӺͶÎÂäÉÏÏÂÁ¬¹áÓëÂß¼­ RFS} !_t+|  
b"#S92R+  

kaobook 2011-08-17 22:48
µÚ23ÕÂSCIÂÛÎÄÖÐÓ¢Óïд×÷µÄÓïÑÔ¼¼ÇÉ h!ogH >S~  
ÖÐÎ÷·½ÎÄ»¯µÄ²îÒìµ¼ÖÂÁËÓïÑÔÈÏʶÉϵIJ»Ò»Ö¡£ÖйúѧÕßÔÚSCIÆÚ¿¯ÂÛÎıêÌâÖо­³£»áÓõ½¡°Elementary introduction of ¡­¡±£¨Ç³Ì¸£©¡¢¡°Primary study of ¡­¡±£¨³õ̽£©µÈ×ÔÇ«´Ê£¬¸øÈËÔì³ÉÒ»ÖÖÑо¿²»ÉîµÄ´í¾õ¡£ÕâÖÖÖÐÎ÷ÎÄ»¯²îÒ컹µ¼ÖÂÁËÐí¶àÈËÓÃÓ¢Óïд×÷ʱ£¬Ò²»áÊܵ½ººÓï±í´ïʽµÄÓ°Ï죻¾­³£²ÉÓÃÓ뺺Óï±í´ï·½Ê½ÀàËÆµÄÓ¢Óï¾äÐÍ£¬¶ø²»ÉÆÓÚʹÓõصÀµÄÓ¢Óï¾äÐÍ¡£ *`rfD*  
ÖµµÃÌá³öµÄÊǺܶàÖйúÇàÄê¿ÆÑÐÈËÔ±ºÍÑо¿ÉúÏÈд³öÂÛÎĵÄÖÐÎĸ壬ÔÙÒë³ÉÓ¢Óï¡£µ«ÊǽðÀ¤ÁÖ½ÌÊÚÈÏΪÂÛÎÄÔÚ׫дʱҪ×ÔʼÖÁÖÕ¶¼ÓÃÓ¢Óïд£¬£¬²»ÒªÏÈдÖÐÎÄÔÚÒë³ÉÓ¢ÎÄ¡£Òª²»È»Ð´³öÀ´µÄÎÄÕ¿ÉÄܾÍÊÇÖйúʽӢÓChinglish£©¡£ <=V{tl  
½ð½ÌÊÚÈÏΪÖйúʽӢÓïÓ¦·ÖΪÁ½ÖÖÀ´¿´´ý¡£Ò»ÖÖÊÇChineseEnglish£¬Ò»ÖÖÊÇChinaEnglish¡£ÆäÖÐChineseEnglish¾ÍÊÇChinglish£¬ÊÇÓÃÖÐʽµÄÓï·¨ºÍӢʽµÄ´Ê»ã×éºÏ³ÉµÄ£¬ÊôÓÚÓïÑԵIJ»¹æ·¶Ê¹Óᣳ£¼ûChinglishÀàÐÍÓУº F}7sb#G  
¡òººÓïÓ²Òë ? 3OfiGX?  
ʾÀýÈçÏ£º `IEA  
¨SGood good study, day day up.£¨ºÃºÃѧϰ£¬ÌìÌìÏòÉÏ¡£) _-lE$ O  
¨SWho two who and who?(ÔÛÁ©Ë­¸úË­£¿) )|vy}Jf7  
¨SGive you some color see see.(¸øÄãµãÑÕÉ«¿´¿´¡£) 14" 57Jt8  
¨SWatch sister(±í½ã) - om9 Z0e  
XPU>} 4{  
ººÓïÖ±Òë /OWwC%tM/  
ʾÀýÒ» ; Y[D#Ja-  
¨S¡°¶«Ê©Ð§ò­¡±°´ÕÕ×ÖÃæÒâ˼ֱÒë¹ýÀ´¾Í³ÉΪDongshi imitates Xishi.µ«ÊÇÍâ¹úÈ˾ÍÃ÷°×ÊÇÔõô»ØÊÂÁË¡£ÒªÈÃÍâ¹úÈËÃ÷°×±ØÐë·­Òë³É¡°The ugly imitates the beautiful in such a distorted way that the ugliness of the ugly becomes worse¡±¸üÇ¡µ±¡£ lOp. c U  
¨S¡°ÇéÈËÑÛÀï³öÎ÷Ê©¡±²»ÊÇ¡°Xishi is in the eye of the beholder¡±,¶øÊÇ¡°Beauty is in the eye the beholder¡±¡£ :-5[0Mx=  
·ÇÓ¢Óïϰ¹ßÐÔ±í´ïʾÀý Eamt_/LKf  
ChinaEnglishÖ¸µÄÔòÊÇÓÉÖйúÌØÓеĶ«Î÷£¬ÊÇÔÊÐí´æÔڵġ£ÀýÈ磬20ÊÀ¼Í30Äê´úÖð×Ö·­ÒëµÄ¡°Long time no see¡±£¨ºÜ¾Ã²»¼û£©ÒѾ­½øÈëÓ¢ÓïµÄ±ê×¼´Ê×é¡£ÔÚ±ä³ÉÓ¢ÓïдʵÄÖÐʽӢÓïÖкܶàÊÇÖйú¶ÀÓеĴʻã»ò¸ÅÄî¡£ÈçÈå¼Ò˼Ï루Confucianism£©¡¢ËÄÊ飨FourBooks£©¡¢Îå¾­£¨FiveClassics£©¡¢ÖªÊ¶¾­¼Ã£¨knowledgeeconomy£©¡¢ºÍƽáÈÆð£¨peacefulrising£©µÈ¡£ÒòΪº£Íâ¶ÔÖйú¹Ø×¢µÄ³ÖÐøÉýΣ¬ÕâЩ¾ßÓÐÖйúÌØÉ«µÄ´Ê»ã²»¶Ï³öÏÖÔÚº£Íâ¸÷ÖÖýÌåÉÏ£¬³ÉΪ¹Ì¶¨±í´ï¡£ÆäËû¾ßÓÐÖйúÌØÉ«µÄ´Ê»ã¼ûÈçÏÂʾÀý£º B ,cFvS  
°´×ÊÅű² to assign priority according to seniority v UVFW'-  
°ÚÍÑÆ¶À§ shake off poverty; lift oneself from poverty '.1P\>x!]  
°ëÀ­×Ó¹¤³Ì uncompleted project 6e rYjq  
°àÃÅŪ¸« teach one¡¯s grandma to suck eggs Uffwzd!  
±ÆÉÏÁºÉ½ be driven to drastic alternatives NJQ)Ttt  
±ßԶƶÀ§µØÇø outlying poverty-stricken areas T{k_3[{0o  
²»ÕýÖ®·ç bad (harmful) practice; unhealthy tendency VaY#_80$s  
²ð¶«Ç½²¹Î÷ǽ rob Peter to pay Paul (0 H =f6N  
¶ÀÉú×ÓÅ® the only child in one¡¯s family 7H 5VzV  
·´¸¯³«Á® combat corruption and build a clean government ?W{+[OXs  
»§¿Ú²¾ residence booklet X2@Ef2EkM  
Ba@~:  
×ܶøÑÔÖ®£¬ÔÚSCIÂÛÎÄд×÷ʱ£¬Òª×¢ÒâÓ¢Óï±í´ïµÄÖÐÎ÷·½ÎÄ»¯²îÒì¡£´ËÍ⣬»¹Òª×¢ÒâÒÔϼ¸¸ö·½Ãæ¡£  ce9P-}d  
1.SCIÂÛÎÄд×÷ʱ̬ 88~Nrl=co  
£¨1£©ÃèÊö×÷Õß×Ô¼ºµÄ¹¤×÷ͨ³£Ê¹Óùýȥʽ£¬ÈçÔÚ¡°Material and Methods¡±ºÍ¡°Results¡±²¿·Ö¡£µ«ÊÇÓÃÏÖÔÚʱ̬ÐðÊö×÷Õß½áÂÛ¡£ X7h uc*  
£¨2£©ÃèÊöËûÈ˵Ť×÷ʱͨ³£Ê¹ÓÃÏÖÔÚʱ»òÏÖÔÚÍê³Éʱ£¬ÔÚ¡°Introduction¡±ÖеÄÎÄÏ׻ع˺͡°Discussion¡±ÖеĴ󲿷֣¨×¢£ºÔÚ¡°Discussion¡±ÖУ¬ÓùýȥʱÃèÊöËûÈ˵Ť×÷²»ÄÜËã´í£©¡£ b^Z2Vf:k]  
ÏÂÁÐÇéÀýÍ⣺ hHN[K  
¨SÈç¹ûÄ㻳ÒÉËûÈ˵Ť×÷ÊÇ·ñÕýȷʱ£¬Í¨³£Ê¹Óùýȥʱ¡£ pOXI*0_g.  
¨S×÷Õß×÷ΪÖ÷Óïʱ£¬Í¨³£Ê¹Óùýȥʱ¡£ 7DJEx~"!2-  
ÀýÈçGreenberg showed that streptomycin inhibits S. nocolor. |@iM(MM[?  
¨S±í¸ñ»òͼ±í×÷ΪÖ÷Óïʱ£¬Í¨³£Ê¹ÓÃÏÖÔÚʱ¡£ ~ tA ^K  
ÀýÈçTable 2 shows the percent of districts in Oklahoma that have individuals identified as filling particular primary positions. Kf:!tRE  
¨SÃèÊö¼ÆËã½á¹ûºÍͳ¼Æ½á¹ûʱʹÓÃÏÖÔÚʱ̬ÐðÊö¡£¼´Ê¹¸Ãʼþ·¢ÉúÔÚ¹ýÈ¥£¬Ò²Ó¦¸ÃʹÓÃÏÖÔÚʱ¡£ P!W%KobZ7|  
These values are significantly greater than those of those of the females of the same age, indicating that the males grew more rapidly. Q;$k?G=l  
2.SCIÂÛÎÄÖÐ×îÈÝÒ׳öÏÖµÄÓÃ´Ê Xx{| [2`  
£¨1£©¶¯´Ê£¨verbs£©¡¢¶¯Ãû´Ê£*****erund£©ºÍÏÖÔÚ·Ö´Ê£¨present participle£©¡£ÏÖÔڷִʺͶ¯Ãû´ÊÒ»Ñù£¬¶¼ÊÇÔÚ¶¯´ÊβÉϼÓing¹¹³É£»¶ø¹ýÈ¥·Ö´Ê£¨past participle£©ÔòÊÇÔÚ¶¯´ÊβÉϼÓed¡¢en¡¢d¡¢tËù¹¹³É¡£ËäÈ»ÈÝÒ×Çø·Ö£¬µ«ÓÐʱºòÒ²¿ÉÄÜ»ìÏý¡£ pPBXUu'  
Ò»°ãÀ´Ëµ£¬¿ÉÓö¯´ÊµÄÇé¿öÓ¦¾¡Á¿±ÜÃâʹÓö¯´ÊµÄÃû´ÊÐÎʽ£»ÄÜÓÃÃû´Ê×÷¶¨ÓïµÄ²»ÒªÓö¯Ãû´Ê×÷¶¨ÓÄÜÓÃÐÎÈÝ´Ê×÷¶¨Óï²»ÒªÓÃÃû´Ê×÷¶¨Óï¡£ /AD&z?My+E  
ÓÐЩ¶¯Ãû¼È¿ÉÊǼ°Îﶯ´ÊÒ²¿ÉÒÔÊDz»¼°Îﶯ´Ê£¬Ó¦¸ÃÓÅÏÈʹÓò»¼°Îﶯ´ÊÔì¾ä£¬¶ø²»ÒªÓü°Îﶯ´ÊµÄ±»¶¯Óï̬³É¾ä¡£ /e0B$UymFu  
£¨2£©²»¶¨¹Ú´Ê£¨the indefinite article£©ºÍ¶¨¹Ú´Ê£¨the definite article£©¡£¹Ú´ÊÊÇÐé´Ê£¬±¾Éí²»Äܵ¥¶ÀʹÓã¬Ò²Ã»ÓдÊÒ壬ËüÓÃÔÚÃû´ÎµÄÇ°Ãæ£¬°ïÖúÖ¸Ã÷Ãû´ÊµÄº¬Òå¡£²»¶¨¹Ú´Êa(an)ÓëÊý´ÊoneͬԴ£¬ÊÇ¡°Ò»¸ö¡±µÄÒâ˼¡£aÓÃÓÚ¸¨ÒôÒôËØÇ°£¬¶øanÔòÓÃÓÚÔªÒôÒôËØÇ°¡£¶¨¹Ú´ÊtheÓëָʾ´ú´Êthis¡¢thatͬԴ£¬ÓС°Õ⣨ÄÇ£©¸ö¡±µÄÒâ˼£¬¿ÉÒÔºÍÒ»¸öÃû´ÊÁ¬Óã¬ÓÃÀ´±íʾij¸ö»òij¸öÌØ¶¨µÄÈË»ò¶«Î÷¡£Ó¢ÓïÖе͍¹Ú´ÊÓ÷¨¸´ÔÓ£¬´ÊÒåÖڶ࣬¶øÇÒººÓïÖÐûÓж¨¹Ú´ÊµÄ¸ÅÄÒò´ËÔÚʹÓÃÊÊӦעÒâ¶à·½ÃæÎÊÌâ¡£¶¨¹Ú´ÊÓ÷¨³£¼ûÓÚÏÂÁÐÇé¿ö£º f?UI+ TU  
¨SÖ¸ÊÀÉ϶ÀÒ»ÎÞ¶þµÄÊÂÎï¡£ %=UD~5!G0  
¨SÓÃÔÚµ¥ÊýÃû´ÊÇ°Ãæ£¬ÒÔ´ú±íͬÀàµÄÈË»òÎï¡£µ«µ±Éæ¼°manºÍwomanÕâÁ½¸öÃû´Êʱ£¬Ò»°ã²»±ØÓá°the¡±¡£ KMj\A d  
¨SÓÃÔÚÐòÊý´ÊºÍÐÎÈÝ´Ê×î¸ß¼¶¼°ÐÎÈÝ´Êonly¡¢very¡¢someµÈǰ¡£ wuH*a3(  
¨SÓ븴ÊýÃû´ÊÁ¬Óã¬Ö¸Õû¸öȺÌå¡£ MW 7~=T  
¨S±íʾËùÓУ¬Ï൱ÓÚÎïÖ÷´ú´Ê£¬ÓÃÔÚ±íʾÉíÌ岿λµÄÃû´Êǰ¡£ !0,q[|m  
¨SÓÃÔÚijЩÓÐÆÕ±éÃû´Ê¹¹³ÉµÄ¹ú¼ÒÃû³Æ¡¢»ú¹ØÍÅÌåµÈרÓÐÃû´Êǰ¡£ T]De{nHu  
¨SÓÃÔÚÊýÄ¿×Öǰ¡£ +c))fPuV  
¨SÓÃÔÚÐÎʽµÄ¸´ÊýÃû´Ê֮ǰ£¬±íʾһ¼ÒÈË¡£ /y G34) aB  
¨SÓÃÔÚ¹ßÓÃÓïÖС£ B-MS@ <2  
ÓÐЩÇé¿öÊDZØÐëÊ¡ÂÔ¹Ú´Ê£º .t_t)'L  
¨S±íʾ²»ÌØÖ¸µÄ¡¢½Ï³éÏóµÄ¸ÅÄîʱ¿É²»¼Ó¡£ hI:.Qp`r  
¨SĿ¼¡¢±êÌâÖÐͨ³£Ê¡ÂÔ¹Ú´Ê¡£ 8gP1]xD  
¨Sͼ¡¢±íµÄÌâÄ¿ÖÐÓÐʱ¿ÉÊ¡ÂÔ¹Ú´Ê¡£ /*qRbN  
¨S»¯Ñ§Ò©Æ·¡¢»¯Ñ§ÎïÖÊǰͨ³£²»¼Ó¹Ú´Ê¡£ 7 ~~ug  
¨SͼÖеĺᡢ×Ý×ø±êµÄÃû´Êǰ²»¼Ó¹Ú´Ê¡£ [<#j K}g  
£¨3£©´ú´Ê£¨pronouns£©.´ú´ÊʱÓÃÀ´´úÌæÃû´ÊµÄ´Ê¡£ÔÚSCIÂÛÎÄÖУ¬×î³£ÓõĴú´ÊÊÇ¡°this¡±¡£Òª×¢Òâ´ú´Ê¡°this¡±µÄÓ÷¨¡£Ò»°ãÀ´Ëµ£¬ÌᳫÔÚ¡°this¡±ºóÃæ±ØÐëÁ¬½ÓÃû´Ê£¬ÕâÑù¡°this¡±ËùÖ¸µÄ¶ÔÏó¾Í»á¸ü¼ÓÇå³þ¡£ÀýÈ磺This problem was resolved in update 887742 for Windows XP. xJCx zJ  
£¨4£©¸±´Ê£¨adverbs£©¡£Ò»°ãÀ´Ëµ£¬Ðí¶à¸±´ÊÓ¦¸ÃÔÚ¶¯´ÊС×éÖ®ÄÚ¶ø²»ÊÇÔÚ×î³õ»ò×îºóµÄλÖá£ÔÚ·ÇÕýʽӢÓ¸±´Ê³£Î»ÓÚ¾ä×Ó¿ªÊ¼»ò½áβµÄ¾ä×Ó¡£ 61S;M8tNv  
ÀýÈ磺[·ÇÕýʽ]Then the solution was replaced¡£ Me .I>7c  
[Õýʽ]The solution was then replaced¡£ vh a9,5_  
£¨5£©½é´Ê£¨preposition£©¡£½é´ÊÊÇÓÃÀ´±íʾһ¸öÊÂÎïÓëÁíÒ»¸öÊÂÎïÖ®¼ä¹ØÏµµÄÐé´Ê£¬Ëü²»µ¥¶ÀʹÓ㬶ø³£ºÍºóÃæµÄÃû´Ê»ò´ú´Ê¹¹³É½é´Ê¶ÌÓï¡£½é´ÊÌáʾµØ·½£¨where£©£¬Ê±¼ä£¨since, when£©ºÍÈË£¨who, whose£©Ê±Ó¦×¼È·Ê¹Óá£ÀýÈ磺 sF {,n0<8  
[²»ÍƼö]Since all tumours are visible at bronchoscopy, this is the investigation of choice. 1,fR kQ  
[ÍÆ¼ö]As all tumours are visible at bronchoscopy, this is the investigation of choice. Z=]S AK`  
£¨6£©Ãû´ÊµÄµ¥¡¢¸´ÊýºÍÖ÷¡¢Î½ÓïµÄÈ˳ơ£Òª×¢ÒâÃû´ÊµÄµ¥¡¢¸´ÊýºÍÖ÷¡¢Î½ÓïµÄÈ˳ÆÅäºÏ¡£ÀýÈ磺 axnlI*!  
[Îó]The new group of drugs were associated with many adverse reactions. `MU~N_  
[Õý]The new group of drugs was associated with many adverse reactions. 0nb%+],pX  
£¨7£©Ãû´ÊÐÞÊΣ¨modifiers of noun£©¡£±ÜÃâʹÓó¤ÏµÁÐÐÎÈÝ´Ê»òÃû´ÊÀ´ÐÞÊÎÃû´Ê¡£ ^p3 GT6  
[ÍÆ¼ö]a modified test of cognitive function WWunS|B!  
[²»ÍƼö] a modified cognitive-function test .TGw+E1k  
£¨8£©ÙµÓ¿ÚÓïºÍÍâÀ´Óï¡£²»Ê¹ÓÃÙµÓ¿ÚÓïºÍÍâÀ´Óï×÷ΪÕýʽ±í´ï¡£ÀýÈ磺 aD: #AmbJ  
[·ÇÕýʽ]Retirement is something most of us must face sooner or later. 1{a%V $S[  
[Õýʽ] Retirement is inevitable. <w9~T TS  
£¨9£©ÂÛÎÄÖеÄÓôÊÓ¦¸Ã±È½ÏÕýʽ¡£²»ÒªÊ¹ÓôʵļòÂÔÐÎʽ£¬Èç¡°don¡¯t¡±£¬¡°can¡¯t¡±ºÍ¡°won¡¯t¡±¡£Ó¦¸Ãдȫ³Æ¡°do not¡±£»¡°can not ¡±ºÍ¡°will not¡±¡£¾ä×ÓÒ²Òª±ÜÃâʹÓá°and so forth¡±¡¢¡°and so on¡±µÈ¡£ %>m.Z#R(  
£¨10£©Êý×Ö¡£Èç¹ûÊý×ÖλÓÚ¾äÊ×£¬Ó¦¸ÃÓÃÓ¢ÎĵÄÍêÕû±í´ï£¬²»Óð¢À­²®Êý×Ö¡£ÀýÈ磺 q_b!+Y  
[²»ÍƼö]¡°30 patients were performed operation.¡± lb_N"90p  
[ÍÆ¼ö]¡°Thirty patients were performed operation.¡± Lk(ESV;r  
£¨11£©Ó¢ÓïÓôÊÔ­Ôò£º E.K^v/dNdq  
¨SÓÃÊìϤµÄÎÄ×ÖÓÅÓÚǣǿµÄÎÄ×Ö¡£ Xd(^7~i  
¨SÓþßÌåÎÄ×ÖÒªÓÅÓÚ³éÏóµÄÎÄ×Ö¡£ Y ^+x<  
¨SÓõ¥Ò»µÄÎÄ×ÖÓÅÓÚ¶Ý´ÊÎÄ×Ö¡£ '9}&@;-_  
¨SÓö̵ÄÎÄ×ÖÒªÓÅÓÚ³¤µÄÎÄ×Ö¡£ %,T*[d&i  
¨SÓô¿ÆÓÎÞ»ªµÄÎÄ×ÖÓÅÓÚ¶à×˶à²ÊµÄÎÄѧÐÔÃèÊöÎÄ×Ö¡£ p {w-  
3.Ó¢Îıêµã·ûºÅ =~;~hZj  
¡òÖÐÎÄÌØÓеıêµã·ûºÅ iHPsRq!  
¨S¶ÙºÅ£¨¡¢£©£º¶ÙºÅÔÚººÓïÖÐÆð·Ö¸î¾ä×ÓÖеIJ¢ÁгɷÖ×÷Óã»Ó¢ÓïÖÐûÓжٺţ¬·Ö¸î¾ä×ÓÖеIJ¢ÁгɷֶàÓöººÅ¡£ e0`z~z]6&  
¨SÊéÃûºÅ£¨¡¶¡·£©£ºÓ¢ÓïûÓÐÊéÃûºÅ£¬ÊéÃû¡¢ÆÚ¿¯ÃûÓÃбÌå»òÏ»®Ïߵȱíʾ¡£ aKj| gwo!  
¨S¼ä¸ôºÅ£¨.£©£ºººÓïÓмä¸ôºÅ£¬µ«ÊÇÓ¢ÓïÖÐûÓмä¸ôºÅ£¬ÐèÒª¼ä¸ôʱ¶àÓöººÅ¡£ eAlOMSL\  
¨S×ÅÖØºÅ£ºÓÐʱººÓïÓÃÔÚÎÄ×ÖϵãʵÐÄÔ²±íʾÐèҪǿµ÷µÄ´ÊÓÕâЩʵÐĵã¾ÍÊÇ×ÅÖØºÅ¡£¶øÓ¢ÓïÖÐûÓÐÕâÒ»·ûºÅ£¬ÐèҪǿµ÷ijЩ³É·Öʱ¿É½èÖúÎÄ×ÖбÌå¡¢ºÚÌå×ÖºÍÏ»®ÏߵȶàÖÖ·½·¨¡£ &ksuk9M  
¡òÓ¢ÎÄÌØÓеıêµã·ûºÅ qX@e+&4P0  
¨SбÏߺšªforward slash(/):Ö÷Òª¹¦ÄÜÊÇ·Ö¸ô×÷ÓᣠNH/A`Wm  
¨SƲºÅ¡ªapostrophe£¨£¬£©:¹¹³ÉÃû´ÊËùÓиñ£»±íʾ´Ê¡¢×Öĸ¡¢ÊýÂëµÈµÄ¸´ÊýÐÎʽ£¬»¹±íʾһ¸ö»ò¼¸¸ö×ÖĸºÍÊý×ÖµÄÊ¡ÂÔ£¬È磺I¡¯ve got it¡£ }t^wa\   
¨SÁ¬×ֺšªhyphen£¨--£©£ºÖ÷ÒªÓÃÓÚijЩǰ׺£¨È磺self-¡¢ex-ºÍall-£©¹¹³É¸´ºÏ´Ê¡£ O) q4^AE$  
¡òººÓ¢¹²Óе«ÐÎʽ²»Í¬µÄ±êµã·ûºÅ ^C'S-2nGH  
¨SÖÐÎĵľäºÅ£¨periods£©ÊÇ¡°Ô²È¦¡±£¨¡££©£¬¶øÓ¢ÎÄÖÐÊǸöʵµã£¨.£©¡£ CP7Fe{P  
¨SÓ¢Óï¾äÖеÄÊ¡ÂԺţ¨ellipsis£©ÊÇÈý¸öµã£¨¡­£©£¬Èç¹ûÊ¡ÂÔºÅÔÚ¾äÄ©¼ÓÉϾäºÅ¾ÍÊÇËĸöµã£¨ ¡­ .£©£¬Î»Öö¼ÔÚÐеף»ÖÐÎĵÄÊ¡ÂÔºÅΪÁù¸öµã£¨¡­¡­£©£¬¾ÓÓÚÐÐÖС£ -qP)L;n  
¨SÓ¢ÓïµÄÆÆÕۺţ¨dash£©ÊÇ£¨-£©£¬¶øÖÐÎÄÊÇ£¨¡ª¡ª£© a 8k2*u  
4.SCIÂÛÎÄÖоä×ӺͶÎÂäÉÏÏÂÁ¬¹áÓëÂß¼­ uMQI Aapb  
£¨1£©SCIÂÛÎÄÖоä×ÓÁ¬¹áÓëÂß¼­£º´ÓÓïÑÔÄÚ²¿À´Ëµ£¬Óï¾ä»ò¶ÎÂä¶¼ÊÇһЩÒâÒåÏà¹ØµÄ¾ä×Óͨ¹ýÒ»¶¨µÄ³Ð½ÓÊֶκϺõÂß¼­µÄ×éÖ¯ÆðÀ´µÄÓïÒåÕûÌ塣ͨ¹ýÒ»×éÒâÒåÏà¹ØµÄ¾ä×Ó²»Í¨¹ýÒ»¶¨µÄתÕÛ´Ê»òÁ¬½Ó´ÊºÏºõÂß¼­µÄÁªÏµÆðÀ´£¬Õâ×é¾ä×Ó¾ÍÄÑÒÔ¹¹³ÉƪÕ¡£Á¬½Ó´ÊÊÇÖ¸ÔÚÂÛÎÄÖÐÓÃÀ´ËµÃ÷ÉÏϾä»òǰºó¾äÁ½¸öÒâ˼֮¼ä¹ØÏµµÄ´Ê»ò´Ê×é¡£Á¬½Ó´Êͨ³£ÓÃÓÚ¿ªÆª£¬Òý³öÀ©Õ¹¾ä£»Ò²¿ÉÓÃÓÚ¾äÖУ¬ÓÈÆäÊÇÓÃÓڽϳ¤µÄ¸´ÔÓ¾ä×ÓÖУ¬ÒÔ×÷ΪÉÏÏÂÎĵÄŦ´ø£»»¹¿ÉÓÃÓÚÎÄÄ©»ò¶ÎÄ©£¬ÓÃÓÚ×ܽáÉÏÎÄ»ò½áÊø±¾¶ÎÄÚÈÝ¡£ÓÐÁËÊʵ±µÄתÕ۴ʺÍÁ¬½Ó´ÊÄÜʹ¾äÓë¾äÖ®¼äÂöÂçÇåÎú¡¢ÌõÀí×ÔÈ»£¬°ïÖú¶ÁÕßÀí½âÂÛÎĵÄ˼·¡£³£¼ûµÄתÕ۴ʺÍÁ¬½Ó´Ê¿ÉÒÔÓÃÀ´±íʾ£º 6&$.E! z  
¨SƽÐлòµÝ½ø¹ØÏµ ia5%  
and; furthermore; W:i Q& [f  
also; in addition(to); F=qILwd  
as well(as); likewise; G=cRdiy`C  
at the same time; moreover; !{-W%=Kf  
besides; similarly; xrg"/?84  
both ¡­ and ¡­ ; still; @6 "MhF  
¨SתÕÛ¹ØÏµ Q Gpj$ _b  
although; otherwise; _x.2&S89  
but; to the opposite; )]fiyXA  
however; while; 2'fd4 rE5  
nevertheless; yet; %r[`HF>  
on the contrary y[i}iT/~  
¨SÄ¿µÄ»òÒò¹û¹ØÏµ .s<0}<Aq>  
as; since; WR #XPbk  
as a result; so; &4OJJ9S  
because(of); so¡­that ¡­; F${s EtH  
consequently; such¡­that¡­; 5,;\z Sz  
due to; therefore; ->I.D?p  
for; thus; b]u=I za  
now that; Y7S1^'E 3  
¨S¾ÙÀý¹ØÏµ nq_$!aB_K  
For example; for another; ZRjM^ d;  
For instance; such as; zYaFbNi  
For one thing; G+=G c(J  
¨S²ã´Î¡¢Ë³Ðò¹ØÏµ ZW;Ec+n_K  
first, second, third, last L!JC)p.  
firstly, secondly, thirdly, finally(²»ÍƼö) &~eCDlX /  
the first, the second, the third, the last UI=v| <'-  
in the first place , in the second place , in the third place ,lastly 2}<tzDI'  
to begin with , then , furthermore, finally 7z$53z  
to start with, next, in addition, finally 7B0`.E^~  
first and foremost, besides, last but not least ;8#6da,  
most important of all, moreover , finally KF&8l/f  
on the one hand, on the other hand(ÊÊÓÃÓÚÁ½µãµÄÇé¿ö) 4j;IyQDvM  
¨S½âÊÍ˵Ã÷¹ØÏµ£º 1o5kP,)  
in other words "#Z e3Uy\  
that is w5q6c%VZ  
¨S¹éÄÉ¡¢×ܽ᣺ ExS&fUn `C  
as a result; on the whole; >W+,(kAS  
briefly; to sum up; HpbwW=;V  
in a word ; in summary; eAO@B  
in brief; collectively; 5[\g87 \  
in short; taken together \Uh/(q7  
ÕýÈ·´îÅäתÕ۴ʺÍÁ¬½Ó´ÊÄÜʹ¾ä×ÓÁ¬¹áÓëÂß¼­ÐÔÇ¿¡£ YeJTB}  
£¨2£©SCIÂÛÎÄÖжÎÂä²¼¾ÖµÄÕûÌåÂß¼­£º¾­³£ÎÒÃÇÒªÐðÊöÒ»¸öÎÊÌâµÄ¼¸¸ö·½Ãæ¡£ÕâÖÖÇé¿öÏ£¬Ò»¶¨Òª×¢Òâ¶ÎÂäÖ®¼äµÄÂß¼­½á¹¹¡£°ÑÄãµÄÏë·¨°´ÕÕÂß¼­Ë³Ðò×éÖ¯£¬»òÕßÖÁÉÙÓ¦°´ÖÈÐòÅÅÁУ¬Ê¹¸÷¶ÎÂäÓлúµØÁ¬½ÓÔÚÒ»Æð¡£ E5gt_,j>  
³ý´ËÖ®Í⣬»¹Òª×¢Òâ¾ä×ÓÖ®¼äÁ¬¹áÓëÂß¼­¡£×ܶøÑÔÖ®£¬ÓúÃתÕ۴ʺÍÁ¬½Ó´ÊÄÜʹ¾ä×ÓÁ¬¹áÓëÂß¼­¡¢ÎÄÕ²ã´ÎÇå³þ¡¢Òâ˼Ã÷È·¡£ 6jMc|he  

kaobook 2011-08-17 22:49
µÚ24ÕÂSCIÂÛÎĵÄд×÷Ô­Ôò uj}%S_9  
1.SCIÂÛÎĵÄд×÷ÓïÑÔ±í´ï×ÜÌåÔ­Ôò @ 0:Eg1-  
£¨1£©ÕýÈ·£¨correctness£©£ºÑ¡ÔñÕýÈ·´Ê»ò´Ê×é¡£ M$v\7vBgO!  
£¨2£©Çå³þ£¨clarity£©£º¿ÆÑ§ÂÛÎĵÄд×÷ÍêÈ«²»Í¬ÓÚÎÄÒÕ×÷Æ·£¬ÒªÇó¾«È·¡¢Çå³þºÍºÁ²»º¬ºý¡£ cgcU2N6y;  
±ÜÃâË×ÓïºÍÄѶ®µÄ»°Ê¾Àý DbI)tDi5D  
¨SAs already state CC6]AM(i  
¨SIt has been found that 9; gy38.3  
¨SIt has long been known that 4M$"0}O;[h  
¨SIt is interesting to note that WYvcN8F  
¨SIt is worth mentioning at this point <@>icDFEHn  
¨SIt may be said that u<\Sf"fs  
¨SIt was demonstrated that $*fEgU% c  
£¨3£©¼ò½à£¨concision£©£ºÎÄ×ÖÒª¼ò½à£¬É¾·±´Ó¼ò¡£ 7CU<R9Kl  
ʾÀý j%S} T)pX  
¡°There is ample evidence indicating that smoking is a risk factor for cancer¡±Ó¦¸Ã¼ò»¯Îª¡°Smoking is a risk factor for cancer¡±¡£ ZV/g_i #  
Óüò½à´Ê¡¢¶Ì¾ä×ÓÀ´±í´ïʾÀý d<_IC7$u>  
¨Sa majority of = most )\e0L/K@  
¨Sat the present time = now 9j5k=IXg#a  
¨Sgive rise to = cause %B>>J%  
¨Sin some cease = sometimes rgv$MnG  
¨Sis defined as = is gE&83i"  
¨Sit is believed that = I think E_xCRfw_i]  
¨Son the basis of = by od/Q"5t[p  
¨Spooled together = pooled *]S&V'Di  
¨Ssubsequent to = after ,7Q b24A  
¨Swith the result that = so that s9b+uUt%  
È¥µô¶àÓàµÄ´Ê£¬ÀýÈç t; #D,gx  
[δÐÞ¸Ä]We plan additional studies in the future in order to confirm previous experiments where replicate determinations consistently showed the pool sizes to essentially increase. =6, w~|W  
[Ð޸ĺó]We plan studies to confirm experiments where replicate determinations showed an increase in pool size. Cm6%wAzC  
[ÔÙÐÞ¸Ä] We plan to confirm the experiments showing an increase in pool size. d-UQc2r  
£¨4£©ÍêÕûÐÔºÍÂß¼­ÐÔ£¨completion and logic£©¡£Ð´ÂÛÎľÍÏñ½²¹ÊÊ£¬²»½öҪעÒâ¾ä×ÓÍêÕû£¬ÂÛÊö¡°¹ÊÊ¡±Ò²ÒªÍêÕû¡£ÌرðҪעÒâÂß¼­ÐÔ±í´ï¡°¹ÊÊ¡±¡£ y $>U[^G[  
(5)Ò»ÖÂÐÔ£¨consistency£©¡£ DvBRK}'  
2.Ìá¸ßÂÛÎÄд×÷ÄÜÁ¦µÄ;¾¶ =W '{xG}  
£¨1£©¶à¶Á¡£Ñ§Ï°ÈκÎÓïÑÔ¶¼ÐèÒª´óÁ¿ÔĶÁ¡£Ñ§Ï°Ó¢ÓïÒ²ÐèÒª´óÁ¿ÔĶÁ¡£Èç¹ûҪ׫д¸ßˮƽÂÛÎÄ£¬Æä¹Ø¼üµÄÊǶÁºÜ¶àÎÄÏס£Õâ¸öµÀÀíºÜ¼òµ¥£¬µ«²»ÉÙѧÕßȴδ±ØÍêÈ«Ã÷°×¡£Ê±Ï£¬ºÜ¶àÈ˶¼ÈÈÖÔÓÚ×öÌâÄ¿£¬ÒÔΪÕâÊÇѧϰӢÓïµÄÕýȷ;¾¶¡£½á¹û×öµÄÁ·Ï°²áÒ»±¾ÓÖÒ»±¾£¬ÊÔÌâ×öÁËÒ»Ì×ÓÖÒ»Ì×£¬×öµÃÍ·»èÑÛ»¨£¬ÐËȤȫÎÞ£¬Ó¢Óïˮƽȴ²¢Ã»ÓÐʵÖÊÐÔÌá¸ß¡£ÔÚÔĶÁʱ£¬ÒªÓÃÓ¢Óï˼¿¼£¬²»±Ø°ÑÓ¢ÎÄ·­Òë³ÉÖÐÎÄ£¬·ñÔò½«´ó´óµØ½µµÍÔĶÁËÙ¶È£¬´Ó¶øÓ°Ïì¶ÔÔĶÁ²ÄÁϵÄÈ«ÃæÀí½â¡£½¨ÒéÈÏÕæµØÑжÁÓ°ÏìÒò×ӸߵĹúÍâÎÄÏ×£¬×îºÃÓ°ÏìÒò×Ó´óÓÚ5ÒÔÉÏ¡£Ðí¶à¿Æ¼¼ÈËÔ±²»ÉÆÓÚ±í´ï×Ô¼ºµÄ¿ÆÑгɹû£¬Ö÷ÒªÊÇÕë¶Ô±¾ÁìÓòÖªÊ¶ÕÆÎյıȽÏÉÙ¡£ÒªÌرðÖØÊÓÂÛÎĵıí´ï£¬Ðû´«×Ô¼º£¨sell yourself£©¡£ÒªËµÃ÷ÂÛÎĵÄÖØÒªÐÔ£¬¾ÍÐèÒª¶à¶ÁÎÄÏס£ KupQtT<  
£¨2£©¶àд¡£¾ÍÊÇÒª×Ô¼º¶¯ÊÖд×÷¡£ÓÉÓÚSCIÂÛÎĵÄд×÷ÎÊÌⲻͬÓÚÆäËüÎÄÕµÄд×÷£¬¸ü²»Í¬ÓÚÎÄÒÕд×÷£¬ËûÔÚд×÷¸ñʽ¡¢±í´ï·½Ê½ºÍÒªÇóÉ϶¼ÓÐ×Ô¼ºµÄÌØµã¡£ I|P#|0< 2  
£¨3£©¶à¸Ä¡£Îĸå³õ¸åÍê³ÉÖ®ºó£¬Òª°´ÕÕSCIÂÛÎĵÄд×÷ÒªÇó·´¸´Ð޸ġ£ ftqeiZ 2  
¨S¿ò¼Ü·½ÃæµÄ·´¸´Ð޸ġ£×öµ½¾«µñϸ×Á¡¢¾«²ÊºÏÀí¡£°üÀ¨£º <`=(Ui$fD  
¡¤ÂÛÎÄÖ÷Ìâ¡¢Â۾ݺÍÂÛÖ¤·½·¨ÊÇ·ñ¿ÆÑ§£» D7,{p2<2T  
¡¤¶ÔÎÄÕµĽṹ¡¢ÓïÑÔÒª×ÐÏ¸ÍÆÇ㬶àÓàµÄÄÚÈݹû¶Ïɾ³ý¡£ Z2{G{]EV(  
¨SÄÚÈÝ·½ÃæµÄÐÞ¸ÄÓëУºË WaDdZIz4  
¡¤ÄÚÈݵÄÔö²¹¡¢É¾³ýºÍµ÷Õû¡£ VL@eR9}9K  
¡¤ÌáÁ¶¡£Ê¹ÎÄÕ´ﵽÎÄ×Ö¼òÁ·£¬ÓôÊ׼ȷ£¬ÄÚÈݾ«´â¡£ 7,D6RP(b  
¡¤Ð£ºË¡£¶ÔԭʼÊý¾Ý£¬ÔËËã¹ý³ÌºÍ×îºó½á¹û£¬¶¼Òª½øÐÐÈÏÕæµÄУºË£¬ÓÈÆäÊǶÔÊýѧʽµÄÍÆµ¼ÒªÈÏÕæÉóºË£¬¿´ÆäÊÇ·ñ´æÔÚ´íÎó¡£ FJ V!B&  
¨SÐÎʽ·½ÃæµÄÐ޸ģº T oK'Pd  
¡¤ÂÛÎĸñʽÊÇ·ñ·ûºÏSCIÆÚ¿¯¹æ¶¨µÄд×÷¸ñʽ¡£ cY%6+uJ1  
¡¤ÓÃ×ÖÊÇ·ñÕýÈ·¡£ 2u^/yl  
¡¤¼ÆÁ¿µ¥Î»ÊÇ·ñ·ûºÏ·¨¶¨¼ÆÁ¿µ¥Î»¡£ sxn^1|O;m  
¡¤±êµã·ûºÅ¼°¸÷ÖÖÈ˹¤ÓïÑÔ·ûºÅµÄʹÓÃÓëÊéдÊÇ·ñÕýÈ·¡¢Çå³þ¡£ 9d >AnTf&H  
3.дSCIÂÛÎÄ»¹Òª¿¼Âǵã 6+_qGV  
£¨1£©ÔÙдSCIÂÛÎÄ֮ǰ£¬Ó¦¸Ã¼ì²éÊÇ·ñ±ðÈËÒѾ­Ð´ÁËÀàËÆµÄÎÄÕ¡£ GPU,.s"&(  
£¨2£©Ë¼Â·µÄ´´ÐÂÐÔ¡£ LLW\1 cxi  
£¨3£©ÂÛÎĵÄÄÚÈÝÒªÕæÊµ¡¢ÕýÈ·¡£ÕâÒ»µãÊǺÜÖØÒªµÄ£¬²»ÅªÐé×÷¼ÙÊÇÁ¼ºÃµÄ¿ÆÑ§µÀµÂ¡£ 5| bc*iqU  
£¨4£©ÎªÊ¹ÎÄÕÂÇå³þ£¬µÚÒ»´ÎÌá³ö¸ÅÄîʱ£¬ÒªÒÔÀ¨ºÅ¸ø³ö½ÏÏêϸµÄ½âÊÍ¡£ 47^R  
£¨5£©ÂÛÎĵÄд·¨Ò»¶¨ÒªÍ»³öÖØµã¡£ Ab)X/g-I @  
£¨6£©ÓÅ»¯Ó¢Óï¡£

kaobook 2011-08-17 22:51
¸½Â¼ ³£ÓüìË÷ÍøÖ· RDWUy (iX  
1.ISIÖ÷Ò³ WX X)_L$2  
http://www.isinet.com l0-zu6i w  
2.Web of Knoeledge C3>`e3v  
http://www.isiwebofknowledge.com %AnqT|\#,  
3.Journal Citation Report "[t b-$ER  
http://scientific.thomson.com/product/jcr (n0h#%  
4.SCIÎÄÏ×¼ìË÷½çÃæ r}Ec_0_lt  
http://isiknowledge.com D*o5fPvFO  
5.EIÖ÷Ò³ qGrUS_~q*  
http://www.ei.org i_M0P12  
6.ElsevierϵÁÐÆÚ¿¯ [+4/ M3J%  
http://www.sciencedirect.com 0` \!O(jJ  
http://elsevier.lib.tsinghua.edu.cn wseb]=U  
http://elsevier.lib.sjtu.edu.cn Q@w=Jt<  
7.IEEE(ÃÀ¹úµçÆøµç×Ó¹¤³ÌʦЭ»á)ÆÚ¿¯ÂÛÎÄ ]mSkjKw  
http://www.ieee.org/web/publications/journmag/index.html jNu`umS  
8.IEEE»áÒéÂÛÎÄ 7;x}W-`iF  
http://www.ieee.org/web/publications/confproc/index.html ^a{cK  
9.ACM(ÃÀ¹ú¼ÆËã»úЭ»á)ÂÛÎÄ $zv&MD!&h  
http://www.acm.org/pubs Cr#Z.  
10.ASME(ÃÀ¹ú»úе¹¤³ÌʦЭ»á)ÆÚ¿¯ÂÛÎÄ \PJpy^i  
http://www.asme.org/Publications/Journals/View_Journals_Online.cfm ?&rt)/DV,  
11.NIH(ÃÀ¹úÈ«¹úÎÀÉúÑо¿Ëù) V4>qR {5  
http://www.nih.gov x}B_;&>&"_  
12.ҽѧË÷Òý 2=V~n)'a  
http://www.pubmed.gov {$fd?| 9h  
13.Academic Press $l+DkR+  
http://www.idealibrary.com ILyI%DA&  
14.kluwer Q$lgC v^M  
http://kluwer.calis.edu.cn Cyu= c1D;  
15.springer D8*t zu-  
http://link.springer-ny.com x?rn< =  
16.Öйú¿ÆÑ§ÔÚÏß w8iXuRv  
http://china.sciencemag.org ,6AnuA  
17.Öйú¿ÆÑ§ÔºÑо¿ËùͼÊé¹ÝÊÕ²Ø $LOwuvu>  
http://www.las.ac.cn/subpage/subframe_detail.jsp?Sub-FrameID=1003 \h48]ZjC`  
PL|zm5923  
ÔÙ´ÎÏòÂÃÃÀ»ªÒáѧÕß½ðÀ¤ÁÖ½ÌÊÚÖÂÒÔ³ç¸ßµÄ¾´Ò⣬¸ÐлËûΪ¹ã´óÖйúѧÕß·¢±íSCIÂÛÎÄËù×÷µÄ·îÏ×£¡ ~`c(7  
+Z=%4  
¾´Àñ£¡ GJTakhj3  

chqu 2011-11-15 21:25
лл·ÖÏí

mengliuhe 2011-11-16 01:55
ºÃÂ鷳Ŷ

xielei0409 2011-11-16 03:09
²»´íµÄÎÄÕ£¡£¡

chqu 2011-11-21 11:08
·Ç³£Ïêϸ£¬Ð»Ð»

haoyl123 2012-01-09 01:35
ѧϰһͨ£¬¸Ð¾õÊǾÞÂé·³µ½¶«¶«

2013Ä꿼²© 2012-05-08 13:47
лл¥Ö÷

2013Ä꿼²© 2012-05-18 18:03
лл¥Ö÷£¬¿¼²©£¬µ¼Ê¦ºÜ¿´ÖÐÎÄÕ£¿

y691935503 2012-05-25 15:14
¶àл

lunwen365 2014-10-06 10:53
SCI£¬Ïë±Ø´ó¼Ò¶¼ÄܱíÏÖ³ö¶úÊìÄÜÏêµÄÑù×Ó£¬ËüÊÇÃÀ¹ú¡¶¿ÆÑ§ÒýÎÄË÷Òý¡·µÄÓ¢Îļò³Æ£¬´´¿¯ÓÚ1961Ä꣬ËüÊǸù¾ÝÏÖ´úÇ鱨ѧ¼Ò¼Ó·Æ¶ûµÂ(Engene Garfield) 19 5 3ÄêÌá³öµÄÒýÎÄ˼Ïë¶ø´´Á¢µÄ¡£ ^VsE2CX  
       SCIÊÇÒ»²¿¹ú¼ÊÐԵļìË÷¿¯Î°üÀ¨ÓУº×ÔÈ»¿ÆÑ§¡¢ÉúÎҽѧ¡¢Å©Òµ¡¢¼¼ÊõºÍÐÐΪ¿ÆÑ§µÈ£¬Ö÷Òª²àÖØ»ù´¡¿ÆÑ§¡£ #'4Psz  
SCIÑ¡ÔñÆÚ¿¯±È½Ï¿ÆÑ§£¬ËüÔËÓÃÒýÎÄÊý¾Ý·ÖÎöºÍͬÐÐÆÀ¹ÀÏà½áºÏµÄ·½·¨£¬³ä·Ö¿¼ÂÇÁËÆÚ¿¯µÄѧÊõ¼ÛÖµ£¬ÔÚÑ¡ÓÃµÄ 3 400ÓàÖÖÆÚ¿¯Àï°üº¬Á˹ú¼ÊÉϽÏÎªÖØÒªµÄÆÚ¿¯¡£ËüËùÔñÈ¡µÄ80ÍòÌõÂÛÎÄ£¬¿ÉÒÔ˵ÊǼ¯¸÷ѧ¿ÆÖ®¾«ÝÍ¡£SCI¼ìË÷ϵͳÀúÀ´³ÉΪÊÀ½çѧÊõ½çÃÜÇÐ×¢ÊÓµÄÖÐÐÄ£¬ÕùÏà½ÇÖðµÄ½¹µã£¬ÊÀ½ç¹«ÈϵÄÎÄÏ×ͳ¼ÆÔ´¡£ zNM*xPgS  
       È»£¬SCI¾ÍÆä±¾Éí¶øÑÔ£¬×îÖØÒªµÄ¹¦ÄÜÊǰïÖú¿Æ¼¼ÈËÔ±»ñÈ¡×îÐèÒªµÄÎÄÏ×ÐÅÏ¢¡£ÕâÒ²ÊDZ༭¸Ã²¿Ë÷ÒýµÄÖ÷ÒªÒâͼ¡£ } 8[  
       SCI×î´óµÄÓŵãÊÇÒýÎŦÄÜ£¬ÔÚÕâÀï¶ÁÕßÄÜºÜ¿ìµØÁ˽⵽ijһ×÷ÕßµÄijƪÂÛÎÄÊÇ·ñ±»ËûÈËÒýÓùý£¬Í¨¹ýÒýÎÄ´ÎÊý¿ÉÒÔÁ˽âijһѧ¿ÆµÄ·¢Õ¹¹ý³Ì¡£Í¬Ê±£¬SCIÒ²¾ßÓз´Ó³¿Æ¼¼ÂÛÎÄÖÊÁ¿ºÍѧÊõˮƽµÄ¹¦ÄÜ¡£ 89UR w9  
>02p,W6S>  
J"K(nKXO_?  
ϲѶ´«À´¹úÄÚÊ×¼ÒÓµÓÐ×Ô¼ºSCI SSCI ¶ÀÁ¢ÔËÓª×ÊÖÊ×Éѯ¹«Ë¾ y*!8[wASHq  
          Ò»¡¢SCI SSCI ´Óҵǰ¾°£º DfX~}km  
ÎÒÃǵÄÓÅÊÆÊÇ ¡¢Ä¿Ç°¹úÄÚÄÜÏñÎÒÃÇÕâÑù²Ù×÷SCI/SSCIÊDZȽÏÉٵģ¬ÎÒÃÇÓÐ×Ô¼ºSCI/SSCIÆÚ¿¯×ÊÔ´ÒÔ¼°ºÍºÜ¶à¹ú¼ÊSCI/SSCIÔÓÖ¾´ï³ÉÕ½ÂÔºÏ×÷µ¥Î»£¬ÌØÆ¸ÇëÁ˹ú¼ÊÖªÃûѧÕßר¼Ò×öѧÊõÖ¸µ¼£¬ÆÀ¹À ¡¢ÈóÉ«¡¢ ÐÞ¸Ä ¡¢ÍƼö·¢±í¡¢¼Û¸ñµÍ¡¢²ã´Î¸ß¡¢ÔÚ¹úÄÚ 211 ¡¢985¡¢´óÖÐרԺУ¿ÆÑÐÔºËù¡¢¼°Ïؼ¶ÒÔÉÏÒ½ÔºÓкܴóµÄÐèÇó¡£¹úÄÚ¸÷´óѧҽԺ¿ÆÑÐÔºËù¶¼°ÑSCI SSCIÆÚ¿¯ÂÛÎÄÁÐΪ×î¸ß¼¶±ðµÄѧÊõ³É¾Í¡£ÕâЩÊÇĿǰ¹ú¼ÊÖ÷Á÷ÆÀ¼Û»úÖÆ¡£ %-<6Z9otc  
ÀýÈç ¹þÒ½´óϵÁе¥Î»¾ùÒªÇó·¢±íSCI¼ìË÷ÂÛÎÄΪְ³ÆÆÀ¶¨µÄÓÐЧÂÛÎÄ¡£Èç¹û·¢±íSCIµÄÓ°ÏìÒò×ÓСÓÚ1£¬Ôò±ØÐëͬʱÓÐÁ½ÆªÒÔÉϱ±´óºËÐÄÂÛÎIJÅÄܲÎÓëÖ°³ÆÆÀ¶¨¡£Èç¹û·¢±íSCIµÄÓ°ÏìÒò×Ó´óÓÚ1£¬Ôòһƪ¼´¿É¡£ÕâÖ»ÊÇÀýÍâ±íÏÖ£¬¹úÄÚÖ÷Á÷ԺУ²»ÏÞÖÆÓ°ÏìÒò×Ó£¬ÓÈÆäÊǶþ±¾ Èý±¾ ְҵԺУ¾Í¸ü²»ÒªÇóÓ°ÏìÒò×ÓÁË£¬ÉõÖÁºÜ¶àµ¥Î»»¹¸ø¸ß¶î½±Àø£¬×÷ÕßÒ»¾ÙÊýµÃ¡£ afE8Kqa:H  
ÀýÈç½­ËÕ»´°²ÊÐÈËÃñÒ½Ôº ·¢±íһƪSCI ҽѧÎÄÕ½±ÀøÎåÍò »¹ÔÚµ±µØ»´°²ÈÕ±¨¿¯µÇÕû°æ±íÑĿǰ¶øÑÔSCI SSCIÔÚ¹úÄÚ»¹ÊǾø¶ÔÊÜ»¶Ó­µÄ¡£ "dHo6CT,y_  
           ¶þ¡¢ ÐÐÒµ¸Å¿ö w\a6ga!xt"  
Ŀǰ£¬¹úÄÚÆÚ¿¯ÖÊÁ¿ÐÐÒµ½ÏÂÒ£¬¼Ù¿¯¡¢ÀÄ¿¯µ½´¦¶¼ÊÇ£¬Õý¹æ¿¯ÎïÒ²¶¼´ò²Á±ßÇò£¬ÒÔÖÂ×·Çó¾­¼ÃÀûÒæ£¬ÂÛÎÄÖÊÁ¿¡¢Ñ§Êõˮƽ ¡¢ÖðÄêϽµ¡¢ºËÐÄÆÚ¿¯ÓÉÓÚ¹ØÏµ¸åÌ«¶à ÖÊÁ¿ÁîÈ˵£ÓÇ£¬¹úÄÚÏÖÔڸ߶ËÖ÷Á÷ԺУ¿ÆÑÐÔºËù ¶¼Ïò¹ú¼Ê¿´Æë Óùú¼Ê¿ÆÑ§±ê×¼£¬Ñ§ÊõÆÀ¼Û»úÖÆÎª×¼ ¡£¹úÄÚ¿¯ÎïÂÒÏó»¹»á³ÖÐø3-5Äê»ò¸ü¶Ì£¬ÓÉÓÚÊܹú¼ÒÕþ²ßÓ°Ïì£¬ËæÊ±¶¼Óм±É²³µÎ£ÏÕ¡£¹ú¼Ê¿¯ÎïSCI SSCI ²»ÊÜÕþ²ßÏÞÖÆÓ°Ïì¡¢²»ÊÜÖ°³Æ ¡¢Ñ§Àú¡¢ ѧλ¡¢¿ÉÒÔÓÀÔ¶³¤ÆÚºÏ×÷¡£ËùÒÔÎÒÃÇץסÆõ»úÓ­ÈжøÉÏ £¬Ç°¾°²»¿ÉÏÞÁ¿ ¡£Í¬Ö¾Ãǹ²Ãã¡£ ujf7r`;u.  
N!./u(b  
p\Fxt1Y@X  
»¶Ó­Ë÷È¡Ïêϸ×ÊÁÏ QQ:1046245582ÓÊÏ䣺wuk223@163.com  18611667875 СÎâ (5 e4>p&+  


²é¿´ÍêÕû°æ±¾: [-- ʲôÊÇSCIÆÚ¿¯ --] [-- top --]


Powered by freekaobo v7.5 SP3 Code ©2003-2010 PHPWind
Gzip enabled

You can contact us